Advertisement

The Influenza Viruses

  • Leslie Hoyle
Chapter
Part of the Virology Monographs Die Virusforschung in Einzeldarstellungen book series (VIROLOGY, volume 4)

Abstract

Virology has developed with such rapidity in recent years that it is increasingly difficult to maintain an adequate knowledge of more than a small part of the science. There is therefore a need for reference works which assess the established knowledge and make some record of past achievement. It is hoped that this work will fulfil this purpose in the case of the influenza viruses. The work is primarily intended for the virologist, and the clinical, pathological and epidemiological aspects of influenza are dealt with only in so far as they relate to the properties of the viruses.

References

  1. A1.
    Ackermann, W. W.: The role of 1-methionine in virus propagation. J. exp. Med. 93, 337–343 (1951).PubMedCentralPubMedGoogle Scholar
  2. A2.
    Ackermann, W. W.: Concerning the relation of the Krebs cycle to virus synthesis. J. biol. Chem. 189, 421–428 (1951).PubMedGoogle Scholar
  3. A3.
    Ackermann, W. W.: The relation of the Krebs cycle to virus synthesis. 2. The effect of sodium fluoroacetate on the propagation of influenza virus in mice. J. exp. Med. 93, 635–642 (1951).PubMedCentralPubMedGoogle Scholar
  4. A4.
    Ackermann, W. W.: α-aminosulphonic acids and viral propagation. Proc. Soc. exp. Biol. (N.Y.) 80, 362–367 (1952).Google Scholar
  5. A5.
    Ackermann, W. W.: Mechanisms of persistent and masked infections in tissue cultures. Ann. N.Y. Acad. Sci. 67, 392–402 (1957).PubMedGoogle Scholar
  6. A6.
    Ackermann, W. W.: Cellular aspects of the cell-virus relationship. Bact. Rev. 22, 223–239 (1958).PubMedGoogle Scholar
  7. A7.
    Ackermann, W. W.: Biochemical studies of virus-infected cells. Ann. N.Y. Acad. Sci. 81, 188–192 (1959).PubMedGoogle Scholar
  8. A8.
    Ackermann, W. W.: Comparative study of the reactive surfaces of polyoma and influenza viruses. Ext. Acta Un. int. Cancer 19 (1963).Google Scholar
  9. A9.
    Ackermann, W. W., and S. Dinka: Concerning the nature of the viral neutralising activity of bovine serum. Acta virol. 9, 526–533 (1965).PubMedGoogle Scholar
  10. A10.
    Ackermann, W. W., N. Ishida, and H. F. Maassab: Growth characteristics of influenza virus concerning the binding of virus by host cells. J. exp. Med. 102, 545–554 (1955).PubMedCentralPubMedGoogle Scholar
  11. A11.
    Ackermann, W. W., and R. B. Johnson: Some energy relations in a host-virus system. J. exp. Med. 97, 315–322 (1953).PubMedCentralPubMedGoogle Scholar
  12. A12.
    Ackermann, W. W., and H. Kurtz: A new host-virus system. Proc. Soc. exp. Biol. (N.Y.) 81, 421–423 (1952).Google Scholar
  13. A13.
    Ackermann, W. W., and P. C. Loh: Chemistry of viral infected cells. Ann. N.Y. Acad. Sci. 88, 1298–1307 (1960).PubMedGoogle Scholar
  14. A14.
    Ackermann, W. W., and H. F. Maassab: Growth characteristics of influenza virus: The influence of a sulphonic acid. J. exp. Med. 99, 105–117 (1954).PubMedCentralPubMedGoogle Scholar
  15. A15.
    Ackermann, W. W., and H. F. Maassab: Growth characteristics of influenza virus. Biochemical differentiation of stages of development. J. exp. Med. 100, 329–339 (1954).PubMedCentralPubMedGoogle Scholar
  16. A16.
    Ackermann, W. W., and H. F. Maassab: Growth characteristics of influenza virus. Biochemical differentiation of stages of development. 2. J. exp. Med. 102, 393–402 (1955).PubMedCentralPubMedGoogle Scholar
  17. A17.
    Ada, G. L.: Ribonucleic acid in influenza virus. Ciba Found. Symp. “The nature of viruses” 104-122 (1957).Google Scholar
  18. A18.
    Ada, G. L., M. Donnelley, and J. Pye: Studies on the complement fixing antigen of influenza virus. 1. Purification of antigen. Aust. J. exp. Biol. med. Sci. 30, 301–311 (1952).PubMedGoogle Scholar
  19. A19.
    Ada, G. L., and A. Gottschalk: The component sugars of the influenza virus particle. Biochem. J. 62, 686–689 (1956).PubMedGoogle Scholar
  20. A20.
    Ada, G. L., and P. E. Lind: Neuraminidase in the chorioallantois of the chick embryo. Nature (Lond.) 190, 1169–1171 (1961).Google Scholar
  21. A21.
    Ada, G. L., P. E. Lind, L. Larkin, and F. M. Burnet: Failure to recover infective ribonucleic acid from myxovirus preparations. Nature (Lond.) 184, 360–361 (1959).Google Scholar
  22. A22.
    Ada, Gr. L., P. E. Lind, and W. G. Laver: An immunological study of avian, viral, and bacterial neuraminidase based on specific inhibition of enzyme by antibody. J. gen. Microbiol. 32, 225–232 (1963).PubMedGoogle Scholar
  23. A23.
    Ada, G. L., and B. T. Perry: Studies on the soluble complement fixing antigens of influenza virus. 3. The nature of the antigens. Aust. J. exp. Biol. med. Sci. 32, 177–185 (1954).PubMedGoogle Scholar
  24. A24.
    Ada, G. L., and B. T. Perry: The nucleic acid content of influenza virus. Aust. J. exp. Biol. med. Sci. 32, 453 (1954).PubMedGoogle Scholar
  25. A25.
    Ada, G. L., and B. T. Perry: Infectivity and nucleic acid content of influenza virus. Nature (Lond.) 175, 209–210 (1955).Google Scholar
  26. A26.
    Ada, G. L., and B. T. Perry: Specific differences in the nucleic acids from A and B strains of influenza virus. Nature (Lond.) 175, 854 (1955).Google Scholar
  27. A27.
    Ada, G. L., and B. T. Perry: Influenza virus nucleic acid: Relationship between biological characters of the virus particle and properties of the nucleic acid. J. gen. Microbiol. 14, 623–633 (1956).PubMedGoogle Scholar
  28. A28.
    Ada, G. L., and B. T. Perry: Properties of the nucleic acid of the Eyan strain of filamentous influenza virus. J. gen. Microbiol. 19, 40–54 (1958).PubMedGoogle Scholar
  29. A29.
    Ada, G. L., B. T. Perry, and A. Abbot: Biological and physical properties of the Eyan strain of filamentous influenza virus. J. gen. Microbiol. 19, 23–39 (1958).PubMedGoogle Scholar
  30. A30.
    Ada, G. L., B. T. Perry, and M. Edney: Infectivity of influenza virus filaments. Nature (Lond.) 180, 1134 (1957).Google Scholar
  31. A31.
    Ada, G. L., B. T. Perry, and J. Pye: Studies on the soluble complement fixing antigen of influenza viruses. 2. Serological behaviour of the antigen. Aust. J. exp. Biol. med. Sci. 31, 391–403 (1953).PubMedGoogle Scholar
  32. A32.
    Ada, G. L., and J. D. Stone: Effect of haemagglutinating viruses on the electrophoretic mobility of human erythrocytes. Nature (Lond.) 165, 189–190 (1950).Google Scholar
  33. A33.
    Ada, G. L., and J. D. Stone: Electrophoretic studies of virus-red cell interaction: Mobility gradient of cells treated with influenza viruses and the receptor destroying enzyme of V. cholerae. Brit. J. exp. Path. 31, 263–274 (1950).PubMedGoogle Scholar
  34. A34.
    Addamiano, L., B. Babudieri, and C. Moscovici: Morphological forms of the influenza virus (Italian). R.C. Ist. sup. Sanità 19, 161–167 (1956).Google Scholar
  35. A35.
    Ado, A. D., and T. M. Alekseyeva: On the toxic effect of influenza virus on the sympathetic nervous system. Acta virol. 1, 161–166 (1957).PubMedGoogle Scholar
  36. A36.
    Ado, A. D., T. A. Alekseyeva, A. Kh. Kanchurin, and S. M. Titova: Problems of the pathogenesis of influenza in the light of pathophysiological investigations (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSK, Moscow (1959).Google Scholar
  37. A37.
    Ado, A. D., and S. M. Titova: A study of influenza in dogs. Probl. Virol. (N.Y.) 4, 36–41 (1959).Google Scholar
  38. A38.
    Agapov, S. I.: The pathogenic properties of swine and human influenza viruses (Russian). Zh. Mikrobiol. (Mosk.) 17, 543 (1935).Google Scholar
  39. A39.
    Ahsbel, S. I., N. G. Stolpetskaya, and V. G. Sokolova: Experience in the treatment of virus influenza and the chemoprophylaxis of this disease under industrial conditions (Russian). Sovetsk. Med. 3, 22–23 (1954).Google Scholar
  40. A40.
    Akao, Y., T. Matsui, E. Sano, H. Shimojo, A. Sugiura, and C. Enomoto: Bull. Inst. publ. Hlth Tokyo 9, 27–34 (1960).Google Scholar
  41. A41.
    Albaladejo, J., and G. Berenguer: The pH reaction and its value for the diagnosis of the phases of influenza virus (Spanish). Microbiol. esp. 11, 119–133 (1958).PubMedGoogle Scholar
  42. A42.
    Albrecht, P., O. Krizanova, and J. Szanto: Location of influenza virus haemagglutination inhibitor demonstrated in chick embryo cells by fluorescent antibodies. Acta virol. 5, 232–235 (1961).PubMedGoogle Scholar
  43. A43.
    Alekperov, M. A.: Functional state of adrenal cortex in influenza (Russian). Sovetsk. Med. 23, 70–73 (1959).Google Scholar
  44. A44.
    Aleksandrova, G. I.: Comparative characteristics of A2 influenza virus strains isolated in the epidemics of 1957 and 1959 (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii”. Tez. Dokl. nauch Sess. Inst. AMN SSSE Moscow 20-21 (1959).Google Scholar
  45. A45.
    Aleksandrova, G. I.: Reactogenic and immunogenic properties and epidemiological effectivity of additionally attenuated vaccine strains of influenza virus (Russian). Vop. Virus 1, 67–73 (1965).Google Scholar
  46. A46.
    Aleksandrova, G. I., and A.A. Smorodintsev: Obtaining of an additionally attenuated vaccinating cryophil influenza strain. Rev. Roumaine Intramicrobiol 2, 179–186 (1965).Google Scholar
  47. A47.
    Alekseeva, T. E., A. I. Mel’nikova, M. A. Nogicheva, and A. S. Shadrin: A study of the anti-influenza antibody content in different epidemic periods in the sera of blood donors, placental sera, and in gamma globulins (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSE, Moscow 159-160 (1959).Google Scholar
  48. A48.
    Alford, R. H., J. A. Kasel, P. J. Gerone, and V. Knight: Human influenza resulting from aerosol inhalation. Proc. Soc. exp. Biol. (N.Y.) 122, 800–804 (1966).Google Scholar
  49. A49.
    Allen, R., R. A. Finkelstein, and S. E. Sulkin: Viral inhibitors in normal animal sera. Tex. Eep. Biol. Med. 16, 391–421 (1958).Google Scholar
  50. A50.
    Allison, A. C.: Observations on the inactivation of viruses by sulphydryl reagents. Virology 17, 176–183 (1962).PubMedGoogle Scholar
  51. A51.
    Allison, A. C., F. E. Buckland, and C. H. Andrewes: Effects of sulphydryl reagents on infectivity of some viruses. Virology 17, 171–175 (1962).PubMedGoogle Scholar
  52. A52.
    Almeida, J. D., and A. P. Waterson: Some observations on the envelope of an influenza virus. J. gen. Microbiol. 46, 107–110 (1967).PubMedGoogle Scholar
  53. A53.
    Altucci, P., F. Coraggio, G. Margherita, and C Galeota: The multiplication of influenza virus A (PR8) in chorioallantoic tissue culture (Italian). Riv. Ist. sieroter. ital. 30, 90–110 (1961).Google Scholar
  54. A54.
    Amelunxen, R. E., and A. A. Werder: Quantitative considerations of influenza virus neutralisation. 1. Number of antibody molecules per virus particle. J. Bact. 80, 271–277 (1960).PubMedGoogle Scholar
  55. A65.
    American Institute of Biological Sciences. “An annotated bibliography of influenza”. Waverly Press, Baltimore 1957-1960.Google Scholar
  56. A56.
    Aminoff, D.: Methods for the quantitative estimation of N-acetyl-neuraminic acid and their application to hydrolysates of sialomucoids. Biochem. J. 81, 384–392 (1961).PubMedGoogle Scholar
  57. A57.
    Amos, H., and E. Vollmayer: Inhibition of influenza virus synthesis by 2-thiouracil. Virology 6, 337–347 (1955).Google Scholar
  58. A58.
    Ananthanarayan, R.: The fabric of virus elementary bodies. Brit. J. exp. Path. 35, 381–388 (1954).PubMedGoogle Scholar
  59. A59.
    Ananthanarayan, E., and C. K. J. Paniker: Non-specific inhibitors of influenza viruses in normal sera. Bull. Wld Hlth Org. 22, 409–419 (1960).Google Scholar
  60. A60.
    Anderson, S. G.: The breadth of antibody response following influenza A infection. Aust. J. exp. Biol. med. Sci. 25, 243–246 (1947).PubMedGoogle Scholar
  61. A61.
    Anderson, S. G.: Mucins and mucoids in relation to influenza virus action. 1. Inactivation by R.D.E. and by viruses of the influenza group of the serum inhibitor of haemagglutination. Aust. J. exp. Biol. med. Sci. 26, 347–354 (1948).PubMedGoogle Scholar
  62. A62.
    Anderson, S. G., and F. M. Burnet: Sporadic and minor epidemic incidence of influenza A in Victoria 1945–46. 1. Phase behaviour of influenza A strains in relation to epidemic characteristics. Aust. J. exp. Biol. med. Sci. 25, 235–242 (1947).PubMedGoogle Scholar
  63. A63.
    Anderson, S. G., F. M. Burnet, S. Fazekas de St Groth, J. F. McCrea, and J. D. Stone: Mucins and mucoids in relation to influenza virus action. 6. General discussion. Aust. J. exp. Biol. med. Sci. 26, 403–411 (1948).PubMedGoogle Scholar
  64. A64.
    Anderson, S. G., F. M. Burnet, and J.D. Stone: A modified Salk test for in vitro titration of influenza antibodies. Aust. J. exp. Biol. med. Sci. 24, 269–275 (1946).PubMedGoogle Scholar
  65. A65.
    Andrewes, C. H.: Interference by one virus with the growth of another in tissue culture. Brit. J. exp. Path. 23, 214–220 (1942).Google Scholar
  66. A66.
    Andrewes, C.H.: Adventures among viruses. 1. Some properties of viruses. A67 2. Epidemic influenza. New Engl. J. Med. 242, 161–166 and 197-203 (1950).PubMedGoogle Scholar
  67. A68.
    Andrewes, C. H.: Epidemiology of influenza in the light of the 1951 outbreak. Proc. roy. Soc. Med. 44, 803–804 (1951).PubMedGoogle Scholar
  68. A69.
    Andrewes, C. H.: The place of viruses in Nature. Proc. roy. Soc. Med. 139, 313–326 (1952).Google Scholar
  69. A70.
    Andrewes, C. H.: Prospects for prevention of influenza. Trans. Coll. Phycns. Philad. June, 20 (1952).Google Scholar
  70. A71.
    Andrewes, C. H.: Epidemiology of influenza. Bull. Wld Hlth Org. 8, 595–612 (1953).Google Scholar
  71. A72.
    Andrewes, C. H.: Influenza: Theme and variations. Calif. Med. 84, 375–380 (1956).PubMedCentralPubMedGoogle Scholar
  72. A73.
    Andrewes, C. H., F. B. Bang, and F. M. Burnet: A short description of the myxovirus group (influenza and related viruses). Virology 1, 176–184 (1955).PubMedGoogle Scholar
  73. A74.
    Andrewes, C. H., and R. E. Glover: Spread of infection from the respiratory tract of the ferret. 1. Transmission of influenza A virus. Brit. J. exp. Path. 22, 91–97 (1941).Google Scholar
  74. A75.
    Andrewes, C. H., R. E. Glover, F. Himmelweit, and W. Smith: Influenza virus as a laboratory contaminant. Brit. J. exp. Path. 25, 130–134 (1944).Google Scholar
  75. A76.
    Andrewes, C. H., and D. M. Horstmann: The susceptibility of viruses to ethyl ether. J. gen. Microbiol. 3, 290–297 (1949).PubMedGoogle Scholar
  76. A77.
    Andrewes, C. H., and A. Isaacs: Antigenic variation among influenza viruses in relation to the production use and standardisation of vaccines. Proc. 3rd int. Meet. Biol. Stand. Opatija 73-75 (1957).Google Scholar
  77. A78.
    Andrewes, C. H., A. Isaacs, and B. P. Marmion: Neutralising action of human nasal secretions on neurotropic influenza virus. Brit. J. exp. Path. 35, 264–269 (1954).PubMedGoogle Scholar
  78. A79.
    Andrewes, C. H., H. King, and M. Van den Ende: Chemotherapeutic experiments with the viruses of influenza A, lymphogranuloma venereum and vaccinia. J. Path. Bact. 55, 173–181 (1943).Google Scholar
  79. A80.
    Andrewes, C. H., P. P. Laidlaw, and W. Smith: The susceptibility of mice to the viruses of human and swine influenza. Lancet 859-862 (1934).Google Scholar
  80. A81.
    Andrewes, C. H., and W. Smith: Influenza: Further experiments on the active immunisation of mice. Brit. J. exp. Path. 18, 43 (1937).Google Scholar
  81. A82.
    Andrewes, C. H., and W. Smith: The effect of foreign tissue extracts on the efficacy of influenza virus vaccines. Brit. J. exp. Path. 20, 305–315 (1939).Google Scholar
  82. A83.
    Andrewes, C. H., and G. Worthington: Some new or little known respiratory viruses. Bull. Wld Hlth Org. 20, 435–443 (1959).Google Scholar
  83. A84.
    Andrews, B. E., A. S. Beare, J. C. McDonald, A. J. Zuckermann, and D. A. J. Tyrrell: Further trials of live influenza vaccine. Brit. med. J. 637-640 (1966).Google Scholar
  84. A85.
    Angela, G. C., and G. Giuliani: The antiviral activity of an analogue of sialic acid (Simo). Action on the influenza virus. Panminerva med. 4, 187–189 (1962).PubMedGoogle Scholar
  85. A86.
    Angulo, J. J.: On the identity of the so-called filamentous forms of influenza and fowl pest viruses. Arch. ges. Virusforsch. 4, 199–206 (1951).PubMedGoogle Scholar
  86. A87.
    Ansheles, I. M.: Material for the epidemiological characterisation of the winter outbreak of influenza in Leningrad 1943/44 (Russian). Rabot. Leningrad vrach. v. god. Otech. voyny Leningrad 6, 36 (1945).Google Scholar
  87. A88.
    Ansheles, I. M.: Material on the epidemiology and specific prophylaxis of influenza Type A (Russian). “Virusnyye infektsii.” Tr. Inst. epidemiol. mikrobiol. i gig imeni Pasteria i Inst. eksper. med. AMN SSSR Leningrad 142-160 (1953).Google Scholar
  88. A89.
    Ansheles, I. M., E. A. Fridman, T. A. Klushina, E. S. Stenina, L. B. Khazenson, and E. F. Tarasova: The influenza pandemic in 1957. Some epidemiological and virological features of influenza in Leningrad (Russian). Vop. Virus 4, 38–43 (1959).PubMedGoogle Scholar
  89. A90.
    Ansheles, I. M., N. N. Romanenko, N. S. Klyuchereva, and Z. N. Danilova: Experience in the study of immunisation against influenza in Leningrad in 1952–53 (Russian). Zh. Mikrobiol. (Mosk.) 10, 63 (1953).Google Scholar
  90. A91.
    Apostolov, K., and T. H. Flewett: Internal structure of influenza virus. Virology 26, 506–508 (1965).PubMedGoogle Scholar
  91. A92.
    Appleby, J. C.: The isolation and properties of a modified strain of neurotropic influenza A virus. Brit. J. exp. Path. 33, 280–287 (1952).PubMedGoogle Scholar
  92. A93.
    Appleby, J. C., and C. H. Stuart-Harris: The use of filtrates of vibrio Cholerae in the classification of influenza virus strains. Brit. J. exp. Path. 31, 797–805 (1950).PubMedGoogle Scholar
  93. A94.
    Archetti, I.: Laboratory trial of vaccination against influenza (Italian). Ext. R.C. It. sup. Sanità 17, 991–998 (1954).Google Scholar
  94. A95.
    Archetti, I.: Appearances associated with filamentous forms of influenza viruses. Arch. ges. Virusforsch. 6, 29–35 (1955).PubMedGoogle Scholar
  95. A96.
    Archetti, I.: Further studies on antigenic variation of influenza A virus. Proc. Soc. exp. Biol. (N.Y.) 80, 212–214 (1952).Google Scholar
  96. A97.
    Archetti, I., and D. S. Bocciarelli: On the structure of filamentous forms of influenza virus. Arch. ges. Virusforsch. 11, 599–606 (1961).Google Scholar
  97. A98.
    Archetti, I., and D. S. Bocciarelli: Contribution to the study of the structure of influenza virus (Italian). Ext. R.C. Ist. sup. Sanità 24, 546–552 (1961).Google Scholar
  98. A99.
    Archetti, I., and F. L. Horsfall: Persistent antigenic variation of influenza A viruses after incomplete neutralisation in ovo with heterologous immune serum. J. exp. Med. 92, 441–462 (1950).PubMedCentralPubMedGoogle Scholar
  99. A100.
    Archetti, I., A. Jemolo, and D. S. Bocciarelli: On the fine structure of influenza viruses. Arch. ges. Virusforsch. 20, 133–136 (1967).PubMedGoogle Scholar
  100. A101.
    Ari, A. B.: Attempt at rapid isolation of influenza virus from throat washings collected from patients during the 1952–53 influenza epidemic by inoculation of embryonated eggs with concentrated viruses on red blood cells. Türk Ij. tecr. Biyol. Derg. 15, 226–230 (1955).Google Scholar
  101. A102.
    Arkhangelsky, D. C., U. I. Savchenko, and Kh. Dj. Zhumatov: Cytomorphology and cytochemistry of experimental RNA influenza infection. Abstr. 9th int. Congr. Microbiol. Moscow 391 (1966).Google Scholar
  102. A103.
    Arya, S. C.: Haemadsorption followed by fluorochrome staining. Brit. med. J. 98-100 (1963).Google Scholar
  103. A104.
    Atkins, E., and W. C. Huang: Studies on the pathogenesis of fever with influenzal viruses. 1. The appearance of an endogenous pyrogen in the blood following intravenous injection of virus.Google Scholar
  104. A105.
    2. The effect of endogenous pyrogen in normal and virus-tolerant recipients.Google Scholar
  105. A106.
    3. The relation of tolerance to the production of endogenous pyrogen. J. exp. Med. 107, 383-401, 403-414, 415-435 (1958).Google Scholar
  106. A107.
    Avetisian, V. A.: Data on the etiology of influenza in Erivan and on some properties of strains isolated in 1958 and 1959 (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSR Moscow 33-34 (1959).Google Scholar
  107. A108.
    Azadova, N. B.: Synthesis of structural proteins of myxoviruses. Abstr. 9th int. Congr. Microbiol. Moscow 498-499 (1966).Google Scholar
  108. B1.
    Badinsky, G., and I. Bruckner: Contribution to the study of filtrable viruses. Attempts to cultivate the viruses of human influenza, climatic bubo, and Aujeszky’s disease on the chorioallantoic membrane of chick embryos (French). Arch. roum. Path. exp. 10, 341–368 (1937).Google Scholar
  109. B2.
    Bang, F. B.: Synergistic action of Haemophilus Influenzae Suis and the swine influenza virus on the chick embryo. J. exp. Med. 77, 7–20 (1943).PubMedCentralPubMedGoogle Scholar
  110. B3.
    Bang, F. B., and A. Isaacs: Morphological aspects of virus cell relationships in influenza, mumps and Newcastle (myxovirus). Ciba Found. Symp. “The nature of viruses” 249-262 (1957).Google Scholar
  111. B4.
    Bankowski, R. A., and T. Mikami: An apparently new respiratory disease of turkeys. Proc. 68th Ann. Meet U.S. Livestock Sanit. Ass. 495-517 (1965).Google Scholar
  112. B5.
    Barb, K., G. J. Koteler, F. Antoni, and Gr. Takatsi: Studies on the nucleic acid metabolism of chorioallantoic membrane cells after influenza virus infection. Acta microbiol. Acad. Sci. hung. 11, 185–192 (1964).PubMedGoogle Scholar
  113. B6.
    Baron, S., and K. E. Jensen: Evidence for genetic interaction between noninfectious and infectious influenza A viruses. J. exp. Med. 102, 677–697 (1955).PubMedCentralPubMedGoogle Scholar
  114. B7.
    Baroyan, O. V.: Basic epidemiological characteristics of influenza after the 1957 pandemic (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. Dokl. nauch Sess. AMN SSSR Moscow 74-76 (1959).Google Scholar
  115. B8.
    Baroyan, O. V., and V. G. Slepushkin: Evaluation of a live monovalent anti-influenza vaccine (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. Dokl. nauch Sess. AMN SSSR Moscow 119-121 (1959).Google Scholar
  116. B9.
    Barry, R. D.: Equilibrium sedimentation of influenza virus in caesium chloride density gradients. Aust. J. exp. Biol. med. Sci. 38, 499–507 (1960).PubMedGoogle Scholar
  117. B10.
    Barry, R. D.: The multiplication of influenza virus. 1. The formation of incomplete virus. Virology 14, 389–397 (1961).PubMedGoogle Scholar
  118. B11.
    Barry, R. D.: The multiplication of influenza virus. 2. Multiplicity reactivation of ultraviolet irradiated virus. Virology 14, 398–405 (1961).PubMedGoogle Scholar
  119. B12.
    Barry, R. D.: The multiplication of influenza virus. 3. Heterologous interference. Virology 14, 406–409 (1961).PubMedGoogle Scholar
  120. B13.
    Barry, R. D.: Effects of inhibitors of nucleic acid synthesis on the production of myxoviruses. Ciba Found. Symp. “Cellular Biology of Myxovirus infections” 51-75 (1964).Google Scholar
  121. B14.
    Barry, R. D., D. R. Ives, and J. G. Cruikshank: Participation of deoxyribonucleic acid in the multiplication of influenza virus. Nature (Lond.) 194, 1139–1140 (1962).Google Scholar
  122. B15.
    Bartolomei-Corsi, O.: Eelations between A2 influenza virus and non-specific inhibitors (Italian). Sperimentale 109, 549–572 (1959).PubMedGoogle Scholar
  123. B16.
    Barua, D., and B. Fauconnier: Non enzymatic elution of influenza virus (French). Ann. Inst. Pasteur 97, 479–496 (1959).Google Scholar
  124. B17.
    Barykin, V., Z. Shaklmaliteva, and Ye. Bauer: Cultivation of the influenza virus (Russian). Zh. Mikrobiol. (Mosk.) 17, 548 (1936).Google Scholar
  125. B18.
    Bateman, J. B., M. S. Davis, and P. A. McCaffrey: Influence of influenza haemagglutinin on haemolysis rates. Proc. Soc. exp. Biol. (N.Y.) 80, 720–722 (1952).Google Scholar
  126. B19.
    Bateman, J. B., M. S. Davis, and P. A. McCaffrey: Eate of reaction of red blood cells with influenza virus haemagglutinin. Amer. J. Hyg. 62, 342–348 (1955).PubMedGoogle Scholar
  127. B20.
    Bateman, J. B., M. S. Davis, and P. A. McCaffrey: A note on the reaction of heated influenza virus protein with red blood cells. Amer. J. Hyg. 62, 349–354 (1955).PubMedGoogle Scholar
  128. B21.
    Bateman, J. B., A. Zellner, M. S. Davis, and P. A. McCaffrey: The electrophoretic properties of red blood cells after reaction with influenza virus haemagglutinin. Arch. Biochem. 60, 384–391 (1956).PubMedGoogle Scholar
  129. B22.
    Bauer, D. J.: Multiplication of the animal viruses. Nature (Lond.) 164, 767 (1949).Google Scholar
  130. B23.
    Bauer, D. J.: Possible correlation between virus particle size and activity of antiviral agents. Nature (Lond.) 209, 639–640 (1966).Google Scholar
  131. B24.
    Bayandina, S. A., A. K. Svetlova, and V. V. Eitova: Clinical peculiarities of the course of influenza A2 in infants (Russian). Pediatriya 36, 38–43 (1958).Google Scholar
  132. B25.
    Baydakova, Z. L., and L. A. Zil’ber: Adaptive variability of influenza virus (Russian). Zh. Mikrobiol. (Mosk.) 12, 86 (1948).Google Scholar
  133. B26.
    Baydakova, Z. L., and L. A. Zil’ber: Influenza virus variability (Russian). Vop. Virus. 2, 204 (1949).Google Scholar
  134. B27.
    Bayer, M. E., and E. Mannweiler: Antigen antibody reactions of influenza virus as seen in the electron microscope. Arch. ges. Virusforsch. 13, 541–547 (1963).PubMedGoogle Scholar
  135. B28.
    Beale, A. J.: A comparison of the soluble antigen production by tissues infected with preparations of extracellular and intracellular influenza virus. J. Hyg. (Lond.) 52, 225–229 (1954).Google Scholar
  136. B29.
    Beale, A. J., and N. B. Finter: The infectivity of chorioallantoic membrane influenza virus and incomplete influenza virus by the six hour soluble antigen production test. J. Hyg. (Lond.) 54, 68–78 (1956).Google Scholar
  137. B30.
    Beard, J. W., D. G. Sharp, A. R. Taylor, I. W. McLean, D. Beard, E. Feller, and J. H. Dingle: Ultracentrifugal, chemical, and electron microscopic identification of the influenza virus. Sth. med. J. 37, 313–320 (1944).Google Scholar
  138. B31.
    Becker, W. B.: Electron microscopy of Tern virus. S. Afr. J. Lab. clin. Med. 8, 163–164 (1962).Google Scholar
  139. B32.
    Becker, W. B.: The morphology of Tern virus. Virology 20, 318–327 (1963).PubMedGoogle Scholar
  140. B33.
    Becker, W. B.: The isolation and classification of Tern virus. Influenza virus A/Tern/South Africa/1961. J. Hyg. (Lond.) 64, 309–320 (1966).Google Scholar
  141. B34.
    Becker, W. B.: Experimental infection of common terns with Tern virus. J. Hygiene (Lond.) 65, 61–65 (1967).Google Scholar
  142. B35.
    Becker, W. B., C. Dauguet, and F. Delahaye: Electron morphology of Tern virus. Enantiomorphic nucleocapsid (French). Ann. Inst. Pasteur 106, 575–580 (1964).Google Scholar
  143. B36.
    Bedson, S. P.: The mode of virus multiplication and the susceptibility of these agents to the antibiotics. J. clin. Path. 9, 83–93 (1956).PubMedGoogle Scholar
  144. B37.
    Belikov, P. F.: Complement fixation reaction as an index of immunity in influenza (Russian). Arkh. biol. nauk. 59, 44 (1940).Google Scholar
  145. B38.
    Belyavin, Gr.: Influenza complement fixation. A simple quantitative micro method. J. Hyg. (Lond.) 51, 492–501 (1953).Google Scholar
  146. B39.
    Belyavin, G.: The direct flocculation of influenza virus. Lancet, 698-701 (1955).Google Scholar
  147. B40.
    Belyavin, G.: Normal serum inhibitors of influenza virus flocculation. Brit. J. exp. Path. 37, 75–80 (1956).PubMedGoogle Scholar
  148. B41.
    Belyavin, G.: The influenza virus flocculation reaction as a method of antigenic typing. J. Hyg. (Lond.) 55, 281–289 (1957).Google Scholar
  149. B42.
    Belyavin, G., and A. Cohen: Chromatography of influenza virus haemagglutination inhibitors. Virology 18, 144–145 (1962).PubMedGoogle Scholar
  150. B43.
    Bennet, I. L., and R. R. Wagner: Production of fever by influenza viruses. 5. Effect of nitrogen mustard HN2. Bull. Johns Hopk. Hosp. 97, 43–46 (1955).Google Scholar
  151. B44.
    Bennet, I. L., R. R. Wagner, and V. S. LeQuire: The production of fever by influenza viruses. 2. Tolerance in rabbits to the pyrogenic effect of influenza viruses. J. exp. Med. 90, 335–347 (1949).Google Scholar
  152. B45.
    Berganini, L., and O. Bartolomei-Corsi: Activity of a bacterial mucinase on some inhibitors of influenza virus haemagglutination (Italian). Sperimentale 106, 76–87 (1956).Google Scholar
  153. B46.
    Berlin, B. S.: Gross physical properties of emulsified influenza virus vaccines and the adjuvant response. J. Immunol. 85, 81–89 (1960).PubMedGoogle Scholar
  154. B47.
    Berlin, B. S.: Antibody responses induced by aqueous and emulsified influenza virus vaccines in mice exposed daily to X rays. J. Immunol. 89, 906–909 (1962).PubMedGoogle Scholar
  155. B48.
    Berlin, B. S.: Antibody responses after injection of aqueous and emulsified influenza virus vaccines in mice chronically exposed to gamma rays. Radiation Res. 18, 223–230 (1963).PubMedGoogle Scholar
  156. B49.
    Berlin, B. S.: The nature of antibodies in mice injected with influenza virus vaccine. Proc. Soc. exp. Biol. (N.Y.) 113, 1013–1016 (1963).Google Scholar
  157. B50.
    Berlin, B. S.: Interruption of macroglobulin synthesis in mice by exposure to X rays. J. Immunol. 93, 315–318 (1964).PubMedGoogle Scholar
  158. B51.
    Berlin, B. S.: Sparing effect of X rays for mice inoculated intranasally with egg-adapted influenza virus, CAM strain. Proc. Soc. exp. Biol. (N.Y.) 117, 864–869 (1964).Google Scholar
  159. B52.
    Berlin, B. S.: Eadiosensitivity of YM antibody response in mice injected with killed influenza virus. Radiation Res. 26, 554–566 (1965).PubMedGoogle Scholar
  160. B53.
    Berlin, B. S.: Early antibody responses of mice given a single injection of emulsified influenza virus vaccine. J. Immunol. 96, 424–429 (1966).PubMedGoogle Scholar
  161. B54.
    Berlyant, M. L., and F. G. Epshteyn: Some material on influenza therapy (Russian). Vo.-med. Zh. 12, 74–75 (1953).Google Scholar
  162. B55.
    Berlyant, M. L., and N. N. Orlova: Epidemiological observations in influenza (Russian). Vo.-med. Zh. 4, 79 (1951).Google Scholar
  163. B56.
    Bernkopf, H.: Differences in haemagglutination by strains of influenza virus in the presence of egg white and normal serum. Proc. Soc. exp. Biol. (N.Y.) 71, 160–163 (1949).Google Scholar
  164. B57.
    Bernkopf, H.: Cultivation of influenza virus in the chorioallantoic membrane of de-embryonated eggs. Proc. Soc. exp. Biol. (N.Y.) 72, 680–682 (1949).Google Scholar
  165. B58.
    Bernkopf, H.: Study of infectivity and haemagglutination of influenza virus in de-embryonated eggs. J. Immunol. 65, 571–583 (1950).PubMedGoogle Scholar
  166. B59.
    Bernkopf, H.: Experiences with the laboratory diagnosis of Asian influenza in Israel. Israel med. J. 17, 209–212 (1958).PubMedGoogle Scholar
  167. B60.
    Berry, L. J., R. B. Mitchell, and D. Rubenstein: Effect of acclimatisation to altitude on susceptibility of mice to influenza A virus infection. Proc. Soc. exp. Biol. (N.Y.) 88, 543–548 (1955).Google Scholar
  168. B61.
    Beutler, E., and H. M. Gezon: The effect of total body X irradiation on the susceptibility of mice to influenza A virus infection. J. Immunol. 68, 227–242 (1952).PubMedGoogle Scholar
  169. B62.
    Beveridge, W. I. B.: Lack of increase of antibody after second injection of influenza virus in man. Aust. J. exp. Biol. med. Sci. 22, 301–305 (1944).Google Scholar
  170. B63.
    Beveridge, W. I. B.: Some topical comments on influenza in horses. Vet. Rec. 77, 427–428 (1965).PubMedGoogle Scholar
  171. B64.
    Beveridge, W. I. B.: Public health significance of animal influenza. Int. Congr. comp. Path. Beirut (1966).Google Scholar
  172. B65.
    Beveridge, W. I. B., and F. M. Burnet: The cultivation of viruses and Rickettsia in the chick embryo. Med. Res. Counc. Rep. 256 (1946).Google Scholar
  173. B66.
    Beveridge, W. I. B., L. W. Mahaffey, and M. A. Rose: Influenza in horses. Vet. Rec. 77, 57–59 (1965).PubMedGoogle Scholar
  174. B67.
    Biddle, F., and G. Belyavin: The haemagglutination inhibitor in edible bird nest: Its biological and physical properties. J. gen. Microbiol. 31, 31–44 (1963).PubMedGoogle Scholar
  175. B68.
    Biddle, F., and A. Cohen: Erythrocyte receptors for type A2 influenza viruses. Nature (Lond.) 196, 297–298 (1962).Google Scholar
  176. B69.
    Biddle, F., and J. P. Stevenson: Flocculation of influenza viruses by horse serum inhibitor. Nature (Lond.) 209, 1223–1225 (1966).Google Scholar
  177. B70.
    Bieling, R., and L. Oelrichs: On the influenza virus inhibitor of hens eggs and on the immunity of the offspring of parents immunised against that virus. Z. Hyg. Infekt.-Kr. 127, 592–603 (1948).Google Scholar
  178. B71.
    Birch-Andersen, A., and K. Paucker: Studies on the structure of influenza virus. 2. Ultrathin sections of infectious and non-infectious particles. Virology 8, 21–40 (1959).PubMedGoogle Scholar
  179. B72.
    Birkovskaya, E. A.: Oxygen treatment of patients with influenza and pneumonia during the influenza pandemic in 1957 (Russian). Aziatskii gripp (Sborn. nauch. rabot) Kiev, 237-240 (1958).Google Scholar
  180. B73.
    Bjorkmann, S. E., and F. L. Horsfall: The production of a persistent alteration in influenza virus by Lanthanum or ultraviolet irradiation. J. exp. Med. 88, 445–461 (1948).Google Scholar
  181. B74.
    Blaskovic, D.: Influenza A and B antibodies in mothers and their infants up to six months after birth. (Czech). Čas. Lék. čes. (Prague) 89, 1195–1199 (1950).Google Scholar
  182. B75.
    Blaskovic, D.: Some properties of S and G antigens and haemagglutinins of myxoviruses (German). Zbl. Bakt. I. Abt. Kef. 175, 396 (1960).Google Scholar
  183. B76.
    Blaskovic, D., P. Albrecht, V. Lackovic, J. Lesso, V. Rathova, and B. Styk: The use of fluorescent antibody method for rapid diagnosis during an epidemic of influenza (Czech). Čs. Epidem. 12, 129–139 (1963).Google Scholar
  184. B77.
    Blaskovic, D., L. Borecky, and V. Rathova: An attempt to prove the circulation of influenza virus in a pre-epidemic period by means of susceptible animals. Čs. Epidem. 8, 376–387 (1959).Google Scholar
  185. B78.
    Blaskovic, D., N. A. Maksimovic, B. Styk, and P. Albrecht: Course of adaptation of the inhibitor resistant influenza virus A2 to ferrets. Čs. Epidem. 10, 158–165 (1961).Google Scholar
  186. B79.
    Blaskovic, D., and V. Rathova: Influenza virus A, A prime, B, C, and Shope Iowa 15 antibody titres in population of Czechoslovakia. Čs. Epidem. 5, 113 (1956).Google Scholar
  187. B80.
    Blaskovic, D., V. Rathova, and L. Borecky: Antigenic relationships to myxoviruses of a virus isolated from a respiratory infection in ducks. Acta virol. 3, 17–24 (1959).PubMedGoogle Scholar
  188. B81.
    Blaskovic, D., and J. E. Salk: A method applicable to the standardisation of influenza virus vaccines. Proc. Soc. exp. Biol. (N.Y.) 65, 352–359 (1947).Google Scholar
  189. B82.
    Blaskovic, D., A. A. Smorodintsev, and B. Styk: Problems of pathogenesis and immunology of virus infections. Acta virol. 3, 97–106 (1959).PubMedGoogle Scholar
  190. B83.
    Blaskovic, D., and F. Sokol: Some properties of the G antigen and haomagglutinin of influenza virus A/FE/Singapore/1957 (Czech). Biol. Prace 4, 75–77 (1958).Google Scholar
  191. B84.
    Blaskovic, D., J. Szanto, P. Albrecht, E. Sadecky, and V. Lackovic: Demonstration of swine influenza virus in pigs by the fluorescent antibody method. Acta virol. 8, 401–409 (1964).PubMedGoogle Scholar
  192. B85.
    Blough, H. A.: The role of the surface state in the morphogenesis of influenza virus filaments. Virology 19, 112–114 (1963).PubMedGoogle Scholar
  193. B86.
    Blough, H. A.: The effect of vitamin A on influenza virus in ovo: Morphological aspects. Biochem. J. 88, 11 (1963).Google Scholar
  194. B87.
    Blough, H. A.: The effect of vitamin A alcohol on the morphology of myxoviruses. 1. The production and comparison of artificially produced filamentous virus. Virology 19, 349–358 (1963).PubMedGoogle Scholar
  195. B88.
    Blough, H. A.: A molecular approach to teratogenesis: Effect of vitamin A on influenza virus in ovo. Nature (Lond.) 199, 33–35 (1963).Google Scholar
  196. B89.
    Blough, H. A.: Role of the surface state in the development of myxoviruses. Ciba Found. Symp. “Cellular biology of myxovirus infections” 120-151 (1964).Google Scholar
  197. B90.
    Blough, H. A.: Selective inactivation of biological activity of myxovirus by glutaraldehyde. J. Bact. 92, 266–268 (1966).PubMedGoogle Scholar
  198. B91.
    Blyumberg, N. A.: Adaption variability of the influenza virus (Russian). Dissertation, Moscow (1949).Google Scholar
  199. B92.
    Boand, A. V., and J. E. Kempf: The identification of influenza virus antibodies by means of the collodion particle agglutination reaction. J. Lab. clin. Med. 37, 914–923 (1951).PubMedGoogle Scholar
  200. B93.
    Boand, A. V., J. E. Kempf, and R. J. Hanson: Phagocytosis of influenza virus. 1. In vitro observations. J. Immunol. 79, 416–421 (1957).PubMedGoogle Scholar
  201. B94.
    Bodily, H. L., M. Corey, and M. D. Eaton: Precipitation and concentration of influenza virus with alum. Proc. Soc. exp. Biol. (N.Y.) 52, 165–168 (1943).Google Scholar
  202. B95.
    Bodily, H. L., and M. D. Eaton: Specificity of the antibody response of human beings to strains of influenza virus. J. Immunol. 45, 193–204 (1942).Google Scholar
  203. B96.
    Bogoch, S., P. Lynch, and A. S. Levine: Influence of brain ganglioside upon the neurotoxic effect of influenza virus in mouse brain. Virology 7, 161–169 (1959).PubMedGoogle Scholar
  204. B97.
    Bohm, P., J. Ross, and L. Baumeister: The cleavage of N-acetyl neuraminic acid from serum by influenza B virus and by Clostridium Welchii A toxin (German). Hoppe-Seylers Z. physiol. Chem. 308, 181–182 (1957).PubMedGoogle Scholar
  205. B98.
    Boldasov, V. K.: Studies on the enzymic properties of inhibitor sensitive and inhibitor resistant strains of A2 influenza viruses. Acta virol. 7, 361–367 (1963).Google Scholar
  206. B99.
    Boldyreva, A. S., and I. A. Kiseleva: Comparative evaluation of methods used for the removal of non-specific inhibitors in the HI reaction (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSE. Moscow, 50-51 (1959).Google Scholar
  207. B100.
    Bordet, P., and L. Quersin-Thiry: Enhancing effect of influenza virus on associated infections (French). Ann. Inst. Pasteur 81, 394–406 (1951); 84, 695-702 (1953).Google Scholar
  208. B101.
    Borecky, L.: On the question of virus receptors. The selective agglutinability of erythrocytes of the ground squirrel (Citellus Citellus). Folia biol. (Prague) 2, 344–350 (1956).Google Scholar
  209. B102.
    Borecky, L.: The sensitivity of A-FE influenza viruses to inhibitors in normal animal sera (Czech). Biol. Prace 4, 32–38 (1958).Google Scholar
  210. B103.
    Borecky, L.: A factor destroying virus receptors in pneumococcal cultures. 2. The effect of pneumococcal factor 103 on erythrocyte receptors and inhibitors. Acta virol. 2, 201–207 (1958).PubMedGoogle Scholar
  211. B104.
    Borecky, L.: A factor destroying virus receptors in pneumococcal cultures. 3. The effect of pneumococcal factor 103 in experiments in vivo. Acta virol. 3, 9–16 (1959).PubMedGoogle Scholar
  212. B105.
    Boreckt, L., D. Kociskova, and L. Hana: An attempt to affect the level of serum inhibitors of myxoviruses in vivo. 1. Effect of ethionine administration on the level of inhibitors in guinea-pig sera. Acta virol. 5, 236–244 (1961).Google Scholar
  213. B106.
    Borecky, L., V. Lackovic, and E. Mrena: The effect of trypsin on influenza virus. Acta virol. 8, 555 (1964).PubMedGoogle Scholar
  214. B107.
    Borecky, L., and V. Rathova: Investigations of possible cross-reactions between preparations of salmonellae containing Vi antigen and inhibitors or antibodies against myxoviruses. Acta virol. 7, 339–349 (1963).PubMedGoogle Scholar
  215. B108.
    Borecky, L., V. Rathova, and D. Kociskova: Attempt to affect the level of serum inhibitors of myxoviruses in vivo. 2. Effect of ethionine administration on virus multiplication. Acta virol. 6, 97–104 (1962).Google Scholar
  216. B109.
    Borecky, L., V. Rathova, D. Kociskova, and L. Hana: Effect of dl ethionine on some factors of non-specific resistance to myxoviruses. J. Hyg. Epidem. (Praha) 6, 65–70 (1962).Google Scholar
  217. B110.
    Borecky, L., and J. Zavada: Effect of anti-cellular sera on infection with myxoviruses. 1. The effect of antichorioallantoic serum. Acta virol. 4, 110–123 (1960).PubMedGoogle Scholar
  218. B111.
    Boretti, G., A. Di Marco, and P. Julita: Preparation and characterisation of an influenza virus inhibitor from horse serum. G. Microbiol. (Naples) 12, 55–69 (1964).Google Scholar
  219. B112.
    Borghans, J. G. A., O. Maksteinieks, J. Versteeg, and J. D. Verlinde: A mixed epidemiological outbreak of acute respiratory disease caused by influenza A virus and APC virus in a group previously vaccinated against influenza A (Dutch). Ned. T. Geneesk. 100, 2110–2116 (1956).PubMedGoogle Scholar
  220. B113.
    Boudreault, A., and V. Pavilanis: Eelationship between cytopathogenic, haemadsorption, and haemagglutination properties of influenza virus (French). Canad. J. Microbiol. 7, 347–353 (1961).Google Scholar
  221. B114.
    Boudreault, A., and Y. Pavilanis: The development of some biological properties of 4 influenza virus strains after successive passage at 29°C and 41°C. Eesearch on cold mutants. Rev. Canad. Biol. 23, 253–260 (1964).PubMedGoogle Scholar
  222. B115.
    Boug, J., C. A. De Bock, H. D. Moed, and A. J. Klein: Antiviral action of derivatives of w-aminoacetophenone. Brit. J. Pharmacol. 13, 404–410 (1958).Google Scholar
  223. B116.
    Bovarnick, M., and P. M. De Burgh: Virus haemagglutination. Science, 105, 550–552 (1947).PubMedGoogle Scholar
  224. B117.
    Bowers, R. H., O. L. Davies, and W. Hurst: A comparison between intranasal instillation and natural inhalation as a means of infecting mice with influenza virus. Brit. J. exp. Path. 33, 601–609 (1952).PubMedGoogle Scholar
  225. B118.
    Bozzo, A.: Studies of the antigenic composition of influenza B viruses. Bull. Wld Hlth Org. 5, 149–163 (1952).Google Scholar
  226. B119.
    Bozzo, A., A. Jacono, S. Ricciardi, and G. Starace: Serological study of four strains of influenza virus isolated in various parts of south Italy in 1953 (Italian). Rev. Inst. Sieroter. ital. 28, 424–435 (1953).Google Scholar
  227. B120.
    Brandao, H.: Use of the Do unit (zero mortality) in virus titrations (Portuguese). Rev. Inst. Med. trop. S. Paulo 4, 343–350 (1962).PubMedGoogle Scholar
  228. B121.
    Brans, L. M.: Studies on the antigenic composition of influenza virus B strains. Onderzoek. Mededel. Inst. praevent. Geneesk. (Leiden) No 9 (1952).Google Scholar
  229. B122.
    Brans, L. M., E. Hertzberger, and J. L. Binkhorst: Studies on the elimination of non-specific inhibitors in sera against influenza viruses with the aid of filtrates of Vibrio Cholerae. Antonie v. Leeuwenhoek 19, 309–323 (1953).Google Scholar
  230. B123.
    Breitenfeld, P. M., and W. Schafer: The formation of fowl plague virus antigens in infected cells as studied with fluorescent antibodies. Virology 4, 328–345 (1957).PubMedGoogle Scholar
  231. B124.
    Brenner, S., and R. W. Horne: A negative staining method for high resolution electron microscopy of viruses. Biochim. biophys. Acta (Amst.) 34, 103–110 (1959).Google Scholar
  232. B125.
    Brightman, I. J., and J. D. Trask: Recovery of a filtrable virus from children sick with influenza. 1. Epidemiologic and clinical observations.Google Scholar
  233. B126.
    2. The experimental disease in ferrets. Amer. J. Dis. Child. 52, 67-77 and 78-91 (1936).Google Scholar
  234. B127.
    Briody, B. A.: Haemagglutination by influenza virus. 1. Modification of the 0 phase of influenza A virus. J. infect. Dis. 83, 283–287 (1948).PubMedGoogle Scholar
  235. B128.
    2. The existence of two phases of influenza B virus.Google Scholar
  236. B129.
    3. The XO phase of influenza A virus. J. exp. Med. 83, 288-292 and 293-298 (1948).Google Scholar
  237. B130.
    Briody, B. A.: Variation in influenza viruses. Bact. Rev. 14, 65–95 (1950).PubMedGoogle Scholar
  238. B131.
    Briody, B. A., and W. A. Cassel: Adaptation of influenza virus to mice. 2. Changes in the growth curve of an A prime strain of influenza virus. J. Immunol. 74, 37–40 (1955).PubMedGoogle Scholar
  239. B132.
    Briody, B. A., W. A. Cassel, and M. A. Medill: Adaptation of influenza virus to mice. 3. Development of resistance to B inhibitor. J. Immunol. 74, 41–45 (1955).PubMedGoogle Scholar
  240. B133.
    Broncova, O., and V. Bydzovsky: Effect of some 5-arylpyrimidines on influenza, vaccinia and Newcastle disease viruses (Czech). Čs. Epidem 11, 179–188 (1962).Google Scholar
  241. B134.
    Bronitki, A., A. Petrescu, P. Petrescu, L. Rothschild, and P. Athanasiu-Storescu: The isolation of a strain of influenza virus of predominantly neurotropic character (Eumanian). Stud. Cercet. Inframicrobiol. 8, 561–569 (1957).Google Scholar
  242. B135.
    Brudnaya, E. I., L. Ya. Zakstel’skaya, and K. K. Luneva: Serological reactions in persons vaccinated a live anti-influenza A2 vaccine (Russian). Vop. Virus 5, 133–135 (1958).Google Scholar
  243. B136.
    Brunner, K. T.: The formation of anti endotoxin in rabbits after injection of influenza virus (German). Path. et Microbiol. (Basle) 25, 91–100 (1962).Google Scholar
  244. B137.
    Bruno-Lobo, M.: “Gripe Asiatica” Inst. Microbiol. Universidade do Brasil (Portuguese). Rio de Janeiro (1958).Google Scholar
  245. B138.
    Bruno-Lobo, G. G., M. Bruno-Lobo, J. V. Vasconcellos, and J. Travassos: Studies on Asian influenza in Rio de Janeiro. 3. Sensitivity of the virus to non-specific inhibitors (Portuguese). An. Microbiol. 5, 69–93 (1957).Google Scholar
  246. B139.
    Bruno-Lobo, M., and J. Travassos: Studies on Asian influenza in Rio de Janeiro. 6. Post-vaccinal immunity (Portuguese). An. Microbiol. 6, 151–176 (1958).Google Scholar
  247. B140.
    Bryans, J. T.: Viral respiratory disease of horses. Scientific Proceed. 101st Ann. Meet. Amer. vet. Med. Ass. July 1964.Google Scholar
  248. B141.
    Buddingh, G. J.: Experimental combined viral and bacterial infection (influenza C and Haemophilus influenzae type B) in embryonated eggs. J. exp. Med. 104, 947–958 (1956).PubMedCentralPubMedGoogle Scholar
  249. B142.
    Bukrinskaya, A. G.: Direct detection of influenza virus in human embryo tissue cultures (Russian). Vop. Virus. 3, 162–165 (1958).Google Scholar
  250. B143.
    Bukrinskaya, A. G.: Behaviour of influenza virus type A2 in tissue cultures of man and animals (Russian). Vop. Virus. 5, 61–68 (1958).Google Scholar
  251. B144.
    Bukrinskaya, A. G.: Formation of incomplete influenza A2 virus and multiplication of virus in tissue cultures of variable sensitivity. Probl. Virol. (N.Y.) 5, 481–485 (1960).Google Scholar
  252. B145.
    Bukrinskaya, A. G.: Resistance of synthesis of influenza virus ribonucleic acid to the action of actinomycin D. Nature (Lond.) 204, 205–206 (1964).Google Scholar
  253. B146.
    Bukrinskaya, A. G., E. A. Vladimerceva, A. K. Gitelman, and Y. A. Smirnov: Myxovirus induced early RNA and early proteins. Abstr. 9th int. Congr. Microbiol. Moscow, 494 (1966).Google Scholar
  254. B147.
    Bukrinskaya, A. G., and G. K. Vorbunova: Reproduction of influenza virus RNA in the presence of low concentrations of actinomycin D (Russian). Vop. Virus. 6, 657 (1964).Google Scholar
  255. B148.
    Bull, D. R., and F. M. Burnet: Experimental immunisation of volunteers against influenza virus B. Med. J. Aust. 1, 389–394 (1943).Google Scholar
  256. B149.
    Burke, D. C., and A. Isaacs: Further studies on interferon. Brit. J. exp. Path. 39, 78–84 (1958).PubMedGoogle Scholar
  257. B150.
    Burke, D. C., and A. Isaacs: Interferon: Relation to heterologous interference and lack of antigenicity. Acta virol. 4, 215–219 (1960).Google Scholar
  258. B151.
    Burke, D. C., A. Isaacs, and J. Walker: The nucleic acid content of influenza virus. Biochim. et biophys. Acta (Amst.) 26, 576–584 (1957).Google Scholar
  259. B152.
    Burke, D. C., and J. M. Morrison: Interferon production in chick embryo cells. 2. The role of DNA. Virology 28, 108–114 (1966).PubMedGoogle Scholar
  260. B153.
    Burke, D. C., and J. Ross: Molecular weight of chick interferon. Nature (Lond.) 208, 1297–1299 (1965).Google Scholar
  261. B154.
    Burnet, F. M.: Influenza virus isolated from an Australian epidemic. Med. J. Aust. 2, 651–653 (1935).Google Scholar
  262. B155.
    Burnet, F. M.: Propagation of the virus of epidemic influenza on the developing egg. Med. J. Aust. 2, 687–689 (1935).Google Scholar
  263. B156.
    Burnet, F. M.: Influenza virus on the developing egg. 1. Changes associated with the development of an egg-passage strain of virus. Brit. J. exp. Path. 17, 282–293 (1936).Google Scholar
  264. B157.
    Burnet, F. M.: Influenza virus on the developing egg. 5. Differentiation of two antigenic types of human influenza virus. Aust. J. exp. Biol. med. Sci. 15, 369–374 (1937).Google Scholar
  265. B158.
    Burnet, F. M.: Influenza virus infections of the chick embryo lung. Brit. J. exp. Path. 21, 147–153 (1940).Google Scholar
  266. B159.
    Burnet, F. M.: Influenza virus infection of the chick embryo by the amniotic route. 1. General character of the infections.Google Scholar
  267. B160.
    2. Titration and serum neutralisation tests. Aust. J. exp. Biol. med. Sci. 18, 353-360, and 19, 39-44 (1940).Google Scholar
  268. B161.
    Burnet, F. M.: Influenza virus A infections of Cynomolgous monkeys. Aust. J. exp. Biol. med. Sci. 19, 281–290 (1941).Google Scholar
  269. B162.
    Burnet, F. M.: Influenza virus B. 1. Observations on the growth in chick embryos and on the occurrence of antibodies in Australian serum.Google Scholar
  270. B163.
    2. Immunisation of human volunteers with living attenuated virus. Med. J. Aust. 1, 671-673 and 673-674 (1942).Google Scholar
  271. B164.
    Burnet, F. M.: Immunisation against epidemic influenza with living and attenuated virus. Med. J. Aust. 1, 385–389 (1943).Google Scholar
  272. B165.
    Burnet, F. M.: Characteristics of the influenza virus-antibody reaction as tested by the method of allantoic inoculation. Aust. J. exp. Biol. med. Sci. 21, 231–238 (1943).Google Scholar
  273. B166.
    Burnet, F. M.: Modification of human red cells by virus action. 3. A sensitive test for mumps antibody in human serum by the agglutination of human red cells coated with a virus antigen. Brit. J. exp. Path. 27, 244–247 (1946).PubMedGoogle Scholar
  274. B167.
    Burnet, F. M.: Mucins and mucoids in relation to influenza virus action. 3. Inhibition of virus haemagglutination by glandular mucins. B168 4. Inhibition by purified mucoid of infection and haemagglutination with the virus strain WSE.Google Scholar
  275. B169.
    5. The destruction of “Francis inhibitor” activity in a purified mucoid by virus action. Aust. J. exp. Biol. med. Sci. 26, 371-379, 381-387, and 389-402 (1948).Google Scholar
  276. B170.
    Burnet, F. M.: The initiation of cellular infection by influenza and related viruses. Lancet 7-11 (1948).Google Scholar
  277. B171.
    Burnet, F. M.: Inactivation of the receptor destroying enzyme of V. Cholerae by immune sera. Aust. J. exp. Biol. med. Sci. 27, 217–222 (1949).PubMedGoogle Scholar
  278. B172.
    Burnet, F. M.: The effect of periodate on the virus-inhibiting qualities of mucoids in solution. Aust. J. exp. Biol. med. Sci. 27, 361–374 (1949).PubMedGoogle Scholar
  279. B173.
    Burnet, F. M.: Inhibition of influenza virus haemagglutination by mucoids. 3. Specific relation between active virus and the corresponding indicator strains in studies of soluble inhibitors. Aust. J. exp. Biol. med. Sci. 27, 575–579 (1949).Google Scholar
  280. B174.
    Burnet, F. M.: The interaction of virus and cell surface. Proc. roy. Soc. Ser. B 138, 47–44 (1951).Google Scholar
  281. B175.
    Burnet, F. M.: Some biological implications of studies on influenza viruses. 1. The process of infection by the virus.Google Scholar
  282. B176.
    2. Reproduction and variation in influenza viruses. Bull. Johns Hopk. Hosp. 88, 119-137 and 137-157 (1951).Google Scholar
  283. B177.
    Burnet, F. M.: Mucoproteins in relation to virus action. Physiol. Rev. 31, 131–150 (1951).PubMedGoogle Scholar
  284. B178.
    Burnet, F. M.: A genetic approach to variation in influenza viruses. 1. The characters of three sub-strains of influenza A virus (WS).Google Scholar
  285. B179.
    Burnet, F. M.: 2 Variation in the strain NWS on allantoic passage. J. gen. Microbiol. 5, 46–53 and 54-58 (1951).PubMedGoogle Scholar
  286. B180.
    Burnet, F. M.: Irreversible binding of influenza virus to the red cell surface. Aust. J. exp. Biol. med. Sci. 30, 119–128 (1952).PubMedGoogle Scholar
  287. B181.
    Burnet, F. M.: Influenza virus group. Ann. N.Y. Acad. Sci. 56, 567 (1953).PubMedGoogle Scholar
  288. B182.
    Burnet, F. M.: Virulence in animal viruses. Lancet, 559 563 (1954).Google Scholar
  289. B183.
    Burnet, F. M.: The riddle of influenza virus. Endeavour 14, 5–11 (1955).Google Scholar
  290. B184.
    Burnet, F. M.: Filamentous forms of influenza. Nature (Lond.) 177, 130 (1956).Google Scholar
  291. B185.
    Burnet, F. M.: Structure of influenza virus. Science 123, 1101–1104 (1956).PubMedGoogle Scholar
  292. B186.
    Burnet, F. M.: Genetics of animal viruses. Handbuch Virusforsch. 4, 3, Erg.-Bd. (1958). Springer-Verlag, Wien.Google Scholar
  293. B187.
    Burnet, F. M., and S. G. Anderson: Modification of human red cells by virus action. 2. Agglutination of modified human red cells by sera from cases of infectious mononucleosis. Brit. J. exp. Path. 27, 236–244 (1946).PubMedGoogle Scholar
  294. B188.
    Burnet, F. M., and W. I. B. Beveridge: Titration of antibody against influenza by allantoic inoculation of the developing chick embryo. Aust. J. exp. Biol. med. Sci. 21, 71–77 (1943).Google Scholar
  295. B189.
    Burnet, F. M., W. I. B. Beveridge, and D.R. Bull: Study of a strain of influenza B virus isolated by chick embryo inoculation. Aust. J. exp. Biol. med. Sci. 22, 9–16 (1944).Google Scholar
  296. B190.
    Burnet, F. M., W. I. B. Beveridge, D. R. Bull, and E. Clarke: Investigation of an influenza epidemic in military camps in Victoria, May 1942. Med. J. Aust. 2, 371–376 (1942).Google Scholar
  297. B191.
    Burnet, F. M., W. I. B. Beveridge, J. McEwin, and W. C. Brake: Studies on the Hirst haemagglutination reaction with influenza and Newcastle disease viruses. Aust. J. exp. Biol. med. Sci. 23, 177–192 (1945).Google Scholar
  298. B192.
    Burnet, F. M., and D.R. Bull: Changes in influenza virus associated with adaptation to passage in chick embryos. Aust. J. exp. Biol. med. Sci. 21, 55–69 (1943).Google Scholar
  299. B193.
    Burnet, F. M., and E. Clarke: Influenza; A survey of the last 50 years in the light of modern work on the virus of epidemic influenza. Monograph No. 4, Walter and Eliza Hall Inst. Melbourne, 1942.Google Scholar
  300. B194.
    Burnet, F. M., and M. Edney: Recombinant viruses obtained from double infections with the influenza A viruses. Aust. J. exp. Biol. med. Sci. 29, 353–362 (1951).PubMedGoogle Scholar
  301. B195.
    Burnet, F. M., and M. Edney: Influence of ions on the interaction of influenza virus and cellular receptors or soluble inhibitors of haemagglutination. Aust. J. exp. Biol. med. Sci. 30, 105–118 (1952).PubMedGoogle Scholar
  302. B196.
    Burnet, F. M., and M. Foley: The results of intranasal inoculation of modified and unmodified influenza virus strains in human volunteers. Med. J. Aust. 2, 655–659 (1940).Google Scholar
  303. B197.
    Burnet, F. M., and M. Foley: Two methods for the detection of influenza virus in human throat washings without the use of ferrets. Med. J. Aust. 3, 68–72 (1941).Google Scholar
  304. B198.
    Burnet, F. M., and K. B. Fraser: Studies on recombination with influenza viruses in the chick embryo. 1. Invasion of the chick embryo by influenza viruses. Aust. J. exp. Biol. med. Sci. 30, 447–558 (1952).PubMedGoogle Scholar
  305. B199.
    Burnet, F. M., K. B. Fraser, and P. E. Lind: Genetic interaction between influenza viruses. Nature (Lond.) 171, 163 (1953).Google Scholar
  306. B200.
    Burnet, F. M., and P. E. Lind: A genetic approach to variation in influenza viruses.Google Scholar
  307. B201.
    3. Recombination of characters in influenza virus strains used in mixed infections. 4. Recombination of characters between influenza virus A strain NWS and strains of different serological sub-types. J. gen. Microbiol. 5, 59-66 and 67-82 (1951).Google Scholar
  308. B202.
    Burnet, F. M., and P. E. Lind: Studies on recombination with influenza viruses in the chick embryo. 3. Reciprocal genetic interaction between two influenza virus strains. Aust. J. exp. Biol. med. Sci. 30, 469–477 (1952).PubMedGoogle Scholar
  309. B203.
    Burnet, F. M., and P. E. Lind: Reactivation of heat-inactivated influenza virus by recombination. Aust. J. exp. Biol. med. Sci. 32, 133–143 (1954).PubMedGoogle Scholar
  310. B204.
    Burnet, F. M., and P. E. Lind: Recombination of influenza viruses in the de-embryonated egg. 1. The use of periodate-treated sera for in vitro characterisation of influenza virus strains. Aust. J. exp. Biol. med. Sci. 32, 145–151 (1954).PubMedGoogle Scholar
  311. B205.
    Burnet, F. M., and P. E. Lind: Becombination of influenza viruses in the de-embryonated egg. 2. The conditions for recombination and the evidence for the possible existence of diploid influenza virus. Aust. J. exp. Biol. med. Sci. 32, 153–163 (1954).PubMedGoogle Scholar
  312. B206.
    Burnet, F. M., and P. E. Lind: Genetics of virulence in influenza viruses. Nature (Lond.) 173, 627–630 (1954).Google Scholar
  313. B207.
    Burnet, F. M., and P.E. Lind: Reversion to virulence in an influenza virus mutant. Aust. J. exp. Biol. med. Sci. 35, 225–239 (1957).PubMedGoogle Scholar
  314. B208.
    Burnet, F. M., and P. E. Lind: Studies on the filamentous forms of influenza virus with special reference to the use of dark-ground microscopy. Arch. ges. Virsuforsch. 7, 413–428 (1957).Google Scholar
  315. B209.
    Burnet, F. M., P. E. Lind, and B. Perry: The action of ribonuclease on the multiplication of influenza viruses in the de-embryonated egg. Aust. J. exp. Biol. med. Sci. 35, 517–529 (1957).Google Scholar
  316. B210.
    Burnet, F. M., P. E. Lind, and K.M. Stevens: Production of incomplete influenza virus in the de-embryonated egg. Aust. J. exp. Biol. med. Sci. 33, 127–141 (1955).PubMedGoogle Scholar
  317. B211.
    Burnet, F. M., and D. Lush: Influenza virus on the developing egg. 8. A comparison of two antigenically dissimilar strains of human influenza virus after full adaptation to the egg membrane. Aust. J. exp. Biol. med. Sci. 16, 261–274 (1938).Google Scholar
  318. B212.
    Burnet, F. M., and D. Lush: Influenza virus strains isolated from the Melbourne 1939 epidemic. Aust. J. exp. Biol. med. Sci. 18, 49–55 (1940).Google Scholar
  319. B213.
    Burnet, F. M., D. Lush, and A. V. Jackson: A virus inactivating agent from human nasal secretion. Brit. J. exp. Path. 20, 377–385 (1939).Google Scholar
  320. B214.
    Burnet, F. M., and J. F. McCrea: Inhibitory and inactivating action of normal ferret sera against an influenza virus strain. Aust. J. exp. Biol. med. Sci. 24, 277–282 (1946).PubMedGoogle Scholar
  321. B215.
    Burnet, F. M., J. F. McCrea, and J.D. Stone: Modification of human red cells by virus action. 1. The receptor gradient for virus action in human red cells. Brit. J. exp. Path. 27, 228–236 (1946).PubMedGoogle Scholar
  322. B216.
    Burnet, F. M., and J. D. Stone: The significance of primary isolation of influenza virus by inoculation of mice or of the allantoic cavity of chick embryos. Aust. J. exp. Biol. med. Sci. 23, 147–150 (1945).Google Scholar
  323. B217.
    Burnet, F. M., and J. D. Stone: Further studies on the O-D change in influenza virus A. Aust. J. exp. Biol. med. Sci. 23, 151–160 (1945).Google Scholar
  324. B218.
    Burnet, F. M., and J. D. Stone: A method for the isolation of influenza virus from throat washings without filtration. Aust. J. exp. Biol. med. Sci. 23, 161–163 (1945).Google Scholar
  325. B219.
    Burnet, F. M., and J. D. Stone: Serological response to influenza B infection in human beings. Differentiation of specific and non-specific type reactions. Aust. J. exp. Biol. med. Sci. 24, 207–212 (1946).PubMedGoogle Scholar
  326. B220.
    Burnet, F. M., and J. D. Stone: The receptor destroying enzyme of V. cholerae. Aust. J. exp. Biol. med. Sci. 25, 227–233 (1947).PubMedGoogle Scholar
  327. B221.
    Burnet, F. M., J. D. Stone, and S. G. Anderson: An epidemic of influenza B in Australia. Lancet 807-811 (1946).Google Scholar
  328. B222.
    Burnet, F. M., J. D. Stone, A. Isaacs, and M. Edney: The genetic character of the O-D change in influenza A. Brit. J. exp. Path. 30, 419–425 (1949).PubMedGoogle Scholar
  329. B223.
    Buslenko, A. I.: Epidemiologic and clinical characteristics of the course of influenza in T.B. patients (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch, Sess. Inst. AMN SSSR Moscow, 201-202 (1959).Google Scholar
  330. B224.
    Buzzell, A., F.B. Brandon, and M. A. Lauffer: Effects of X radiation on influenza virus. Arch. Biochem. 58, 318–331 (1955).PubMedGoogle Scholar
  331. C1.
    Cairns, H. J. F.: Protection by receptor destroying enzyme against infection with a neurotropic variant of influenza virus. Nature (Lond.) 167, 335 (1951).Google Scholar
  332. C2.
    Cairns, H. J. F.: The growth of influenza viruses and Newcastle disease virus in mouse brain. Brit. J. exp. Path. 32, 110–117 (1951).PubMedGoogle Scholar
  333. C3.
    Cairns, H. J. F.: Quantitative aspects of influenza virus multiplication. 3. Average liberation time. J. Immunol. 69, 168–173 (1952).Google Scholar
  334. C4.
    Cairns, H. J. F.: The limited growth of influenza viruses in mouse brain. Aust. J. exp. Biol. med. Sci. 32, 123–128 (1954).PubMedGoogle Scholar
  335. C5.
    Cairns, H. J. F.: Multiplicity reactivation of influenza virus. J. Immunol. 75, 326–329 (1955).PubMedGoogle Scholar
  336. C6.
    Cairns, H. J. F.: Site of the chorioallantoic inhibitor of influenza virus haemagglutinin. Nature (Lond.) 178, 744–745 (1956).Google Scholar
  337. C7.
    Cairns, H. J. F.: The asynchrony of infection by influenza virus. Virology 3, 1–14 (1957).PubMedGoogle Scholar
  338. C8.
    Cairns, H. J. F., and M. Edney: Quantitative aspects of influenza virus multiplication. 1. Production of incomplete virus. J. Immunol. 69, 155–160 (1952).PubMedGoogle Scholar
  339. C9.
    Cairns, H. J. F., and S. Fazekas de St Groth: The number of allantoic cells in the chick embryo. J. Immunol. 78, 191–200 (1957).PubMedGoogle Scholar
  340. C10.
    Cairns, H. J. F., and P. J. Mason: Production of influenza A virus in the cell of the allantois. J. Immunol. 71, 38–40 (1953).PubMedGoogle Scholar
  341. C11.
    Cajal, N., O. Burducea, S. Mateascu, G. Marinescu, M. Cepleanu, and Y. Cepelovici: The development of experimental virus infections (influenza, poliomyelitis, Coxsackie, rabies, and herpes) under the influence of radioactive phosphorus P 32 and radioactive iodine I 131 (Rumanian). Stud. Cercet. Inframicrobiol. 12, 29–37 (1961).PubMedGoogle Scholar
  342. C12.
    Canchola, J. G., R. M. Chanock, B. C. Jeffries, E. E. Christmas, H. W. Kim, A. J. Vargosco, and R. H. Parrot: Recovery and identification of human myxoviruses. Bact. Rev. 29, 496–503 (1965).PubMedGoogle Scholar
  343. C13.
    Carlinfanti, E.: Studies of the receptor destroying factor from different viruses (Italian). Riv. Ist. sieroter. ital. 23, 141–150 (1948).PubMedGoogle Scholar
  344. C14.
    Carlinfanti, E.: Rapid liberation of influenza virus from red cells by Newcastle disease virus. Riv. Ist. sieroter. ital. 23, 151–155 (1948).Google Scholar
  345. C15.
    Carson, S., and A. W. Frisch: The inactivation of influenza viruses by tannic acid and related compounds. J. Bact. 66, 572–575 (1953).PubMedGoogle Scholar
  346. C16.
    Carubelli, R., V. P. Bhavanandan, and A. Gottschalk: Studies on glycoproteins. 11. The O-glycosidic linkage of N-acetylgalactosamine to seryl and threonyl residues in ovine submaxillary gland glycoprotein. Biochim. biophys. Acta (Amst.) 101, 67–82 (1965).Google Scholar
  347. C17.
    Cateigne, G.: Anti-influenza vaccine (French). Rev. Prat. (Paris) 8, 1446–1451 (1958).Google Scholar
  348. C18.
    Cateigne, G., C. Hannoun, and R. Panthier: Antigenic characters of influenza virus in the 1948–49 epidemic (French). C. R. Soc. Biol. (Paris) 143, 812–814 (1949).Google Scholar
  349. C19.
    Cateigne, G., and P. Reculard: Work on the adaptation of two strains of influenza virus A to chick embryo cells in vitro (French). Ann. Inst. Pasteur 11, 229–234 (1966).Google Scholar
  350. C20.
    Centanni, E., and O. Savunozzi: (1900) Cited by Stubbs, E. L. in “Diseases of poultry” 4th edit. Biester and Schwartz, Iowa State Univ. Press.Google Scholar
  351. C21.
    Chagnon, A., J. C. Gilker, and A. Boudreault: Infectivity and haemagglutinating properties of influenza virus at varying pH (French). Canad. J. Microbiol. 11, 845–851 (1965).Google Scholar
  352. C22.
    Chalkina, O. M.: Immunological changes in the blood of people vaccinated with the virus of epidemic influenza (Russian). Arkh. biol. nauk. 52, 125 (1938).Google Scholar
  353. C23.
    Chalkina, O. M.: Susceptibility of white rats to the influenza virus (Russian). Zh. Mikrobiol. (Mosk.) 10-11, 23 (1943).Google Scholar
  354. C24.
    Chalkina, O. M.: Increase in the immunogenic power of influenza vaccine with a biologic stimulator (Russian). Yop. Virus 2, 235 (1949).Google Scholar
  355. C25.
    Chalkina, O. M., S. A. Burov, and N. A. Ilin: The evaluation of the epidemiologic effectiveness of live anti-influenza vaccine during the 1959 outbreaks of influenza A2 and B (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSE, Moscow, 80-82 (1959).Google Scholar
  356. C26.
    Chalkina, O. M., and A. G. Gulamov: The use of white rats for the laboratory diagnosis of influenza (Russian). Zh. Mikrobiol. (Mosk.) 10-11, 26 (1943).Google Scholar
  357. C27.
    Chalkina, O. M., and O. S. Zak: Yirological characterisation of a Type A influenza outbreak (Russian). “Bibliografiya i annotatsii rabot otdela virusologii.” Inst. Eksper. med. AMN SSSE Za, 1947–1949, Leningrad (1950).Google Scholar
  358. C28.
    Chambers, L. A., and W. Henle: Precipitation of active influenza A virus from extra-embryonic fluids by protamine. Proc. Soc. exp. Biol. (N.Y.) 48, 481–483 (1941).Google Scholar
  359. C29.
    Chambers, L. A., and W. Henle: Studies on the nature of the virus of influenza. 1. The dispersion of the virus of influenza A in tissue emulsions and in extraembryonic fluids of the chick.Google Scholar
  360. C30.
    2. The size of the infectious unit in influenza A. J. exp. Med. 77, 251-264, and 265-276 (1943).Google Scholar
  361. C31.
    Chang, H. T., and J. E. Kempf: The hypotensive action of influenza virus on rats. J. Immunol. 65, 75–84 (1950).PubMedGoogle Scholar
  362. C32.
    Chang, S. S., and C. Y. Chen: Inhibitor spectra and effects of various treatments on the inhibitors of influenza virus haemagglutination. J. Formosan Med. Ass. 59, 1110–1122 (1960).Google Scholar
  363. C33.
    Chapman, J., and R. R. Hyde: Antigenic differences in viruses from cases of influenza and colds. Amer. J. Hyg. 31, 46–68 (1940).Google Scholar
  364. C34.
    Cheburkina, N. V.: Study of cell metabolism in virus infections (Russian). Annot. rabot. Inst. virusol. AMN SSSR za 1949, Moscow, 8 (1950).Google Scholar
  365. C35.
    Cheburkina, N. V., and L. Ya. Zakstelskaya: Metabolism in the chick embryo in influenzal infection (Russian). Zh. Mikrobiol. (Mosk.) 9, 15 (1960).Google Scholar
  366. C36.
    Cheburkina, N. V., and L. Ya. Zakstelskaya: Metabolism in the developing chick embryo in influenzal infection (Russian). Probl. obshch. virusol. Tez. dokl. 6-y Inst. virusol. AMN SSSR Moscow 58 (1953).Google Scholar
  367. C37.
    Chen, C. Y., W. F. Kuo, and S. S. Chang: Studies on the strains of A2 (asian) influenza virus isolated in Taiwan. Mem. Coll. Med. Taiwan Univ. 11, 1–10 (1965).Google Scholar
  368. C38.
    Chernukh, A. M., I. S. Rudakova, N. S. Tolmacheva, and A. M. Prochorova: A comparative study of the effect produced by esculamine and aminoadamantane on the experimental influenza. Abstr. 9th int. Congr. Microbiol., Moscow 545 (1966).Google Scholar
  369. C39.
    Chesbro, W. R., and L. R. Hadrick: Comparison of the tendency to stick to glass and haemagglutination produced in erythrocyte suspensions by ferric chloride and by influenza virus. Nature (Lond.) 182, 1164 (1958).Google Scholar
  370. C40.
    Chevance, L. G., and G. Cateigne: A new test for the study of influenza virus (French). Ann. Inst. Pasteur 104, 264–273 (1963).Google Scholar
  371. C41.
    Choppin, P. W.: Plaque formation by influenza A2 virus in monkey kidney cells. Virology 18, 332–334 (1962).PubMedGoogle Scholar
  372. C42.
    Choppin, P. W.: On the emergence of influenza virus filaments from host cells. Virology 21, 278–281 (1963).PubMedGoogle Scholar
  373. C43.
    Choppin, P. W.: Multiplication of two kinds of influenza A2 virus particles in monkey kidney cells. Virology 21, 342–352 (1963).PubMedGoogle Scholar
  374. C44.
    Choppin, P. W., J. S. Murphy, and W. Stoekenius: The surface structure of influenza virus filaments. Virology 13, 548–550 (1961).PubMedGoogle Scholar
  375. C45.
    Choppin, P. W., S. Osterhout, and I. Tamm: Immunological characteristics of N.Y. strains of influenza virus from the 1957 pandemic. Proc. Soc. exp. Biol. (N.Y.). 98, 513–520 (1958).PubMedGoogle Scholar
  376. C46.
    Choppin, P. W., and W. Stoekenius: Interactions of ether-disrupted influenza A2 virus with erythrocytes, inhibitors, and antibodies. Virology 22, 482–492 (1964).PubMedGoogle Scholar
  377. C47.
    Choppin, P. W., and I. Tamm: Studies of two kinds of virus particles which comprise influenza A2 virus strains. 1. Characterisation of stable homogeneous substrains in reactions with specific antibody mucoprotein inhibitors, and erythrocytes.Google Scholar
  378. C48.
    2. Reactivity with virus inhibitors in normal sera.Google Scholar
  379. C49.
    3. Morphological characteristics: Independence of morphological and functional traits. J. exp. Med. 112, 895-920, 921-944, and 945-952 (1960).Google Scholar
  380. C50.
    Chu, C. M.: Agglutination of red blood cells of different animal species by influenza and Newcastle disease viruses. J. Hyg. (Lond.) 46, 239–246 (1948).Google Scholar
  381. C51.
    Chu, C. M.: Enzyme action of viruses and bacterial products on human red cells. Nature (Lond.) 162, 606–607 (1948).Google Scholar
  382. C52.
    Chu, C. M.: Inactivation of haemagglutinin and infectivity of influenza and Newcastle disease viruses by heat and by formalin. J. Hyg. (Lond.) 46, 247–251 (1948).Google Scholar
  383. C53.
    Chu, C. M.: The action of normal mouse serum on influenza virus. J. gen. Microbiol. 5, 739–757 (1951).PubMedGoogle Scholar
  384. C54.
    Chu, C. M.: The etiology and epidemiology of influenza: An analysis of the 1957 epidemic. J. Hyg. Epidem. (Praha) 2, 1–8 (1958).Google Scholar
  385. C55.
    Chu, C. M., C. H. Andrewes, and A. W. Gledhill: Influenza in 1948–49. Bull. Wld Hlth Org. 3, 197–214 (1950).Google Scholar
  386. C56.
    Chu, C. M., I. M. Dawson, and W. J. Elford: Filamentous forms associated with newly isolated influenza virus. Lancet 602 (1949).Google Scholar
  387. C57.
    Chu, C. M., C. Shao, and C. C. Hou: Study of strains of influenza viruses isolated during the 1957 epidemic in Changchun (Russian). Vop. Virus 2, 278–281 (1957).PubMedGoogle Scholar
  388. C58.
    Clark, R. J., A. Isaacs, and J. Walker: Derivatives of 3:4 xylidine and related compounds as inhibitors of influenza virus: Relationships between chemical structure and biological activity. Brit. J. Pharmacol. 13, 424–435 (1958).PubMedGoogle Scholar
  389. C59.
    Clarke, E., and F. P. O. Nagler: Haemagglutination by viruses. The range of susceptible cells with special reference to agglutination by vaccinia virus. Aust. J. exp. Biol. med. Sci. 21, 103–106 (1943).Google Scholar
  390. C60.
    Clarke, S. K. R., and D. A. J. Tyrrell: The neutralisation of influenza and other viruses by homologous immune serum. Studies in roller tube tissue cultures. Arch. ges. Virusforsch. 8, 453–468 (1958).Google Scholar
  391. C61.
    Cleeland, R., and A. P. McKee: Antigenic variation of Asian influenza virus. Proc. Soc. exp. Biol. (N.Y.) 99, 371–374 (1958).Google Scholar
  392. C62.
    Cleeland, R., and J.Y. Sugg: Effect of trypsin on a susceptible strain of influenza virus. J. Immunol. 85, 539–545 (1960).PubMedGoogle Scholar
  393. C63.
    Cleeland, R., and J. Y. Sugg: Inactivation of haemagglutinating capacity of type A influenza virus by trypsin treatment. Proc. Soc. exp. Biol. (N.Y.) 112, 913–917 (1963).Google Scholar
  394. C64.
    Cleeland, R., and J. Y. Sugg: Serologic and antigenic properties of type A influenza virus after trypsin treatment. J. Immunol. 93, 414–419 (1964).PubMedGoogle Scholar
  395. C65.
    Cochran, K. W., H. F. Maassab, A. Tsunoda, and B.S. Berlin: Studies on the antiviral activity of amantadine hydrochloride. Ann. N. Y. Acad. Sci. 130, 432–439 (1965).PubMedGoogle Scholar
  396. C66.
    Cocito, C., P. Laduron, and P. De Somer: Nucleotide composition of RNA viruses. Proc. Soc. gen. Microbiol. April 1963.Google Scholar
  397. C67.
    Coffey, J. P., and W. J. Jessop: Maternal influenza and congenital deformities. Lancet 935-938 (1959).Google Scholar
  398. C68.
    Coggeshall, L. T., and J. Maier: Effect of various sulphonamides, sulphones, and other compounds against experimental influenza and poliomyelitis infection in white mice. J. Pharmacol. 76, 161–166 (1942).Google Scholar
  399. C69.
    Cohen, A.: Protection of mice against Asian influenza virus infection by a normal horse serum inhibitor. Lancet 791-794 (1960).Google Scholar
  400. C70.
    Cohen, A., and G. Belyavin: Haemagglutination-inhibition of Asian influenza viruses: A new pattern of response. Virology 7, 59–74 (1959).PubMedGoogle Scholar
  401. C71.
    Cohen, A., and G. Belyavin: The influenza virus haemagglutination inhibitors of normal rabbit serum. 1. Separation of the inhibitory components. Virology 13, 58–67 (1961).PubMedGoogle Scholar
  402. C72.
    Cohen, A., and G. Belyavin: An automatic titration method for influenza haemagglutination inhibitors and its application to large scale antibody surveys. Abstr. 9th int. Congr. Microbiol. Moscow 379 (1966).Google Scholar
  403. C73.
    Cohen, A., G. Belyavin, and S. E. Newland: Analysis of the horse serum inhibitor of A2 influenza virus haemagglutination and infectivity. Abstr. D 30.4. 8th int. Congr. Microbiol. (1962).Google Scholar
  404. C74.
    Cohen, A., and F. Biddle: The effect of passage in different hosts on the inhibitor sensitivity of an Asian influenza virus strain. Virology 11, 458–473 (1960).PubMedGoogle Scholar
  405. C75.
    Cohen, A., F. Biddle, and S. E. Newland: Analysis of horse serum inhibitors of A2 influenza virus haemagglutination. Brit. J. exp. Path. 46, 497–513 (1965).PubMedGoogle Scholar
  406. C76.
    Cohen, A., and J. Dorman: Non-specific inhibitors of A2 influenza virus in human sera. Acta virol. 9, 519–525 (1965).PubMedGoogle Scholar
  407. C77.
    Cohen, A., and W. Smith: The heterogeneity of influenza virus particles within a single influenza virus strain. Brit. J. exp. Path. 38, 385–395 (1957).PubMedGoogle Scholar
  408. C78.
    Cohn, Z. A.: Quantitative distribution of phosphorus in chorioallantoic membrane as affected by infection with influenza virus. Proc. Soc. exp. Biol. (N.Y.) 79, 566–568 (1952).Google Scholar
  409. C79.
    Colville, J. M., J.M. Dunbar, and H. R. Morgan: Temperature and host cell factors in the growth of influenza virus (PR8 strain) in avian tissues in vitro. J. Immunol. 76, 264–269 (1956).PubMedGoogle Scholar
  410. C80.
    Commission on acute respiratory diseases. Endemic influenza. Amer. J. Hyg. 47, 290-296 (1948).Google Scholar
  411. C81.
    Commission on acute respiratory diseases. Influenza B. Study of a localised outbreak preceding the 1945 epidemic. Amer. J. Hyg. 47, 297-303 (1948).Google Scholar
  412. C82.
    Commission on influenza. Vaccination against Asian influenza. J. Amor. med. Ass. 165, 2054-2058 (1957).Google Scholar
  413. C83.
    Committee on standard serological procedures in influenza diagnostic studies. An agglutination-inhibition test proposed as a standard of reference in influenza diagnostic studies. J. Immunol. 65, 347-353 (1950).Google Scholar
  414. C84.
    Coto, V., C. A. Galeota, and F. Coraggio: Inhibition of interferon production by a halogenated pyrimidine derivative 5-fluoro-2-deoxyuridine. Tex. Rep. Biol. Med. 24, 158–163 (1966).PubMedGoogle Scholar
  415. C85.
    Cox, H. R., J. Van der Scheer, S. Aiston, and E. Bohnel: The purification and concentration of influenza virus by means of alcohol precipitation. J. Immunol. 56, 149–166 (1947).PubMedGoogle Scholar
  416. C86.
    Cox, C. D., A. Zerschling, and R. Melroy: Haemolysis of PR8 virus sensitised erythrocytes. Proc. Soc. exp. Biol. (N.Y.) 84, 693–696 (1953).Google Scholar
  417. C87.
    Creighton, C.: A history of epidemics in Britain. Cambridge University Press 2 vols. 1891 and 1894.Google Scholar
  418. C88.
    Csaky, T. Z., F. Lanni, and J. W. Beard: Purification of the egg white inhibitor of influenza virus haemagglutination by filtration. Proc. Soc. exp. Biol. (N.Y.) 75, 105–108 (1950).Google Scholar
  419. C89.
    Csonka, A., and A. Koch: Effects of formaldehyde on influenza virus. 3. Effects on the virus as antigen. Acta microbiol. Acad. Sci. hung. 9, 89–96 (1962).PubMedGoogle Scholar
  420. C90.
    Culver, J. D., E. H. Lennette, G. Navarre, and G. A. Donahue: The recall phenomenon in the antibody response to influenza virus vaccines. J. Immunol. 81, 452–459 (1958).PubMedGoogle Scholar
  421. C91.
    Culver, J. O., E. H. Lennette, G. Navarre, and C. H. Kempe: The response to influenza vaccines as determined by levels of complement fixing antibody in the acute phase of patients with respiratory disease. J. Immunol. 84, 98–105 (1960).PubMedGoogle Scholar
  422. C92.
    Culver, O., E. H. Lennette. T. E. Stevens, and R. E. Nitz: Antibody response to influenza vaccines containing the Asian strain. J. Immunol. 85, 197–202 (1960).PubMedGoogle Scholar
  423. C93.
    Curtain, C. C.: The action of urea on the urinary inhibitor of influenza virus haemagglutination. Aust. J. exp. Biol. med. Sci. 31, 615–622 (1953).PubMedGoogle Scholar
  424. C94.
    Curtain, C. C.: The nature of the bond split by the influenza virus enzyme. Aust. J. exp. Biol. med. Sci. 31, 623–630 (1953).PubMedGoogle Scholar
  425. C95.
    Curtain, C. C.: The adsorption of influenza virus by haemagglutination inhibitors coupled to powdered cellulose. Brit. J. exp. Path. 35, 255–263 (1954).PubMedGoogle Scholar
  426. C96.
    Curtain, C. C., E. L. French, and J. Pye: The preparation and properties of an inhibitor of influenza virus haemagglutination from human meconium. Aust. J. exp. Biol. med. Sci. 31, 349–360 (1953).PubMedGoogle Scholar
  427. C97.
    Curtain, C. C., B. P. Marmion, and J. Pye: Separation of an inhibitor of influenza virus haemagglutination from human sputum. Nature (Lond.) 171, 33–34 (1953).Google Scholar
  428. C98.
    Curtain, C. C., and J. Pye: A mucoprotein from bovine submaxillary glands with restricted inhibitory action against influenza virus haemagglutination. Aust. J. exp. Biol. med. Sci. 33, 315–322 (1955).PubMedGoogle Scholar
  429. C99.
    Cutting, W. C., R. H. Dreisbach, R. M. Halpern, E. A. Irwin, D. W. Jenkins, F. Proescher, and H.B. Tripi: Chemotherapy in virus infections. J. Immunol. 57, 379–390 (1947).PubMedGoogle Scholar
  430. D1.
    Dachy, H. A.: Influenza virus and staphylococcal infection (French). 17th Congr. Ass. pediat. lang. franç. Montpellier, 1958.Google Scholar
  431. D2.
    Dales, S., and P. W. Choppin: Attachment and penetration of influenza virus. Virology 18, 489–493 (1962).PubMedGoogle Scholar
  432. D3.
    Daniels, J. B., M. D. Eaton, and M. E. Perry: Effect of glucose on the growth of influenza virus in de-embryonated eggs and in tissue cultures. J. Immunol. 69, 321–329 (1952).PubMedGoogle Scholar
  433. D4.
    Danon, D., Z. Jerushalmy, A. Kohn, and A. De Vries: In vitro phagocytosis by leucocytes of influenza virus adsorbed onto erythrocytes. Electron microscopic and cinematographic observations. Virology 15, 258–262 (1961).Google Scholar
  434. D5.
    Danon, D., Z. Jerushalmy, and A. De Vries: Incorporation of influenza virus in human blood platelets in vitro. Electron microscopical observations. Virology 9, 719–722 (1959).PubMedGoogle Scholar
  435. D6.
    Davenport, F. M.: Alternate passage of influenza virus. A comparison of the effects of serial passage and alternate passage of type B influenza virus in hamsters. J. Immunol. 67, 83–92 (1951).PubMedGoogle Scholar
  436. D7.
    Davenport, F. M.: Reliability of 50% egg infectivity titrations with suspensions of influenza viruses prepared from mouse lungs. Proc. soc. exp. Biol. (N.Y.) 82, 1–5 (1953).Google Scholar
  437. D8.
    Davenport, F. M.: The inequality of potential in influenza virus for adaptation to mice. J. Immunol. 72, 485–488 (1954).PubMedGoogle Scholar
  438. D9.
    Davenport, F. M.: Vaccination against respiratory diseases caused by viruses. J. Mich. med. Soc. 57, 702–705 (1958).PubMedGoogle Scholar
  439. D10.
    Davenport, F. M.: Control of influenza by vaccination. Proc. 6th int. Congr. trop. Med. Malaria 5, 454–466 (1959).Google Scholar
  440. D11.
    Davenport, F. M.: Inactivated influenza virus vaccines. Amer. Rev. resp. Dis. 83, 146–150 (1961).PubMedGoogle Scholar
  441. D12.
    Davenport, F. M.: Pathogenesis of influenza. Bact. Rev. 25, 294–300 (1961).PubMedGoogle Scholar
  442. D13.
    Davenport, F. M.: Influenza. Industry and Tropical Hlth 4 (1961).Google Scholar
  443. D14.
    Davenport, F. M.: Current knowledge of influenza vaccine. J. Amer. med. Ass. 182, 11–13 (1962).Google Scholar
  444. D15.
    Davenport, F. M.: Factors of importance in the control of influenza. Medical clinics of North America 47, 1185–1190 (1963).PubMedGoogle Scholar
  445. D16.
    Davenport, F. M., and T. Francis: A comparison of the growth curves of adapted and unadapted lines of influenza virus. J. exp. Med. 93, 129–137 (1951).PubMedCentralPubMedGoogle Scholar
  446. D17.
    Davenport, F. M., and A. V. Hennessy: A serologic recapitulation of past experiences with influenza A; Antibody response to monovalent vaccine. J. exp. Med. 104, 85–97 (1956).PubMedCentralPubMedGoogle Scholar
  447. D18.
    Davenport, F. M., and A. V. Hennessy: Predetermination by infection and by vaccination of antibody response to influenza virus vaccines. J. exp. Med. 106, 835–850 (1957).PubMedCentralPubMedGoogle Scholar
  448. D19.
    Davenport, F. M., and A. V. Hennessy: The clinical epidemiology of Asian influenza. Ann. intern. Med. 49, 493–501 (1958).PubMedGoogle Scholar
  449. D20.
    Davenport, F. M., A. V. Hennessy, and J. A. Bell: Immunologic advantages of emulsified influenza virus vaccines. Milit. Med. 127, 95–100 (1962).Google Scholar
  450. D21.
    Davenport, F. M., A. V. Hennessy, S. H. Bernstein, O. F. Harper, and W. H. Klingensmith: Comparative incidence of influenza A-prime in 1953 in completely vaccinated and unvaccinated military groups. Amer. J. publ. Hlth 45, 1138–1146 (1955).Google Scholar
  451. D22.
    Davenport, F. M., A. V. Hennessy, F. M. Brandon, R. G. Webster, C. D. Barrett, and Gr. O. Lease: Comparisons of serologic and febrile responses in humans to vaccination with influenza A viruses or their haemagglutinins. J. Lab. clin. Med. 63, 5–13 (1964).PubMedGoogle Scholar
  452. D23.
    Davenport, F. M., A. V. Hennessy, J. Drescher, J. Mulder, and T. Francis: Further observations on the relevance of serologic recapitulation of human infection with influenza viruses. J. exp. Med. 120, 1087–1097 (1964).PubMedCentralPubMedGoogle Scholar
  453. D24.
    Davenport, F. M., A. V. Hennessy, and T. Francis: Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J. exp. Med. 98, 641–656 (1953).PubMedCentralPubMedGoogle Scholar
  454. D25.
    Davenport, F. M., A. V. Hennessy, and T. Francis: Influence of primary antigenic experience upon the development of a broad immunity to influenza. Trans. Ass. Amer. Phycns 70, 81–90 (1957).Google Scholar
  455. D26.
    Davenport, F. M., A. V. Hennessy, H. B. Houser, and W. F. Cryns: An evaluation of an adjuvant influenza virus vaccine tested against influenza B in 1954–55. Amer. J. Hyg. 64, 304–313 (1956).PubMedGoogle Scholar
  456. D27.
    Davenport, F. M., A. V. Hennessy, C H. Stuart-Harris, and T. Francis: Epidemiology of influenza: Comparative serological observations in England and the USA. Lancet 469 (1955).Google Scholar
  457. D28.
    Davenport, F. M., and F. L. Horsfall: The associative reactions of pneumonia virus of mice (PVM) and influenza viruses: The effects of pH and electrolytes upon virus-host cell combinations. J. exp. Med. 88, 621–644 (1948).PubMedCentralPubMedGoogle Scholar
  458. D29.
    Davenport, F. M., R. Rott, and W. Schafer: Physical and biological properties of influenza virus components obtained after ether treatment. Fed. Proc. 18, 563 (1959).Google Scholar
  459. D30.
    also: J. exp. Med. 112, 765–782 (1960).Google Scholar
  460. D31.
    Davies, P., and R. D. Barry: Nucleic acid of influenza virus. Nature (Lond.) 211, 384–387 (1966).Google Scholar
  461. D32.
    Davies, W. L., R. R. Grunert, R. F. Haff, J. W. McGahen, E. M. Neumayer, M. Paulstock, J. C. Watts, T. R. Wood, E. C. Hermann, and C.E. Hoffmann: Antiviral activity of 1-adamantanamine (amantadine). Science 144, 862–863 (1964).PubMedGoogle Scholar
  462. D33.
    Davies, W. L., R. R. Grunert, and C. E. Hoffmann: Influenza virus growth and antibody response in amantadine treated mice. J. Immunol. 95, 1090–1094 (1965).PubMedGoogle Scholar
  463. D34.
    Davoli, R., and O. Bartolomei-Corsi: Antibodies against the Asian influenza virus in the normal population (Italian). Sperimentale 107, 358–362 (1957).PubMedGoogle Scholar
  464. D35.
    Dawson, C. R., M. A. Epstein, and K. Hummeler: Cytochemical and electron microscopical observations on the presence and origin of adenosine triphosphatase-like activity at the surface of two myxoviruses. J. Bact. 89, 1526–1532 (1965).PubMedGoogle Scholar
  465. D36.
    Dawson, I. M., and W. J. Elford: Electron microscope studies on the interaction of certain viruses with fowl red cell membranes. Nature (Lond.) 163, 63–64 (1949).Google Scholar
  466. D37.
    Dawson, I. M., and W. J. Elford: The investigation of influenza related viruses in the electron microscope by a new technique. J. gen. Microbiol. 3, 298–311 (1949).PubMedGoogle Scholar
  467. D38.
    De Burgh, P. M., P. C. Yu, C. Howe, and M. Bovarnick: Preparation from human red cells of a substance inhibiting virus haemagglutination. J. exp. Med. 87, 1–9 (1948).Google Scholar
  468. D39.
    DeMeio, J. L., E. L. Wooldridge, J. E. Whiteside, and J. E. Seal: Epidemic influenza B and C in Navy recruits 1953–54. 2. Antigenic studies on influenza virus type C. Proc. Soc. exp. Biol. (N.Y.) 88, 436–438 (1955).Google Scholar
  469. D40.
    Dempster, G., and B. Buchner: Seriological pattern of influenza virus strains isolated in Canada from 1948–1951. Canad. med. Ass. J. 69, 119–124 (1953).PubMedGoogle Scholar
  470. D41.
    Denk, H, and W. Kovac: Immunofluorescence studies of the growth of influenza virus in mouse lung. 1. Studies of infection with mouse-adapted virus (German). Arch. ges. Virusforsch. 17, 641 (1965).PubMedGoogle Scholar
  471. D42.
    Denk, H., and W. Kovac: Immunofluorescence studies of the growth of influenza virus in mouse lung. 2. Studies of infection with non mouse-adapted virus. Arch. ges. Virusforsch. 18, 244–252 (1966).PubMedGoogle Scholar
  472. D43.
    Denk, H., and W. Kovac: Immunofluorescence studies on intranasal influenza virus infection in immunised mice (German). Arch. ges. Virusforsch. 18, 294–303 (1966).Google Scholar
  473. D44.
    Depoux, E., and P. Fiset: Serological behaviour of influenza viruses. 1. The effect of different fowl erythrocytes on the results of serological tests. Bull. Wld Hlth Org. 11, 981–986 (1954).Google Scholar
  474. D45.
    Depoux, R., and A. Isaacs: Interference between influenza and vaccinia viruses. Brit. J. exp. Path. 35, 415–418 (1954).PubMedGoogle Scholar
  475. D46.
    Depoux, R., and A. Isaacs: Effect of inhibitors on interference between influenza and vaccinia viruses. Brit. J. exp. Path. 35, 419–425 (1954).PubMedGoogle Scholar
  476. D47.
    Depoux, R., and M. V. Mussett: Attempts to potentiate immunity to influenza in mice. J. Hyg. (Lond.) 52, 469–474 (1954).Google Scholar
  477. D48.
    Derevici, A.: Action of certain metals on haemagglutination (Rumanian). Comunicarilo Acad. R.P.R. 2, 375–376 (1952).Google Scholar
  478. D49.
    Derevici, A., A. Petrescu, L. Eothschild, and A. Bronitki: Epidemiologic and ecologic aspects of summer influenza in 1957 in the Romanian Peoples Republic (Rumanian). Stud. Cercet. Inframicrobiol. 9, 21–30 (1958).Google Scholar
  479. D50.
    Derevici, A., D. Sarateanu, A. Bronitki, A. Petrescu, L. Rothschild, N. Draganescu, C. Satmari, J. Petrusca, A. Stangu, A. Timerman, and M. Pironcof: The dynamic of serial influenzal antibodies in infants and adults vaccinated with “autochtone” vaccine (Rumanian). Stud. Cercet. Inframicrobiol. 6, 429–441 (1955).PubMedGoogle Scholar
  480. D51.
    Derevici, A., D. Sarateanu, L. Rothschild, A. Petrescu, A. Bronitki, J. Selevartz, and O. Moscovivi: Laboratory investigations during the 1967 influenza epidemic in the Romanian Peoples Republic (Rumanian). Stud. Cercet. Inframicrobiol. 8, 507–516 (1957).Google Scholar
  481. D52.
    De Ritis, F., G. Giusti, and V. Villari: The effect of N-ethyl maleimide on influenza virus multiplication (Italian). Arch. ges. Virusforsch. 5, 432–440 (1954).Google Scholar
  482. D53.
    Dick, G. W. A., and R. M. Taylor: Bovine plasma albumin in buffered saline as a diluent for viruses. J. Immunol. 62, 311–317 (1949).PubMedGoogle Scholar
  483. D54.
    Dickinson, L.: The formaldehyde derivatives of aminoacids and the mode of action of a formaldehyde-tyrosine derivative against influenza A virus in ovo. Brit. J. Pharmacol. 10, 56–60 (1955).PubMedGoogle Scholar
  484. D55.
    Diebel, R., and J. E. Hotchin: Quantitative application of fluorescent antibody technique to influenza virus infected cell cultures. Virology 8, 367–380 (1959).Google Scholar
  485. D56.
    Dinter, Z.: A variant of the fowl plague virus in Bayern (German). Tierärztl. Umsch. 4, 185–186 (1949).Google Scholar
  486. D57.
    Ditchfield, J. N. W. MacPherson, and A. Zbitnew: Upper respiratory disease in thoroughbred horses: Studies of its viral etiology in the Toronto area 1960 to 1963. Ann. J. comp. Med. Vet. Sci. 29, 18–22 (1965).Google Scholar
  487. D58.
    Doll, E. R.: Influenza of horses. Amer. Rev. resp. Dis. 83, 48–50 (1961).PubMedGoogle Scholar
  488. D69.
    Domracheva, Z. V.: An influenza A2 outbreak in men and horses (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSR Moscow 47 (1959).Google Scholar
  489. D60.
    Donald, H. B., and A. Isaacs: Some properties of influenza virus filaments shown by electron microscopic particle counts. J. gen. Microbiol. 11, 325–331 (1954).PubMedGoogle Scholar
  490. D61.
    Donald, H. B., and A. Isaacs: Counts of influenza virus particles. J. gen. Microbiol. 10, 457–464 (1954).PubMedGoogle Scholar
  491. D62.
    Dorman, D. C.: Effect of urea on A2 influenza virus. Nature (Lond.) 203, 789–791 (1964).Google Scholar
  492. D63.
    Dowdle, W. R., W. B. Yarbrough, and R. Q. Robinson: U.S. epizootic of equine influenza 1963. Publ. Hlth Rep. (Wash.) 79, 398–402 (1964).Google Scholar
  493. D64.
    Draganov, K. I.: Hypothesis on the nature of elementary bodies and “NV” bodies in cultures of influenza virus (Russian). J. gen. Biol. Moscow 17, 13–22 (1956).Google Scholar
  494. D65.
    Draganov, K. I.: New electron microscopic data on the study of the influenza virus (Russian). Byull. Eksper. biol. i med. 10, 53 (1953).Google Scholar
  495. D66.
    Draganov, K. I., and A. N. Slepushkin: Comparative electron microscopic study of the influenza virus cultivated in the chorioallantoic cavity and in tissue culture (Russian). Vop. Virus. 4, 64 (1954).Google Scholar
  496. D67.
    Drescher, J.: Determination of haemagglutinin and antibody content. 1. Description of photometric procedure for determining virus content.Google Scholar
  497. D68.
    2. Investigations on inhibitory antibody and description of a photometric method for determining antibody content (German). Zbl. Bakt. 1. Abt. Orig. 169, 314-348 and 461-470 (1957).Google Scholar
  498. D69.
    Drescher, J.: The influenza pandemic of 1957. Reports and discussions at a meeting of specialists Nov. 1957 in Berlin. Concerning A/Asia/57 Y-aluminium oxide vaccines. Abhandl. Bundesgesundheitsamt 1, 42–49 (1958).Google Scholar
  499. D70.
    Drescher, J.: Adsorption phenomena as a means of differentiating viral species. Zbl. Bakt. I. Abt. Orig. 176, 295–301 (1959).Google Scholar
  500. D71.
    Drescher, J.: Comparison of the adsorption of influenza virus strain B/Berlin/2/55 on aluminium oxide and on aluminium hydroxide. Amer. J. Hyg. 74, 104–118 (1961).PubMedGoogle Scholar
  501. D72.
    Drescher, J., F. M. Davenport, and A. V. Hennessy: Photometric methods for the measurement of haemagglutinating viruses and antibody. 2. Further experience with antibody determinations and the description of a technique for analysis of virus mixtures. J. Immunol. 89, 805–814 (1962).Google Scholar
  502. D73.
    Drescher, J., A. V. Hennessy, and F. M. Davenport: Photometric methods for the measurement of haemagglutinating viruses and antibody. 1. Further experience with a novel photometric method for measuring haemagglutinins. J. Immunol. 89, 794–804 (1962).Google Scholar
  503. D74.
    Drescher, J., and F. C. Lange: The determination of haemagglutinin and antibody. 4. Description of a photometric procedure for the determination of specific and unspecific inhibiting antibodies (German). Zbl. Bakt. I. Abt. Orig. 173, 185–195 (1958).Google Scholar
  504. D75.
    Drevo, M., A. Spousta, B. Blasco, and D. Slonim: Preparation of specific equine serum against influenza (Czech.). Čs. Epidem. 7, 175–181 (1958).Google Scholar
  505. D76.
    Dreyzin, R. S.: Method of preparing concentrated and purified influenza virus by the method of elution with formolised erythrocytes (Russian). Gripp. Tr. AMN SSSR Moscow 28, 82 (1953).Google Scholar
  506. D77.
    Dreyzin, R. S.: Conditions of reaction of the influenza virus with susceptible erythrocytes in the presence of specific antibodies (Russian). Gripp. Tr. AMN SSSR Moscow 28, 198 (1953).Google Scholar
  507. D78.
    Dreyzin, R. S.: The methods of studying the effect of chemotherapeutic preparations on an experimental influenza model (Russian). Vop. Virus. 4, 344 (1954).Google Scholar
  508. D79.
    Dreyzin, R. A., A. A. Davydova, E. E. Zolotarskaya, and A. G. Bukrinskaya: Differential diagnostic methods for adenoviruses and the viruses of herpes, influenza and poliomyelitis (Russian). Vop. Virus. 5, 178–183 (1958).Google Scholar
  509. D80.
    Dreyzin, R. S., and M. I. Karlina: The effect of an iodine preparation and apple pectin on experimental influenzal infection (Russian). Vop. Virus. 4, 331 (1954).Google Scholar
  510. D81.
    Dreyzin, R. S., and N. N. Sokolova: The effect of eucalyptus leaf extracts on the multiplication of influenza virus in the developing chick embryo (Russian). Vop. Virus 4, 323 (1954).Google Scholar
  511. D82.
    Dreyzin, R. S., and Ye. S. Zalmanzan: Serological diagnosis of fatal cases of influenzal pneumonias. Vop. Virus 4, 290 (1954).Google Scholar
  512. D83.
    Drzeniek, R.: Inhibition of neuraminidase by polyanions. Nature (Lond.) 211, 1205–1206 (1966).Google Scholar
  513. D84.
    Drzeniek, R., J. C. Seto, and R. Rott: Characterisation of neuraminidases from myxoviruses. Biochim. biophys. Acta (Amst.) 128, 547–558 (1966).Google Scholar
  514. D85.
    Dubakina, A. V., I. A. Sutina, and B. S. Vul’vovich: Efficacy of immunisation against influenza with dry live vaccine in Stalingrad in 1952 (Russian). Zh. Mikrobiol. (Mosk.) 10, 63 (1953).Google Scholar
  515. D86.
    Dubakina, A. V., and E. E. Kushnareva: Some features of the 1957 influenza outbreak in the Stalingrad district (Russian). Vop. Virus 4, 162–164 (1959).PubMedGoogle Scholar
  516. D87.
    Dubinakova, A. M.: Data on haematology and rhinocytology of influenza in 1957 (Russian). Vop. Virus 5, 83–86 (1958).Google Scholar
  517. D88.
    Dubrovina, T. Ya.: Conditions of isolation of infectious ribonucleic acid from influenza virus. Acta virol. 10, 117–123 (1966).PubMedGoogle Scholar
  518. D89.
    Duc-Nguyen, H., H. M. Rose, and C. Morgan: An electron microscopic study of changes at the surface of influenza-infected cells as revealed by ferritin conjugated antibodies. Virology 28, 404–412 (1966).PubMedGoogle Scholar
  519. D90.
    Dudgeon, J. A., H. Mellanby, R. E. Glover, and C. H. Andrewes: Influenza in Groat Britain in 1946–47. Brit. J. exp. Path. 29, 132–141 (1948).PubMedGoogle Scholar
  520. D91.
    Dudgeon, J. A., C. H. Stuart-Harris, R. E. Glover, C. H. Andrewes, and W.H. Bradley: Influenza B in 1945–46. Lancet 627-631 (1946).Google Scholar
  521. D92.
    Dujarric De La Riviere, R., and J. Cheve: Influenza virus in ferrets. Study of different French strains of influenza virus (French). Ann. Inst. Pasteur 59, 445–456 (1937).Google Scholar
  522. D93.
    Dulbecco, R., and M. Vogt: Plaque formation and isolation of pure lines with poliomyelitis viruses. J. exp. Med. 99, 167–182 (1954).PubMedCentralPubMedGoogle Scholar
  523. D94.
    Dulbecco, R., and M. Yogt: One step growth curves of Western Equine encephalomyelitis virus on chicken embryo cells grown in vitro and analysis of virus yields from single cells. J. exp. Med. 99, 183–199 (1954).PubMedCentralPubMedGoogle Scholar
  524. D95.
    Duncan, I. B. R., M. O. Creighton, and B. Jeans: Epidemic Type A influenza in Southwestern Ontario in 1963. Canad. med. Ass. J. 91, 541 (1964).PubMedGoogle Scholar
  525. D96.
    Dunham, W. B., and W. J. MacNeal: Inactivation of influenza virus by mild antiseptics. J. Immunol. 49, 123–128 (1944).Google Scholar
  526. D97.
    Durand, P.: The susceptibility of certain Tunisian rodents to influenza virus (French). C.R. Soc. Biol. (Paris) 139, 718–719 (1945).Google Scholar
  527. D98.
    Dzagurov, S. G.: Experimental study of the effect of antibiotics on microbes encountered in influenza and on the influenza A virus (Russian). Tr. ob’yed. nauch. Sess. AMN SSSR, Moscow, 162-171 (1953).Google Scholar
  528. E1.
    Eaton, M. D.: Transmission of epidemic influenza virus by contact in mice. J. Bact. 39, 220–241 (1940).Google Scholar
  529. E2.
    Eaton, M. D.: Experimental immunisation of mice with the virus of epidemic influenza. 1. Quantitative studies on the antigenicity of active and inactive virus. J. Immunol. 39, 43–45 (1940).Google Scholar
  530. E3.
    Eaton, M. D.: Strain specificity of complement fixation with sera of mice immune to the virus of influenza A and swine influenza. J. Immunol. 41, 383–389 (1941).Google Scholar
  531. E4.
    Eaton, M. D., L. T. Adler, P. Bond, and A. R. Scala: The effect of thyroxin on respiration and virus growth in chick embryo tissue cultures. J. infect. Dis. 98, 239–248 (1956).PubMedGoogle Scholar
  532. E5.
    Eaton, M. D., L. T. Adler, and M. E. Perry: Virus growth and cellular energy production. Effect of substances chemically related to thyroxin on influenza viruses. Proc. Soc. exp. Biol. (N.Y.) 84, 57–60 (1953).Google Scholar
  533. E6.
    Eaton, M. D., and M. D. Beck: Experimental immunisation of mice with the virus of epidemic influenza. 2. Immunity after intranasal inoculation of mouse passage, tissue culture, and ferret passage strains. J. Immunol. 39, 57–64 (1940).Google Scholar
  534. E7.
    Eaton, M. D., and M. D. Beck: A new strain of virus of influenza B isolated during an epidemic in California. Proc. Soc. exp. Biol. (N.Y.) 48, 177–180 (1941).Google Scholar
  535. E8.
    Eaton, M. D., M. Corey, W. Van Herick, and G. Meiklejohn: A comparison of various methods of demonstrating influenza virus in throat washings. Proc. Soc. exp. Biol. (N.Y.) 58, 6–9 (1945).Google Scholar
  536. E9.
    Eaton, M. D., C. G. Levenson, and M. Perry: Inhibition of the growth of viruses in the chick embryo by aromatic diamidines. J. Immunol. 68, 1–9 (1952).PubMedGoogle Scholar
  537. E10.
    Eaton, M. D., I. E. Low, A. R. Scala, and S. Uretsky: Inhibition by ammonium ion of the growth of influenza virus in chorioallantoic tissue. Virology 18, 102–108 (1962).PubMedGoogle Scholar
  538. E11.
    Eaton, M. D., B. Magasanik, M.E. Perry, and D. Karibian: Inhibition of influenza and mumps viruses in tissue culture by basic aminoacids. Proc. Soc. exp. Biol. (N.Y.) 77, 505–508 (1951).Google Scholar
  539. E12.
    Eaton, M. D., and W.P. Martin: Personnel of Naval Lab. Res. unit No. 1. Immunisation with inactive virus of influenza B. Comparison of antibody response with that produced by infection. Publ. Hlth Rep. (Wash.) 57, 445–451 (1942).Google Scholar
  540. E13.
    Eaton, M. D., and G. Meiklejohn: Vaccination against influenza: A study in California during the epidemic of 1943–44. Amer. J. Hyg. 42, 28–44 (1945).Google Scholar
  541. E14.
    Eaton, M. D., and M.E. Perry: Further observations on the effect of 2,4-dinitrophenol on the growth of influenza virus. J. infect. Dis. 93, 269–277 (1953).PubMedGoogle Scholar
  542. E15.
    Eaton, M. D., M.E. Perry, C. G. Levenson, and I. M. Gocke: Studies on the mode of action of aromatic diamidines on influenza and mumps virus in tissue culture. J. Immunol. 68, 321–334 (1952).PubMedGoogle Scholar
  543. E16.
    Eaton, M. D., and A. R. Scala: Reversible effect of hypotonic solutions on the growth of influenza virus in tissue cultures. Proc. Soc. exp. Biol. (N.Y.) 92, 289–297 (1956).Google Scholar
  544. E17.
    Eaton, M. D., and A. R. Scala: Interrelated effects of cysteine, thyroxin, and substrate on the growth of influenza virus in tissue cultures. Arch. ges. Virus-forsch. 7, 274–283 (1957).Google Scholar
  545. E18.
    Eaton, M. D., and A. R. Scala: Inhibitory effect of glutamine and ammonia on replication of influenza virus in ascites tumour cells. Virology 13, 300–307 (1961).PubMedGoogle Scholar
  546. E19.
    Eaton, M. D., A. R. Scala, and I. E. Low: Aminoacid imbalance and incomplete virus replication. Arch. ges. Virusforsch. 14, 583–598 (1964).PubMedGoogle Scholar
  547. E20.
    Eckert, E. A.: Envelope proteins derived from influenza virus. J. Bact. 91, 1907–1910 (1966).PubMedGoogle Scholar
  548. E21.
    Eckert, E. A.: Characterisation of a low molecular weight antigenic protein from the envelope of influenza virus. J. Bact. 92, 1430–1434 (1966).PubMedGoogle Scholar
  549. E22.
    Eckert, E. A., F. Lanni, D. Beard, and J. W. Beard: Effect of swine influenza virus on the viscosity of the egg-white inhibitor of haemagglutination. Science 109, 463–464 (1949).PubMedGoogle Scholar
  550. E23.
    Eddy, B. E.: A study of influenza virus vaccines by a serum-virus neutralisation test and by active immunisation. J. Immunol. 57, 195–202 (1949).Google Scholar
  551. E24.
    Eddy, B. E., and R. W. G. Wyckoff: Influenza virus in sectioned tissues. Proc. Soc. exp. Biol. (N.Y.) 75, 290–293 (1950).Google Scholar
  552. E25.
    Edmunds, P. N.: Immunity to old and new strains of influenza A virus. Brit. med. J. 155-156 (1951).Google Scholar
  553. E26.
    Edney, M.: The influence of calcium ion on the reaction of the V. Cholerae enzyme RDE and influenza virus with specific mucopolysaccharides. Aust. J. exp. Biol. med. Sci. 27, 253–264 (1949).PubMedGoogle Scholar
  554. E27.
    Edney, M.: Genetic analysis of the development of serum resistance in an influenza virus strain. J. gen. Microbiol. 17, 25–38 (1957).PubMedGoogle Scholar
  555. E28.
    Edney, M., and F. M. Burnet: Influence of ions on thermal inactivation and modification of an influenza virus. Aust. J. exp. Biol. med. Sci. 30, 129–138 (1952).PubMedGoogle Scholar
  556. E29.
    Edney, M., and A. Isaacs: Interference between active and inactive influenza viruses in the chick embryo. 3. Inhibition of virus haemagglutination in the chorioallantoic membrane. Aust. J. exp. Biol. med. Sci. 28, 603–612 (1951).Google Scholar
  557. E30.
    Edward, D. G. ff.: Resistance of influenza viruses to drying and its demonstration on dust. Lancet 664-666 (1941).Google Scholar
  558. E31.
    Edward, D. G. ff., W. J. Elford, and P. P. Laidlaw: Studies on air-borne infection. 1. Experimental technique and preliminary observations on influenza and infectious ectromelia. J. Hyg. (Lond.) 43, 1–10 (1943).Google Scholar
  559. E32.
    Edward, D. G. ff., D. Lush, and R. B. Bourdillon: Studies on air-borne virus infections. 2. The killing of virus aerosols by ultraviolet radiation. J. Hyg. (Lond.) 43, 11–15 (1943).Google Scholar
  560. E33.
    Efimova, K. V., L. V. Zakharova, and E. N. Milyaeva: Epidemiologic characteristics of influenza in Kuibyshev from 1957–1959 (Russian). “Problemy Gripp. i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow, 90-92 (1959).Google Scholar
  561. E34.
    Efimova, V. A., and L. Ya. Zakstel’skaya: The mechanism of anamnestic reactions to A influenza virus strains (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow, 167-168 (1959).Google Scholar
  562. E35.
    Elford, W. J., and C. H. Andrewes: Centrifugation studies: Viruses of vaccinia, influenza, and Eous sarcoma. Brit. J. exp. Path. 17, 422–430 (1936).Google Scholar
  563. E36.
    Elford, W. J., C. H. Andrewes, and F. F. Tang: The sizes of the viruses of human and swine influenza as determined by ultrafiltration. Brit. J. exp. Path. 17, 51–53 (1936).Google Scholar
  564. E37.
    Enders, J. F., and H.E. Pearson: Resistance of chicks to infection with influenza virus. Proc. Soc. exp. Biol. (N.Y.) 48, 143–146 (1941).Google Scholar
  565. E38.
    Epshteyn, F. G., A. S. Gorbunova, and P. M. Karakuyumchan: Skin test in influenza (Russian). Yop. Virus. 4, 298 (1954).Google Scholar
  566. E39.
    Epshteyn, F. G., and V. S. Panasyuk: Experience in the treatment of influenza with atabrine (Russian). Vo.-med. Zh. 4, 32–34 (1951).Google Scholar
  567. E40.
    Epshteyn, F. G., N. V. Sergeev, and E. J. Sorokina: The clinical course of Asian influenza in adults (Russian). Klin. med. Moskva. 36, 35–42 (1958).Google Scholar
  568. E41.
    Evans, C. A., and E. R. Rickard: The toxic effect of influenca virus in the rabbit eye. Proc. Soc. exp. Biol. (N.Y.) 58, 74–75 (1945).Google Scholar
  569. F1.
    Fadeyeva, L. L.: Study of the properties of the influenza virus cultivated in tissues outside the body (Russian). Problemy grippa i OKVDP. Tez. dokl. ob’yed. Sess. Inst. AMN SSSR, Moscow 12 (1952).Google Scholar
  570. F2.
    Fadeyeva, L. L.: Isolation of the influenza virus by means of the tissue culture method (Russian). Problemy grippa i OKVDP. Tez. dokl. ob’yed. Sess. Inst. AMN SSSR, Moscow 22 (1952).Google Scholar
  571. F3.
    Fadeyeva, L. L.: Biological properties of the influenza virus cultured in animal and human tissues (Russian). Dissertation, Moscow (1952).Google Scholar
  572. F4.
    Fadeyeva, L. L.: Tissue cultures of the influenza virus (Russian). Zh. Mikrobiol. (Mosk.) 2, 47 (1953).Google Scholar
  573. F5.
    Fadeyeva, L., and A. I. Davientzo: Epidemiological testing of influenza tissue vaccine (Russian). Zh. Mikrobiol. (Mosk.) 10, 25 (1953).Google Scholar
  574. F6.
    Fadeyeva, L. L., V. V. Ritova, and L. Ya. Zakstel’skaya: Perfection of an influenza tissue vaccine (Russian). Vop. Virus 4, 393 (1954).Google Scholar
  575. F7.
    Faillard, H.: Isolation of N-acetylneuraminic acid from mucin by means of receptor destroying enzyme of V. Cholerae (German). Hoppe-Seylers Z. physiol. Chem. 305, 145–148 (1956).PubMedGoogle Scholar
  576. F8.
    Faillard, H.: Liberation of N-acetylneuraminic acid from mucin by the receptor destroying enzyme of V. Cholerae (German). Hoppe-Seylers Z. physiol. Chem. 307, 62–86 (1957).PubMedGoogle Scholar
  577. F9.
    Fairbrother, R. W., and L. Hoyle: Observations on the aetiology of influenza. J. Path. Bact. 44, 213–223 (1937).Google Scholar
  578. F10.
    Fairbrother, R. W., and L. Hoyle: Active immunisation against influenza: The use of heat-killed elementary body suspensions. Brit. J. exp. Path. 18, 430–436 (1937).Google Scholar
  579. F11.
    Fairbrother, R. W., and A. E. Martin: Serologic studies in epidemic influenza with particular reference to the persistence of antibodies after infection. Lancet 718 (1938).Google Scholar
  580. F12.
    Fairbrother, R. W., and A. E. Martin: Further observations on the value of heated elementary body suspensions in immunisation against experimental influenza. Arch. ges. Virusforsch. 1, 114–119 (1939).Google Scholar
  581. F13.
    Falkovich, L. I., M. I. Ignetova, G. A. Piskunova, and Ye. V. Arkhina: Study of the virus of epidemic influenza. Experiment in vaccination of people with the influenza virus (Russian). Tr. Mosk. oblet. Inst. Infekt. bolezn. imeni. Mechnikova, Moscow, 239 (1939).Google Scholar
  582. F14.
    Farkas, E., and G. Takatsy: Isolation of strains of influenza virus (Hungarian). Nepegeszsegugy Budapest 30, 402–409 (1949).Google Scholar
  583. F15.
    Fauconnier, B.: Changes in pH of allantoic fluid inoculated with influenza virus, growth of virus in slightly acid allantoic fluid (French). Ann. Inst. Pasteur 85, 222–229 (1953).Google Scholar
  584. F16.
    Fauconnier, B.: Development of influenza virus and pH of the allantoic fluid of embryonated egg. 5. Acidifying and inhibitory effect of ammonium salts (French). Ann. Inst. Pasteur 90, 171–181 (1955).Google Scholar
  585. F17.
    Fauconnier, B.: Spontaneous variation of type A influenza virus towards serum inhibitors of normal animals (French). Ann. Inst. Pasteur 97, 377–384 (1959).Google Scholar
  586. F18.
    Fauconnier, B., and H. Beauchamp: A study of the duration of viraemia in mice inoculated with influenza virus (French). Ann. Inst. Pasteur 86, 660–663 (1954).Google Scholar
  587. F19.
    Fauconnier, B., and M. Chaigneau: Inhibition of influenza virus multiplication by thioparatoluidine and certain of its derivatives (French). Ann. Inst. Pasteur 94, 514–516 (1958).Google Scholar
  588. F20.
    Fauconnier, B., R. M. Lartitegui, and D. Barua: Experimental adaptation of influenza virus to inhibitors of normal sera. 1. Isolation of a non-sensitive variant by cultivation of the sensitive strain in the presence of its inhibitor (French). Ann. Inst. Pasteur 97, 473–478 (1959).Google Scholar
  589. F21.
    Fazekas De St Groth, S.: Destruction of influenza receptors in the mouse lung by an enzyme from V. Cholerae. Aust. J. exp. Biol. med. Sci. 26, 29–36 (1948).PubMedGoogle Scholar
  590. F22.
    Fazekas De St Groth, S.: Regeneration of virus receptors in mouse lungs after artificial destruction. Aust. J. exp. Biol. med. Sci. 26, 271–285 (1948).Google Scholar
  591. F23.
    Fazekas De St Groth, S.: Viropexis: The mechanism of influenza virus infection. Nature (Lond.) 162, 294–295 (1948).Google Scholar
  592. F24.
    Fazekas De St Groth, S.: Modification of virus receptors by metaperiodate. 1. The properties of IO4 treated red cells. Aust. J. exp. Biol. med. Sci. 27, 65–81 (1949).PubMedGoogle Scholar
  593. F25.
    Fazekas De St Groth, S.: Influenza: A study in mice. Lancet 1101-1105 (1950).Google Scholar
  594. F26.
    Fazekas De St Groth, S.: Studies in experimental immunology of influenza. 1. The state of virus receptors and inhibitors in the respiratory tract. Aust. J. exp. Biol. med. Sci. 28, 15–29 (1950).PubMedGoogle Scholar
  595. F27.
    6. The duration of induced immunity. Aust. J. exp. Biol. med. Sci. 28, 559-568 (1950).Google Scholar
  596. F28.
    9. The mode of action of pathotopic adjuvants. Aust. J. exp. Biol. med. Sci. 29, 339-352 (1951)Google Scholar
  597. F29.
    Fazekas De St Groth, S.: Quick test for the early diagnosis of influenza. Nature (Lond.) 167, 43 (1951).Google Scholar
  598. F30.
    Fazekas De St Groth, S.: Production of non-infective particles among influenza viruses: Do changes in virulence accompany the Von Magnus phenomenon? J. Hyg. (Lond.) 53, 276–291 (1955).Google Scholar
  599. F31.
    Fazekas De St Groth, S.: Evaluation of quantal neutralisation tests. Nature (Lond.) 191, 891–893 (1961).Google Scholar
  600. F32.
    Fazekas De St Groth, S.: Steric inhibition: Neutralisation of a virus-borne enzyme. Ann. N.Y. Acad. Sci. 103, 674–687 (1963).Google Scholar
  601. F33.
    Fazekas De St Groth, S., and H. J. F. Cairns: Quantitative aspects of influenza multiplication. 4. Definition of constants and general discussion. J. Immunol. 69, 173–181 (1952).Google Scholar
  602. F34.
    Fazekas De St Groth, S., and M. Donnelley: Studies in experimental immunology of influenza. 2. Production of viral antigens. Aust. J. exp. Biol. med. Sci. 28, 31–44 (1950).PubMedGoogle Scholar
  603. F35.
    3. The antibody response. Aust. J. exp. Biol. med. Sci. 28, 45-60 (1950).Google Scholar
  604. F36.
    4. The protective value of active immunisation. Aust. J. exp. Biol. med. Sci. 28, 61-75 (1950).Google Scholar
  605. F37.
    5. Enhancement of immunity by pathotopic vaccination. Aust. J. exp. Biol. med. Sci. 28, 77-85 (1950).Google Scholar
  606. F38.
    8. Pathotopic adjuvants. Aust. J. exp. Biol. med. Sci. 29, 323-337 (1951).Google Scholar
  607. F39.
    Fazekas De St Groth, S., and M. Edney: Quantitative aspects of influenza virus multiplication. 2. Heterologous interference. J. Immunol. 69, 160–168 (1952).Google Scholar
  608. F40.
    Fazekas De St Groth, S., and A. Gottschalk: Ovomucin: A substrate for the enzyme of influenza virus. 2. Demonstration of its inhomogeneity. Brit. J. exp. Path. 32, 21–24 (1951).Google Scholar
  609. F41.
    Fazekas De St Groth, S., and A. Gottschalk: Studies on glycoproteins. 10. Equilibrium measurements on influenza virus-glycoprotein systems. Biochim. biophys. Acta (Amst.) 78, 248–257 (1963).Google Scholar
  610. F42.
    Fazekas De St Groth, S., and D. M. Graham: Modification of virus receptors by metaperiodate. 2. Infection through modified receptors. Aust. J. exp. Biol. med. Sci. 27, 83–98 (1949).PubMedGoogle Scholar
  611. F43.
    Fazekas De St Groth, S., and D. M. Graham: Absence of incomplete virus production in certain influenza strains. Nature (Lond.) 172, 1193 (1953).Google Scholar
  612. F44.
    Fazekas De St Groth, S., and D. M. Graham: Artificial production of incomplete influenza virus. Nature (Lond.) 173, 637 (1954).Google Scholar
  613. F45.
    Fazekas De St Groth, S., and D. M. Graham: The production of incomplete virus particles among influenza strains: Experiments in eggs. Brit. J. exp. Path. 35, 60–74 (1954).PubMedGoogle Scholar
  614. F46.
    Fazekas De St Groth, S., and D. M. Graham: Studies on experimental immunology of influenza. 0. Passive immunity and its enhancement. Aust. J. exp. Biol. med. Sci. 32, 369–386 (1954).Google Scholar
  615. F47.
    Fazekas De St Groth, S., and D. M. Graham: The production of incomplete virus particles among influenza strains: Chemical induction of the Von Magnus phenomenon. Brit. J. exp. Path. 36, 205–213 (1955).PubMedGoogle Scholar
  616. F48.
    Fazekas De St Groth, S., and R. G. Webster: The neutralisation of animal viruses. 3. Equilibrium conditions in the influenza virus antibody system. J. Immunol. 90, 140–150 (1963).Google Scholar
  617. F49.
    4. Parameters of the influenza virus-antibody system. J. Immunol. 90, 151-164 (1963).Google Scholar
  618. F50.
    Fazekas De St Groth, S., and R. G. Webster: The antibody response. Ciba Found. Symp. “Cellular biology of myxovirus infections” 246-271 (1964).Google Scholar
  619. F51.
    Fazekas De St Groth, S., and R. G. Webster: Disquisition on original antigenic sin. 1. Evidence in man.Google Scholar
  620. F52.
    2. Proof in lower creatures. J. exp. Med. 124, 331-345, and 347-361 (1966).Google Scholar
  621. F53.
    Fazekas De St Groth, S., and D. O. White: An improved assay for the infectivity of influenza viruses. J. Hyg. (Lond.) 56, 151–162 (1958).Google Scholar
  622. F54.
    Fazekas De St Groth, S., and D. O. White: The dose-response relationship between influenza viruses and the surviving allantois. J. Hyg. (Lond.) 56, 523–534 (1958).Google Scholar
  623. F55.
    Fazekas De St Groth, S., and D. O. White: Comparison of the infectivity of influenza viruses in two host systems: The allantois of intact eggs and surviving allantois-on-shell. J. Hyg. (Lond.) 56, 535–546 (1958).Google Scholar
  624. F56.
    Fazekas De St Grotii, S., J. Withell, and K. J. Lafferty: An improved assay method for neutralising antibodies against influenza viruses. J. Hyg. (Lond.) 56, 415–426 (1958).Google Scholar
  625. F57.
    Fedorov, Ye. A.: Cytology of impressions from the nasal mucosa in influenza and in catarrhs of the respiratory tract (Russian). Zh. Mikrobiol. (Mosk.) 6, 25 (1951).Google Scholar
  626. F58.
    Fedorov, Ye. A.: Clinical-laboratory diagnosis of influenza (Russian). Zh. Mikrobiol. (Mosk.) 1, 56 (1952).Google Scholar
  627. F59.
    Fedova, D., and L. Zelenkova: The use of the fluorescent antibody method for the rapid identification of influenza virus in the epithelial cell sediment of allantoic or amniotic fluid of infected chick embryos.Google Scholar
  628. F60.
    2. The identification of influenza virus in nasal smears by the fluorescent antibody technique. J. Hyg. Epidem. (Praha) 9, 127-134, and 135-146 (1965).Google Scholar
  629. F61.
    Feldman, H. A., and S. S. Wang: Sensitivity of various viruses to chloroform. Proc. Soc. exp. Biol. (N.Y.) 106, 736–738 (1961).Google Scholar
  630. F62.
    Feltynowski, A.: An aluminium replica method for the study on the red cell surface, especially of influenza virus adsorption on intact chicken red cells (Polish). Medycyna Doswiadczalna 4, 423–438 (1953).Google Scholar
  631. F63.
    Fenner, F.: The reactivation of animal viruses. Brit. med. J. 135-142 (1962).Google Scholar
  632. F64.
    Fenner, F., and J. F. Sambrook: The genetics of animal viruses. Ann. Rev. Microbiol. 18, 47–94 (1964).Google Scholar
  633. F65.
    Filippova-Nutrikrina, Z. L.: Therapy with cortisone during virus influenza (Russian). “Kliniya i Meditsina.” Moscow, 149-153 (1954).Google Scholar
  634. F66.
    Finland, M., and M.W. Barnes: Laboratory experiences with influenza in Boston during the winter 1949–50. J. infect. Dis. 97, 48–56 (1955).PubMedGoogle Scholar
  635. F67.
    Finland, M., and M.W. Barnes: Influenza A in Boston in 1951 and 1953. Isolation of virus and serological studies in patients, including a study of antigenic relationships among strains of influenza A virus isolated in Boston from 1943 through 1953. Amer. J. Hyg. 62, 1–20 (1955).PubMedGoogle Scholar
  636. F68.
    Finter, N. B.: Studies on interferon. Abstr. Proc. Soc. gen. Microbiol. Jan. 1965.Google Scholar
  637. F69.
    Finter, N. B., and A. J. Beale: The 6-hour soluble antigen production test for comparing the infectivity of influenza virus preparations. J. Hyg. (Lond.) 54, 58–67 (1956).Google Scholar
  638. F70.
    Finter, N. B., O. C. Liu, and W. Henle: Studies on host-virus interaction in the chick embryo influenza virus system. 0. An experimental analysis of the Von Magnus phenomenon. J. exp. Med. 101, 461–478 (1955).PubMedCentralPubMedGoogle Scholar
  639. F71.
    Finter, N. B., O. C. Liu, M. Liebermann, and W. Henle: Studies on host-virus interaction in the chick embryo influenza virus system. 8. An experimental analysis of various de-embryonation techniques. J. exp. Med. 100, 33–52 (1954).PubMedCentralPubMedGoogle Scholar
  640. F72.
    Fiset, P., and E. Depoux: Serological behaviour of influenza viruses. 2. Patterns of antigenic relationship. Bull. Wld Hlth Org. 11, 987–993 (1954).Google Scholar
  641. F73.
    Fiset, P., and H.B. Donald: A method for influenza antibody absorption. Brit. J. exp. Path. 34, 616–620 (1953).Google Scholar
  642. F74.
    Fisher, T. N., and H. S. Ginsberg: Eeactions of influenza viruses with guineapig polymorphonuclear leucocytes. 2. The reduction of white blood cell glycosis by influenza viruses and receptor destroying enzyme (EDE).Google Scholar
  643. F75.
    3. Studies on the mechanism by which influenza viruses inhibit phagocytosis. Virology 2, 637-655 and 656-664 (1956).Google Scholar
  644. F76.
    Fleischer, M. S.: The effect of various dyes in vitro and in vivo upon influenza virus infection in mice. J. Immunol. 62, 245–255 (1949).Google Scholar
  645. F77.
    Fletcher, E. D., J. E. Hirschfield, and M. Forbes: Effect of 2-diethyl-aminoethyl-4-methylpiperazine-1-carboxylate on influenza viruses in tissue culture. Proc. Soc. exp. Biol. (N.Y.) 121, 68–72 (1966).Google Scholar
  646. F78.
    Flick, J. A., B. Sanford, and S. Mudd: The effect of salt concentration on the interaction of influenza A virus and erythrocytes. J. Immunol. 61, 65–77 (1949).PubMedGoogle Scholar
  647. F79.
    Florman, A. L., A.B. Weiss, and F.E. Council: Effect of large doses of streptomycin and influenza viruses on chick embryos. Proc. Soc. exp. Biol. (N.Y.) 61, 16–18 (1946).Google Scholar
  648. F80.
    Fong, J.: Sulphur mustard-inactivated influenza virus as interfering agent. J. Immunol. 71, 241–245 (1953).PubMedGoogle Scholar
  649. F81.
    Fong, J., and E. Bernal: In vitro action of mustards on the infective and toxic components of influenza A (PR8) virus. J. Immunol. 70, 89–96 (1953).PubMedGoogle Scholar
  650. F8a.
    F8a_Fong, J., and E. Bernal: In vitro action of sulphur mustard and chloroethylainine derivatives upon antigenicity of influenza A (PES) virus. J. Immunol. 70, 97–102 (1953).PubMedGoogle Scholar
  651. F83.
    Fong, J., and B. Blum: Action of mustards on interfering, haemagglutinating and eluting capacities of influenza A (PR8) virus. J. Immunol. 71, 26–29 (1953).PubMedGoogle Scholar
  652. F84.
    Fong, J., K. Louis, and C. Ching: Effect of interfering virus and RDE upon development of toxic reactions. Proc. Soc. exp. Biol. (N.Y.) 84, 246–248 (1953).Google Scholar
  653. F85.
    Fortuin, G. J., and J. D. Verlinde: Vaccination against influenza (Dutch). Ned. T. Geneesk. 98, No. 31 (1954).Google Scholar
  654. F86.
    Francis, T.: Transmission of influenza by filtrable virus. Science 80, 457–459 (1934).PubMedGoogle Scholar
  655. F87.
    Francis, T.: Immunological relationships of strains of filtrable viruses recovered from cases of human influenza. Proc. Soc. exp. Biol. (N.Y.) 32, 1172–1175 (1935).Google Scholar
  656. F88.
    Francis, T.: Quantitative relationship between the immunising dose of epidemic influenza virus and the resulting immunity. J. exp. Med. 69, 283–300 (1939).PubMedCentralPubMedGoogle Scholar
  657. F89.
    Francis, T.: The inactivation of epidemic influenza virus by nasal secretions of human individuals. Science 91, 198–199 (1940).PubMedGoogle Scholar
  658. F90.
    Francis, T.: A new type of virus from epidemic influenza. Science 91, 405–408 (1940).Google Scholar
  659. F91.
    Francis, T.: Differentiation of influenza A and influenza B by the complement fixation reaction. Proc. Soc. exp. Biol. (N.Y.) 45, 861–863 (1940).Google Scholar
  660. F92.
    Francis, T.: The problem of epidemic influenza. Trans. Coll. Phycns. Philad. 8, 218–227 (1941).Google Scholar
  661. F93.
    Francis, T.: The development of the 1943 vaccination study of the Commission on influenza. Amer. J. Hyg. 42, 1–11 (1945).Google Scholar
  662. F94.
    Francis, T.: Dissociation of haemagglutinating and antibody measuring capacities of influenza virus. J. exp. Med. 85, 1–7 (1947).PubMedCentralPubMedGoogle Scholar
  663. F95.
    Francis, T.: Apparent serological variation within a strain of influenza virus. Proc. Soc. exp. Biol. (N.Y.) 65, 143–147 (1947).Google Scholar
  664. F96.
    Francis, T.: The significance of multiple immunological types of influenza virus. Cincinn. J. Med. 31, 97–101 (1950).Google Scholar
  665. F97.
    Francis, T.: Plan for the evaluation of vaccination against influenza. Amer. J. publ. Hlth 41, No. 8 (1951).Google Scholar
  666. F98.
    Francis, T.: Significance of antigenic variation of influenza viruses in relation to vaccination in man. Fed. Proc. 11, 808–812 (1952).PubMedGoogle Scholar
  667. F99.
    Francis, T.: Influenza: The newe acquayntance. Ann. intern. Med. 39, 203–221 (1953).PubMedGoogle Scholar
  668. F100.
    Francis, T.: The current status of the control of influenza. Ann. intern. Med. 43, 534–538 (1955).PubMedGoogle Scholar
  669. F101.
    Francis, T.: Mobilisation against influenza. Science 126, 1–2 (1957).Google Scholar
  670. F102.
    Francis, T.: Influenza in perspective. Amer. Rev. resp. Dis. 83, 98–104 (1961).PubMedGoogle Scholar
  671. F103.
    Francis, T.: Epidemic influenza. Amer. Rev. resp. Dis. 88, 148–151 (1963).PubMedGoogle Scholar
  672. F104.
    Francis, T., and T. P. Magill: Immunological studies with the virus of influenza. J. exp. Med. 62, 505–516 (1935).PubMedCentralPubMedGoogle Scholar
  673. F105.
    Francis, T., and T.P. Magill: The incidence of neutralising antibodies for human influenza virus in the serum of human individuals of different ages. J. exp. Med. 63, 655–668 (1936).PubMedCentralPubMedGoogle Scholar
  674. F106.
    Francis, T., and T. P. Magill: Direct transmission of human influenza virus to mice. Proc. Soc. exp. Biol. (N.Y.) 36, 132–133 (1937).Google Scholar
  675. F107.
    Francis, T., and T.P. Magill: Antigenic differences in strains of epidemic influenza virus. 2. Cross immunisation tests in mice. Brit. J. exp. Path. 19, 284–293 (1938).Google Scholar
  676. F108.
    Francis, T., T.P. Magill, E. T. Rickard, and D.M. Beck: Etiological and serological studies in epidemic influenza. Amer. J. publ. Hlth 27, 1141–1160 (1937).Google Scholar
  677. F109.
    Francis, T., and E. Minuse: Influence of saliva upon haemagglutination by influenza virus. Proc. Soc. exp. Biol. (N.Y.) 69, 291–294 (1948).Google Scholar
  678. F110.
    Francis, T., and H. E. Moore: A study of the neurotropic tendency in strains of the virus of epidemic influenza. J. exp. Med. 72, 717–728 (1940).PubMedCentralPubMedGoogle Scholar
  679. F111.
    Francis, T., H.E. Pearson, J. E. Salk, and P.N. Brown: Immunity in human subjects artificially infected with influenza virus type B. Amer. J. publ. Hlth 34, 317–334 (1944).Google Scholar
  680. F112.
    Francis, T., H.E. Pearson, E.R. Sullivan, and P.M. Brown: The effect of subcutaneous vaccination with influenza virus upon the virus inactivating capacity of nasal secretion. Amer. J. Hyg. 37, 294–300 (1943).Google Scholar
  681. F113.
    Francis, T., and K. Penttinen: The failure of merdicien to modify influenza virus infections. J. Immunol. 63, 337–339 (1949).PubMedGoogle Scholar
  682. F114.
    Francis, T., J. J. Quilligan, and E. Minuse: Kesemblance of a strain of swine influenza virus to human A-prime strain. Proc. Soc. exp. Biol. (N.Y.) 71, 216–220 (1949).Google Scholar
  683. F115.
    Francis, T., J. J. Quilligan, and E. Minuse: Identification of another epidemic respiratory disease. Science 112, 495–497 (1950).PubMedGoogle Scholar
  684. F116.
    Francis, T., and J. E. Salk: A simplified procedure for the concentration and purification of influenza virus. Science 96, 499–500 (1942).PubMedGoogle Scholar
  685. F117.
    Francis, T., J. E. Salk, and W. M. Brace: The protective effect of vaccination against epidemic influenza B. J. Amer. med. Ass. 131, 275–278 (1946).Google Scholar
  686. F118.
    Francis, T., J. E. Salk, H. E. Pearson, and P. N. Brown: Protective effect of vaccination against induced influenza A. Proc. Soc. exp. Biol. (N.Y.) 55, 104–105 (1944).Google Scholar
  687. F119.
    Francis, T., J. E. Salk, and J. J. Quilligan: Experience with vaccination against influenza in the spring of 1947. Amer. J. publ. Hlth 37, 1013–1016 (1947).Google Scholar
  688. F120.
    Francis, T., and R. E. Shope: Neutralisation tests with sera of convalescent and immunised animals and the viruses of human and swine influenza. J. exp. Med. 63, 645–653 (1936).PubMedCentralPubMedGoogle Scholar
  689. F121.
    Francis, T., and C.H. Stuart-Harris: Studies on the nasal histology of epidemic influenza virus infection in the ferret. 1. The development and repair of the nasal lesion.Google Scholar
  690. F122.
    2. Histological and serological observations on ferrets receiving repeated inoculations of epidemic influenza virus. J. exp. Med. 68, 789-801, and 813-830 (1938).Google Scholar
  691. F123.
    Francis, T., and M. Vicente de Torregrosa: Combined infection of mice with H. influenzae and influenza virus by the intranasal route. J. infect. Dis. 76, 70–77 (1945).Google Scholar
  692. F124.
    Franklin, R. M.: The synthesis of fowl plague virus products in a proflavine-inhibited tissue culture system. Virology 6, 525–539 (1958).PubMedGoogle Scholar
  693. F125.
    Franklin, R. M., and P. M. Breitenfeld: The abortive infection of Earle’s L cells by fowl plague virus. Virology 8, 293–307 (1959).PubMedGoogle Scholar
  694. F126.
    Franklin, R. M., and E. Wecker: Inactivation of some animal viruses by hydroxylamine and the structure of ribonucleic acid. Nature (Lond.) 184, 343–345 (1959).Google Scholar
  695. F127.
    Fraser, K. B.: Antibody to purified virus inhibitor. Brit. J. exp. Path. 32, 552–558 (1951).PubMedGoogle Scholar
  696. F128.
    Fraser, K. B.: Genetic interaction and interference between the MEL and NWS strains of influenza A virus. Brit. J. exp. Path. 34, 319–328 (1953).PubMedGoogle Scholar
  697. F129.
    Fraser, K. B.: Features of the MEL-NWS recombination systems in influenza A virus. 1. The effect of age of the mouse on the intracerebral growth of the MEL strain of influenza A virus.Google Scholar
  698. F130.
    2. The formation of NM recombinant strains of influenza A virus in mouse brain.Google Scholar
  699. F131.
    3. The pathogenicity of recombinant Neuro-MEL viruses grown in mouse brain and chick embryo brain.Google Scholar
  700. F132.
    4. Increments of virulence during successive cycles of double infection with two strains of influenza virus. Virology 9, 168-177, 178-190, 191-201, and 202-214 (1959).Google Scholar
  701. F133.
    Fraser, K. B.: Immunofluorescence of abortive and complete infections of influenza A virus in hamster BHK21 cells and mouse L cells. J. gen. Virol. 1, 1–12 (1967).PubMedGoogle Scholar
  702. F134.
    Fraser, K. B., and F.M. Burnet: Studies on recombination with influenza viruses in the chick embryo. 2. Genetic interaction between influenza virus strains in the chick embryo. Aust. J. exp. Biol. med. Sci. 30, 459–468 (1952).PubMedGoogle Scholar
  703. F135.
    Fraser, K. B., K. C. Nairn, M. G. McEntegart, and C. S. Chadwick: Neurotropic and non-neurotropic influenza A infection of mouse brain studied with fluorescent antibody. J. Path. Bact. 78, 423–433 (1959).PubMedGoogle Scholar
  704. F136.
    French, E. L.: The pyrogenic effect of the influenza-mumps group of viruses in the laboratory rabbit. Aust. J. exp. Biol. med. Sci. 30, 479–488 (1952).PubMedGoogle Scholar
  705. F137.
    French, E. L., and J. K. Dincen: Primary isolation of influenza A virus: The optimal conditions for amniotic infection. Aust. J. exp. Biol. med. Sci. 36, 257–265 (1958).PubMedGoogle Scholar
  706. F138.
    French, H.: Ministry of Health Eeport No. 4. H.M.S.O. London, 1920.Google Scholar
  707. F139.
    Fridman, E. A.: Some data on the problem of non-homogeneous structure of virus population (Russian). Virus infekt. 19, 67–75 (1959).Google Scholar
  708. F140.
    Fridman, E. A.: The heterogeneity of type A2 influenza virus population. Acta virol. 4, 274–282 (1960).Google Scholar
  709. F141.
    Fridman, E. A., I. M. Ansheles, E. S. Stenina, T. N. Davyova, B. I. Meitin, and T. A. Klushina: Analysis of epidemiological and immuno-virological data obtained during the 1957 and 1959 waves of influenza epidemic in Leningrad. “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow, 114-117 (1959).Google Scholar
  710. F142.
    Friedewald, W. F.: The immunological response to influenza virus infection as measured by the complement fixation test. Eelation of the complement fixing antigen to the virus particle. J. exp. Med. 78, 347–366 (1943).PubMedCentralPubMedGoogle Scholar
  711. F143.
    Friedewald, W. F.: Enhancement of the immunising capacity of influenza virus vaccines with adjuvants. Science 99, 453–454 (1944).PubMedGoogle Scholar
  712. F144.
    Friedewald, W. F.: Qualitative differences in the antigenic composition of influenza A virus strains. J. exp. Med. 79, 633–647 (1944).PubMedCentralPubMedGoogle Scholar
  713. F145.
    Friedewald, W. F.: Adjuvants in immunisation with influenza virus vaccines. J. exp. Med. 80, 477–491 (1944).PubMedCentralPubMedGoogle Scholar
  714. F146.
    Friedewald, W. F., and E. W. Hook: Influenza virus infection in the hamster. A study of inapparent infection and virus adaptation. J. exp. Med. 88, 343–353 (1948).PubMedCentralPubMedGoogle Scholar
  715. F147.
    Friedewald, W. F., E.S. Miller, and L. E. Whatley: The nature of nonspecific inhibition of virus haemagglutination. J. exp. Med. 86, 65–75 (1947).PubMedCentralPubMedGoogle Scholar
  716. F148.
    Friedewald, W. F., and E. G. Pickels: Size of infective particle and haemagglutinin of influenza virus as determined by centrifugal analysis. Froc. Soc. exp. Biol. (N.Y.) 52, 261–262 (1943).Google Scholar
  717. F149.
    Friedewald, W. F., and E. G. Pickels: Centrifugation and ultrafiltration studies on allantoic fluid preparations of influenza virus. J. exp. Med. 79, 301–317 (1944).PubMedCentralPubMedGoogle Scholar
  718. F150.
    Friedman, R. M., and J.A. Sonnabend: Inhibition of interferon action by puromycin. J. Immunol. 95, 696–703 (1965).PubMedGoogle Scholar
  719. F151.
    Frisch, A. W., and J. Carson: Mode of inactivation of influenza virus by tannic acid. J. Bact. 66, 576–580 (1953).PubMedGoogle Scholar
  720. F152.
    Frisch-Niggemeyer, W.: Absolute amount of ribonucleic acid in viruses. Nature (Lond.) 178, 307–308 (1956).Google Scholar
  721. F153.
    Frisch-Niggemeyer, W.: Chemical composition and internal structure of influenza virus with particular regard to the so-called “soluble antigen” (German). Zbl. Bakt. I. Abt. Orig. 183, 294–317 (1961).Google Scholar
  722. F154.
    Frisch-Niggemeyer, W., and L. Hoyle: The nucleic acid and carbohydrate content of influenza virus A and of virus fractions produced by ether disintegration. J. Hyg. (Lond.) 54, 201–212 (1956).Google Scholar
  723. F155.
    Frommhagen, L. H., N. K. Freeman, and C. A. Knight: The lipid constituents of influenza virus, chick allantoic membrane, and sedimentable allantoic protein. Virology 5, 173–174 (1958).PubMedGoogle Scholar
  724. F156.
    Frommhagen, L. H., and C. A. Knight: The polysaccharide and ribonucleic acid content of purified influenza virus. Virology 2, 430–431 (1956).Google Scholar
  725. F157.
    Frommhagen, L. H., and C. A. Knight: Column purification of influenza virus. Virology 8, 198–208 (1959).PubMedGoogle Scholar
  726. F158.
    Frommhagen, L. H., C. A. Knight, and N. K. Freeman: The ribonucleic acid, lipid, and polysaccharide constituents of influenza virus preparations. Virology 8, 176–197 (1959).PubMedGoogle Scholar
  727. F159.
    Frommhagen, L. H., and E. H. Lennette: Spontaneous dissappearance of the slow-sedimenting component of influenza virus preparations. Virology 7, 247–248 (1959).PubMedGoogle Scholar
  728. F160.
    Fukumi, H.: Studies on the P-Q phases of A/Asian/57 influenza viruses. Bull. Wld Hlth Org. 20, 421–434 (1959).Google Scholar
  729. F161.
    Fulton, F.: Growth cycle of influenza virus. Nature (Lond.) 164, 189 (1949).Google Scholar
  730. F162.
    Fulton, F.: The titration of influenza virus neutralising antibodies. J. Hyg. (Lond.) 50, 265–274 (1952).Google Scholar
  731. F163.
    Fulton, F., and P. Armitage: Surviving tissue suspensions for influenza virus titrations. J. Hyg. (Lond.) 49, 247–262 (1951).Google Scholar
  732. F164.
    Fulton, F., and K. E. Dumbell: The serological comparison of strains of influenza virus. J. gen. Microbiol. 3, 97–110 (1949).PubMedGoogle Scholar
  733. F165.
    Fulton, F., and A. Isaacs: Influenza virus multiplication in the chick chorioallantoic membrane. J. gen. Microbiol. 9, 119–131 (1953).PubMedGoogle Scholar
  734. F166.
    Furer, N. M., I. P. Fomina, O. I. Artanomova, and T. I. Balezina: Antiviral action of antibiotics obtained from cultures of actinomyces violaceus. Antibiotiki, Moscow 4, 30–35 (1959).Google Scholar
  735. F167.
    Furesz, J.: Studies on inhibitors of influenza virus haemagglutination in normal rabbit and ferret sera. Canad. J. Microbiol. 5, 505–511 (1959).Google Scholar
  736. G1.
    Gajdusek, D. C.: Suspended cell tissue cultures for study of virus growth kinetics. Proc. Soc. exp. Biol. (N.Y.) 83, 621–624 (1953).Google Scholar
  737. G2.
    Galeazzi, F., and G. Visio: Studies on the synergism between influenza virus and bacteria. 2. Organotropism of staphylococcus aureus in mice inoculated with influenza virus (Italian). Riv. Ist. sieroter. ital. 33, 47–58 (1958).PubMedGoogle Scholar
  738. G3.
    Galper, G. S.: Experience in atabrine prophylaxis of influenza (Russian). Vo.-med. Zh. 11, 78 (1953).Google Scholar
  739. G4.
    Gamburg, V. P.: New data concerning the thermostable serum inhibitor (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. Dokl. nauch Sess. Inst. AMN SSSR, Moscow, 55-57 (1959).Google Scholar
  740. G5.
    Gard, S.: Haemagglutination as a diagnostic method. Theoretical aspects. Acta path. Suppl. 91, 107–117 (1951).Google Scholar
  741. G6.
    Gard, S.: Aspects of the formation of incomplete virus. 2nd Symp. Soc. gen. Microbiol. 211-244 (1953).Google Scholar
  742. G7.
    Gard, S., and P. Von Magnus: Studies on interference in experimental influenza. 2. Purification and centrifugation experiments. Ark. Kemi. Mineral. Geol. 24b, No. 8 (1947).Google Scholar
  743. G8.
    Gard, S., P. Von Magnus, A. Svedmyr, and A. Birch-Andersen: Studies on the sedimentation of influenza virus. Arch. ges. Virusforsch. 4, 591–611 (1952).PubMedGoogle Scholar
  744. G9.
    Gausch, C. R., and J. S. Younger: A tissue culture color test for measuring influenza virus and antibody. Proc. Soc. exp. Biol. (N.Y.) 101, 853–856 (1951).Google Scholar
  745. G10.
    Gavrilov, V. I.: Study of influenza A virus variability under experimental conditions (Russian). Probl. obshch. virol. Tez. Dokl. 6-y Sess. Inst. Virusol. AMN SSSR, Moscow, 37 (1953).Google Scholar
  746. G11.
    Gavrilov, V. I.: Influenza A virus variation in passage through the bodies of immunised mice (Russian). Dissertation, Moscow (1954).Google Scholar
  747. G12.
    Gaydamaka, M. G.: Study of the effectiveness of specific substances in the prophylaxis of influenza during the 1957 epidemic in Kharkov (Russian). Aziatskii Gripp (sborn. nauch. rabot) Kiev 266-268 (1958).Google Scholar
  748. G13.
    Gaydamaka, M. G., E. M. Mikulinskaya, D. D. Fyadina, and A. S. Dromashko: Data on the epidemiological effectiveness of anti-influenza vaccination in Kharkov in 1957 (Russian). Vop. Virus. 5, 135–140 (1958).Google Scholar
  749. G14.
    Gaydamaka, M. G., G. P. Vaganov, A. S. Dromashko, B. D. Shvetskaya, and D. P. Fyalina: Disease of the upper respiratory tract in horses following the human influenza epidemic in 1957. Bull Wld Hlth Org. 20, 505–508 (1959).Google Scholar
  750. G15.
    Gent, W. L. G., N. A. Gregson, D. B. Gammack, and J. H. Raper: The lipid-protein unit in myelin. Nature (Lond.) 204, 553–555 (1964).Google Scholar
  751. G16.
    Gerber, P., and E. Adams: Development of resistance of influenza B virus to polysaccharides. Science 128, 1571 (1958).PubMedGoogle Scholar
  752. G17.
    Gerber, P., D. Hamre, and C. G. Loosli: Antigenic variants of influenza A virus (PR8). 2. Serological and immunological characteristics of variants derived from variants. J. exp. Med. 103, 413–424 (1956).PubMedCentralPubMedGoogle Scholar
  753. G18.
    Gerber, P., C. G. Loosli, and D. Hamre: Antigenic variants of influenza A virus (PR8). 1. Their development during serial passage in the lungs of partially immune mice. J. exp. Med. 101, 627–638 (1955).PubMedCentralPubMedGoogle Scholar
  754. G19.
    Germanova, K. I., and T. Ya. Goncharskaya: Antiviral properties of streptothricins A B C D and F. Abstr. 9th Int. Congr. Microbiol. 537 (1966).Google Scholar
  755. G20.
    Gerngross, O. G., T. V. Pysina, and L. N. Serebryakova: Etiology of influenza outbreaks in Vladivostock in 1957–59 and antigenic structure of the isolated strains (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow, 24-26 (1959).Google Scholar
  756. G21.
    Gerone, P. J., T. G. Ward, and W. A. Chappel: Combined infection in mice with influenza virus and diplococcus pneumoniae. Amer. J. Hyg. 66, 331–341 (1957).PubMedGoogle Scholar
  757. G22.
    Gierer, A., and G. Schramm: Infectivity of ribonucleic acid from tobacco mosaic virus. Nature (Lond.) 177, 702–703 (1956).Google Scholar
  758. G23.
    Gierer, A., and G. Schramm: Infectivity of ribonucleic acid from tobacco mosaic virus (German). Z. Naturforsch. 11b, 138–142 (1956).Google Scholar
  759. G24.
    Ginsberg, H. S.: Comparison of quantities of egg and mouse adapted influenza viruses required to infect each host. Proc. Soc. exp. Biol. (N.Y.) 84, 249–252 (1953).Google Scholar
  760. G25.
    Ginsberg, H. S.: Formation of non-infectious influenza virus in mouse lungs: Its dependence upon extensive pulmonary consolidation initiated by the viral inoculum. J. exp. Med. 100, 581–603 (1954).PubMedCentralPubMedGoogle Scholar
  761. G26.
    Ginsberg, H. S.: Production of pulmonary lesions by influenza viruses in immunised mice. J. Immunol. 72, 24–29 (1954).PubMedGoogle Scholar
  762. G27.
    Ginsberg, H. S.: Suppression of influenza viral pneumonia in mice by the nonspecific action of Xerosin. J. Immunol. 75, 430–440 (1955).PubMedGoogle Scholar
  763. G28.
    Ginsberg, H. S., and J.R. Blackburn: Reactions of influenza viruses with guineapig polymorphonuclear leucocytes. 1. Virus-cell interaction. Virology 2, 618–636 (1956).PubMedGoogle Scholar
  764. G29.
    Ginsberg, H. S., and F. L. Horsfall: A labile component of normal serum which combines with various viruses. Neutralisation of infectivity and inhibition of haemagglutination by the component. J. exp. Med. 90, 475–495 (1949).PubMedCentralPubMedGoogle Scholar
  765. G30.
    Ginsberg, H. S., and F. L. Horsfall: Quantitative aspects of the multiplication of influenza A virus in the mouse lung. Relation between the degree of viral multiplication and the extent of pneumonia. J. exp. Med. 95, 135–145 (1952).PubMedCentralPubMedGoogle Scholar
  766. G31.
    Ginsberg, H. S., and A. T. Wilson: Inactivation of several viruses by liquid ethylene oxide. Proc. Soc. exp. Biol. (N.Y.) 73, 614–616 (1950).Google Scholar
  767. G32.
    Giordano, G., and G. Pino: Researches on anti-influenza vaccination. 2. Comparison of immune responses to one and two doses of vaccine given intradermally (Italian). Riv. Ist. sieroter. ital. 28, 501–509 (1953).PubMedGoogle Scholar
  768. G33.
    Girardi, A. J., H. McMichael, and W. Henle: The use of HeLa cells in suspension for the quantitative study of virus propagation. Virology 2, 532–544 (1956).PubMedGoogle Scholar
  769. G34.
    Gitelman, A. K., O. Burducea, and A. G. Bukrinskaya: Inhibitory effect of histones and actinomycin D on myxovirus reproduction with a special reference to input multiplicity of infection. Abstr. 9th int. Congr. Microbiol. 531 (1966).Google Scholar
  770. G35.
    Glover, R. E.: Spread of infection from the respiratory tract of the ferret. 2. Association of influenza A virus and streptococcus group C. Brit. J. exp. Path. 22, 98–107 (1941).Google Scholar
  771. G36.
    Golbert, Z. V., and O.P. Peterson: Histopathologic changes in white mice after the intraperitoneal injection of large doses of influenza virus (Russian). Vop. Virus. 1, 190 (1948).Google Scholar
  772. G37.
    Gompels, A. E. H.: Antigenic relationships of swine influenza virus. J. gen. Microbiol. 9, 140–148 (1953).PubMedGoogle Scholar
  773. G38.
    Gorbunova, A. S.: Biological properties of the influenza viruses and problems of their classification (Russian). Zh. Mikrobiol. (Mosk.) 2, 39 (1953).Google Scholar
  774. G39.
    Gorbunova, A. S.: Antigenic relationships between influenza viruses of the types A, A1 and A2 (Russian). Vop. Virus. 4, 401–406 (1959).PubMedGoogle Scholar
  775. G40.
    Gorbunova, A. S., and V. I. Gavrilov: Evaluation of the complement fixation reaction as a method of serological differentiation of influenza virus strains (Russian). Vop. Virus. 4, 55 (1954).Google Scholar
  776. G41.
    Gorbunova, A. S., and V. A. Isachenko: Peculiarities of identification of strains of A 2 influenza viruses isolated in 1957 (Russian). Vop. Virus. 5, 48-53 (1958).Google Scholar
  777. G42.
    Gorbunova, A. S., A. N. Lozhkina, V. M. Stakhanova, V. I. Isachenko, T. P. Voronina, A. I. Simakov, and A. A. Kopeikin: Antigenic pattern of A2 influenza viruses according to materials from the strain service of the Regional Influenza Centre of the USSR (Russian). Vop. Virus 5, 25–35 (1958).Google Scholar
  778. G43.
    Gorbunova, A. S., and S. E. Marennikova: The problem of the O and D variants of the influenza virus (Russian). Byull. eksp. Biol. Med. 10, 292 (1949).Google Scholar
  779. G44.
    Gorbunova, A. S., and S. E. Marennikova: The problem of the O and D variants of the influenza virus (Russian). Annot. rabot. Inst. virol. AMN SSSR Za 1949, Moscow (1950).Google Scholar
  780. G45.
    Gorbunova, A. S., E. V. Molibog, F. K. Gonsovsky, G. I. Fjodorova, U. A. Abenova, and N. A. Maximovitch: Influenza virus strains different in their enzymic activity and character of their interaction with cells. Abstr. 9th int. Congr. Microbiol. 373 (1966).Google Scholar
  781. G46.
    Gordon, I.: Demonstration of antigenic differences between different strains of influenza B. J. Immunol. 44, 231–236 (1942).Google Scholar
  782. G47.
    Gorev, N. E.: The use of broth culture filtrates of Pseudomonas fluorescens for the destruction of non-specific thermostable (At 56°C) influenza virus inhibitors in human and animal sera. Acta virol. 2, 171–178 (1958).PubMedGoogle Scholar
  783. G48.
    Gostling, J. V. T.: Growth of influenza A virus in cultured cells of embryo mouse lung. Brit. J. exp. Path. 39, 679–684 (1958).PubMedGoogle Scholar
  784. G49.
    Gotlieb, T., and G. K. Hirst: The experimental production of combination forms of virus. 3. The formation of doubly antigenic particles from influenza A and B virus and a study of the ability of individual particles of X virus to yield two separate strains. J. exp. Med. 99, 307–320 (1954).PubMedCentralPubMedGoogle Scholar
  785. G50.
    Gotlieb, T., and G. K. Hirst: The experimental production of combination forms of virus. 6. Reactivation of influenza viruses after inactivation by ultraviolet light. Virology 2, 235–248 (1956).PubMedGoogle Scholar
  786. G51.
    Goto, H.: Virological and immunological studies of Asian influenza in 1960 (Japanese). Sapporo Med. J. 24, 205–210 (1963).Google Scholar
  787. G52.
    Gottschalk, A.: N-substituted isoglucosamine released from mucoproteins by the influenza virus enzyme. Nature (Lond.) 167, 845–847 (1951).Google Scholar
  788. G53.
    Gottschalk, A.: The influenza virus enzyme and its mucoprotein substrate. Yale J. Biol. Med. 26, 352–364 (1954).PubMedCentralPubMedGoogle Scholar
  789. G54.
    Gottschalk, A.: The synthesis of 2-carboxypyrrole from D-glucosamine and pyruvic acid: Its bearing on the structure of neuraminic acid. Arch. Biochem. 69, 37–44 (1957).PubMedGoogle Scholar
  790. G55.
    Gottschalk, A.: The influenza virus neuraminidase. Nature (Lond.) 181, 377–378 (1958).Google Scholar
  791. G56.
    Gottschalk, A.: On the mechanism underlying initiation of influenza virus infection. Ergebn. Mikrobiol. 32, 1–22 (1959).Google Scholar
  792. G57.
    Gottschalk, A.: The molecular structure of ovine submaxillary gland glycoprotein. Proc. Internat. Conf. “Salivary glands and their secretions”, Washington, Pergamon Press 351-364 (1964).Google Scholar
  793. G58.
    Gottschalk, A., and S. Fazekas De St Groth: On the relationship between the indicator profile and prosthetic group of mucoproteins inhibitory for influenza virus haemagglutinin. J. gen. Microbiol. 22, 690–696 (1960).PubMedGoogle Scholar
  794. G59.
    Gottschalk, A., and E. R. B. Graham: A neuraminidase susceptible disaccharide from bovine salivary mucoprotein. Z. Naturforsch. 13b, 821–822 (1958).Google Scholar
  795. G60.
    Gottschalk, A., and E. R. B. Graham: 6-a-D-sialyl-N-acetylgalactosamine: The neuraminidase-susceptible prosthetic group of bovine salivary mucoprotein. Biochim. biophys. Acta (Amst.) 34, 380–391 (1959).Google Scholar
  796. G61.
    Gottschalk, A., and P. E. Lind: Ovomucin, a substrate for the enzyme of influenza virus. 1. Ovomucin as an inhibitor of haemagglutination by heated Lee virus. Brit. J. exp. Path. 30, 85–92 (1949).PubMedGoogle Scholar
  797. G62.
    Gottschalk, A., and P. E. Lind: Product of interaction between influenza virus enzyme and ovomucin. Nature (Lond.) 164, 232–233 (1949).Google Scholar
  798. G63.
    Gottschalk, A., and B. T. Perry: Ovomucin, a substrate for the enzyme of influenza virus. 3. Enzyme activity as an integral function of the influenza virus particle. Brit. J. exp. Path. 32, 408–413 (1951).PubMedGoogle Scholar
  799. G64.
    Graham, A. F.: The chemical analysis of purified influenza virus A (PR8 strain) containing radioactive phosphorus. Canad. J. Res. 28, 186–195 (1950).Google Scholar
  800. G65.
    Graham, A. F.: The fractionation of phosphorus containing constituents in the allantoic membrane of the embryonated egg. Canad. J. Res. 28, 271–280 (1950).Google Scholar
  801. G66.
    Graham, A. F., G. Dempster, and B. Buchner: The toxicity of P32 for normal and influenza infected embryos. J. Bact. 63, 426–427 (1952).PubMedGoogle Scholar
  802. G67.
    Graham, A. F., and L. McClelland: Uptake of radioactive phosphorus by influenza virus. Nature (Lond.) 163, 949 (1949).Google Scholar
  803. G68.
    Graham, A. F., and L. McClelland: The uptake of radioactive phosphorus by influenza virus A (PES strain). Canad. J. Kes. 28, 121–134 (1950).Google Scholar
  804. G69.
    Granoff, A.: Plaque formation with influenza strains. Virology 1, 252 (1955).PubMedGoogle Scholar
  805. G70.
    Granoff, A., and D.W. Kingsbury: Effect of actinomycin D on the replication of Newcastle disease and influenza viruses. Ciba Found. Symp. “Cellular biology of myxovirus infections” 96-119 (1964).Google Scholar
  806. G71.
    Granoff, A., O. C. Liu, and W. Henle: A small haemagglutinating component in preparations of Newcastle disease virus. Proc. Soc. exp. Biol. (N.Y.) 75, 684–691 (1950).Google Scholar
  807. G72.
    Green, I. J., M. Lieberman, and W. J. Mogabgab: The behavior of influenza viruses in various tissue culture systems. J. Immunol. 78, 233–239 (1957).PubMedGoogle Scholar
  808. G73.
    Green, E. H., A. F. Rasmussen, and J. E. Smadel: Chemoprophylaxis of experimental influenza infection in eggs. Publ. Hlth Rep. (Wash.) 61, 1401–1403 (1946).Google Scholar
  809. G74.
    Green, M., and M. A. Stahmann: Virus inhibition by some aminoacid analogues. Arch. Biochem. 55, 63–70 (1955).PubMedGoogle Scholar
  810. G75.
    Green, R. H., and D. W. Woolley: Inhibition by certain polysaccharides of haemagglutination and of multiplication of influenza virus. J. exp. Med. 86, 55–64 (1947).PubMedCentralPubMedGoogle Scholar
  811. G76.
    Grist, N. R., J. B. Landsman, and T. Anderson: Studies in the aetiology of pneumonia in Glasgow 1950–51. Lancet 640 (1962).Google Scholar
  812. G77.
    Grieff, D., H. Blumenthal, M. Chiga, and H. Pinkerton: The effects on biological materials of freezing and drying by vacuum sublimination. 2. Effect on influenza virus. J. exp. Med. 100, 89–101 (1954).Google Scholar
  813. G78.
    Gross, W. O.: Properties of two strains of virus from the influenza epidemics of 1952 and 1953 (German). Z. Hyg. Infekt.-Kr. 138, 224–245 (1953).Google Scholar
  814. G79.
    Gross, W.O.: Can an influenza virus after isolation be identified with the prevalent epidemic strain? (German). Z. Hyg. Infekt.-Kr. 138, 246–260 (1953).Google Scholar
  815. G80.
    Grossberg, S. E.: Cytocidal assay and propagation of human influenza viruses in cultured primary hamster kidney cells. Proc. Soc. exp. Biol. (N.Y.) 113, 546–553 (1963).Google Scholar
  816. G81.
    Grossberg, S. E.: Human influenza A viruses: Rapid plaque assay in hamster kidney cells. Science 144, 1246–1247 (1964).PubMedGoogle Scholar
  817. G82.
    Grossberg, S. E., E. W. Hook, and R. R. Wagner: Haemorrhagic encephalopathy in chicken embryos infected with influenza virus. 3. Viral interference at a distant site induced by prior allantoic infection. J. Immunol. 88, 1–8 (1962).PubMedGoogle Scholar
  818. G83.
    Grossgebauer, K.: Dark field and phase contrast microscopic observations in connection with serological investigations on myxoviruses (German). Zbl. Bakt. I. Abt. Orig. 171, 430–439 (1958).Google Scholar
  819. G84.
    Groupe, V., C. G. Engle, P. E. Gaffney, and R. A. Manaker: Virucidal activity of representative anti-infective agents against influenza and vaccinia viruses. Appl. Microbiol. 3, 333–336 (1955).PubMedCentralPubMedGoogle Scholar
  820. G85.
    Groupe, V., and E.C. Hermann: Modification of the neurotoxic effect of influenza virus in mice by Xerosin. J. Immunol. 74, 249–254 (1955).PubMedGoogle Scholar
  821. G86.
    Groupe, V., and L. H. Pugh: Inactivation of influenza virus and of viral haemagglutinin by the ciliate tetrahymena geleii. Science 115, 307–308 (1952).PubMedGoogle Scholar
  822. G87.
    Groupe, V., and L. H. Pugh: Interference between influenza virus and infectious bronchitis of chickens. J. Bact. 63, 295–296 (1952).PubMedGoogle Scholar
  823. G88.
    Grubb, T. C., M. L. Miesse, and B. Puetzer: The inactivation of influenza virus by certain vapors. J. Bact. 53, 61–66 (1947).PubMedGoogle Scholar
  824. G89.
    Grunert, R. R., J. W. McGahen, and W. L. Davies: The in vivo antiviral activity of 1-adamantanamine (Amantadine). 1. Prophylactic and therapeutic activity against influenza viruses. Virology 26, 262–269 (1965).PubMedGoogle Scholar
  825. G90.
    Gulrajani, T. S.: Studies on respiratory diseases of pigs. 3. Persistence of influenza viruses in the respiratory tract. J. comp. Path. Therap. 61, 101–107 (1951).Google Scholar
  826. G91.
    Gustyrev, V. P.: Immunologic and epidemiologic effectiveness of inoculations against influenza with live vaccine (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow, 128-129 (1959).Google Scholar
  827. G92.
    Gutman, N. R., and L. Mentkevich: Significance of the A prime virus in the influenza epidemic process (Russian). Zh. Mikrobiol. (Mosk.) 9, 38 (1954).Google Scholar
  828. G93.
    Guzhiyenko, G. N., and M. A. Morozenko: Treatment of influenza in children with dry influenza antiserum (Russian). “Virusnyye Infecktsii” Moscow, 207-212 (1953).Google Scholar
  829. H1.
    Haas, R., and H. Wulff: The growth of influenza virus in tissue cultures of ferret kidney cells (German). G. Microbiol. 1, 65–71 (1955).Google Scholar
  830. H2.
    Haas, R., and H. Wulff: Multiplication of influenza virus in cultures of calf kidney tissue (German). Z. Hyg. Infekt.-Kr. 143, 568–577 (1957).Google Scholar
  831. H3.
    Hachisuka, Y., and N. Kato: The inhibitory effect of 4-aminopterin on influenza virus propagation in tissue culture. Nagoya J. med. Sci. 18, 29–31 (1955).Google Scholar
  832. H4.
    Haff, K. F., P. W. Schriver, C. G. Engle, and B. C. Stewart: Pathogenesis of influenza in ferrets. 1. Tissue and blood manifestations of disease. J. Immunol. 96, 659–667 (1966).PubMedGoogle Scholar
  833. H5.
    Haff, R. F., P. W. Schriver, and K. C. Stewart: Pathogenesis of influenza in ferrets. Nasal manifestations of disease. Brit. J. exp. Path. 47, 435–444 (1966).PubMedGoogle Scholar
  834. H6.
    Haff, E. F., and E.C. Stewart: Role of sialic acid receptors in adsorption of influenza virus to chick embryo cells. J. Immunol. 94, 842–851 (1965).PubMedGoogle Scholar
  835. H7.
    Hahnemann, F. V., and V. Eeinecke: In ovo production of interferon induced by influenza virus of varying degrees of incompleteness. Acta path. microbiol. scand. 63, 241–248 (1965).PubMedGoogle Scholar
  836. H8.
    Hale, W. M., and A. P. McKee: The value of influenza vaccination when done at the beginning of an epidemic. Amer. J. Hyg. 42, 21–27 (1945).Google Scholar
  837. H9.
    Hale, W. M., and A. P. McKee: The intracranial toxicity of influenza virus for mice. Proc. Soc. exp. Biol. (N.Y.) 59, 81–84 (1945).Google Scholar
  838. H10.
    Hallauer, C.: Variants and mutants in viruses pathogenic for animals. Bull. Schweiz. Akad. med. Wiss. 16, 173–184 (1960).PubMedGoogle Scholar
  839. H11.
    Halonen, P.: Amantadine hydrochloride in the prophylaxis of respiratory virus infections. Abstr. 9th int. Congr. Microbiol. Moscow, 548 (1966).Google Scholar
  840. H12.
    Hamburger, V., and K. Habel: Teratogenic and lethal effects of influenza A and mumps viruses on early chick embryos. Proc. Soc. exp. Biol. (N.Y.) 66, 608–617 (1947).Google Scholar
  841. H13.
    Hamre, D., J. Appel, and C. G. Loosli: Viraemia in mice with pulmonary influenza A virus infection. J. Lab. clin. Med. 47, 182–193 (1955).Google Scholar
  842. H14.
    Hamre, D., C. G. Loosli, and E. C. Ewert: Antigenic variants of influenza A virus (PR8 strain). 6. Results of repeated passages of the same variant in mice immunised with monovalent homologous vaccine or polyvalent vaccine. J. infect. Dis. 108, 151–162 (1961).PubMedGoogle Scholar
  843. H15.
    Hamre, D., C. G. Loosli, and P. Gerber: Antigenic variants of influenza A virus (PR8 strain). 3. Serological relationships of a line of variants derived in sequence in mice given homologous vaccine. H16 4. Serological characters of a second line of variants developed in mice given polyvalent vaccine. J. exp. Med. 107, 829-844, and 845-855 (1958).Google Scholar
  844. H17.
    Hana, L., and L. Hoyle: The disintegration of the internal ribonucleoprotein of influenza virus A with the production of serologically distinct components. Acta virol. 10, 506–512 (1966).Google Scholar
  845. H18.
    Hana, L., O. Krizanova, B. Styk, and F. Sokol: Some data on the nature of the cofactor enhancing the activity of imperfect antibodies against A2 influenza virus strains. Acta virol. 5, 325 (1961).Google Scholar
  846. H19.
    Hana, L., and B. Styk: Some properties of influenza C virus inhibitor from rat serum. Acta virol. 3, 85–90 (1959).PubMedGoogle Scholar
  847. H20.
    Hana, L., and B. Styk: Influence of delipidisation on the haemagglutination inhibiting activity of rat serum against influenza type C viruses. Acta virol. 4, 392–393 (1960).Google Scholar
  848. H21.
    Hana, L., and B. Styk: Lipoids as inhibitors of haemagglutinating-inhibiting activity against “avid” strains of A2 influenza. Acta virol. 5, 190–192 (1961).Google Scholar
  849. H22.
    Hana, L., and B. Styk: Characterisation of antibodies, cofactor, and non-specific viral inhibitors on sephadex G-200. Acta virol. 6, 479 (1962).PubMedGoogle Scholar
  850. H23.
    Hana, L., and B. Styk: An attempt to differentiate Beta-inhibitor from co-factor occurring in bovine serum. Acta virol. 6, 77–83 (1962).PubMedGoogle Scholar
  851. H24.
    Hana, L., B. Styk, and D. Kociskova: Estimation of the distribution and the character of inhibitors against “avid” A2 influenza virus strains in protein fractions of guineapig and horse sera obtained by paper electrophoresis. Acta virol. 4, 356–364 (1960).Google Scholar
  852. H25.
    Hana, L., B. Styk, and S. Schramek: Studies on the size of antibodies, co-factor, and non-specific inhibitors of influenza virus using separation on sephadex G-200. Science Tools 10, 4–7 (1963).Google Scholar
  853. H26.
    Hanan, E.: The effect of tocopherol esters on influenza virus. Proc. Soc. exp. Biol. (N.Y.) 75, 440–444 (1950).Google Scholar
  854. H27.
    Hanig, M., and H. Bernkopf: The sedimentable components of influenza virus propagated in de-embryonated eggs. J. Immunol. 65, 585–590 (1950).PubMedGoogle Scholar
  855. H28.
    Hanig, M., and J. M. Steim: The difference in effective hydrodynamic diameters of “FAST” and “SLOW” influenza viruses propagated in de-embryonated eggs. Virology 12, 499–510 (1960).PubMedGoogle Scholar
  856. H29.
    Hannoun, C.: Action of purine and pyrimidine analogues on the multiplication of influenza virus in chick embryos (French). Atti Congr. Int. Microbiol. 6th Congr. Eome 1, 431–432 (1953).Google Scholar
  857. H30.
    Hannoun, C.: Effect of conjunctival instillation of influenza virus in rabbits and mice (French). Ann. Inst. Pasteur 96, 170–177 (1959).Google Scholar
  858. H31.
    Hanson, R. J., J. E. Kempf, and A. V. Boand: Phagocytosis of influenza virus. 2. Its occurrence in normal and immune mice. J. Immunol. 79, 422–427 (1957).PubMedGoogle Scholar
  859. H32.
    Harboe, A.: The course in Norway of the influenza pandemic caused by the virus of type A/Asia/57. (Norwegian). Saertrykk Nordisk Med. 60, 1701 (1958).Google Scholar
  860. H33.
    Harboe, A.: HI antibodies in ferrets cross-infected with distantly related influenza viruses. Acta path. microbiol. scand. 57, 211–221 (1963).PubMedGoogle Scholar
  861. H34.
    Harboe, A.: The influenza virus haemagglutination inhibition by antibody to host material. Acta path. microbiol. scand. 57, 317–330 (1963).PubMedGoogle Scholar
  862. H35.
    Harboe, A.: The normal allantoic antigen which neutralises the influenza virus HI antibody to host material. Acta path. microbiol. scand. 57, 488–492 (1963).PubMedGoogle Scholar
  863. H36.
    Harboe, A., and R. Reenaas: The course of antibody development to influenza A2 strains. Acta path, microbiol. scand. 46, 266–272 (1959).Google Scholar
  864. H37.
    Harboe, A., R. Reenaas, and M. Oppedal: Studies on Francis inhibitor of influenza virus haemagglutination in rabbit serum fractions obtained by electrophoresis on starch grain. Acta path, microbiol. scand. 44, 92–105 (1958).Google Scholar
  865. H38.
    Harboe, R., F. Rost, K. Juul, and T. Madland: Percentage of individuals presenting antibody to A/Asia/57 after an influenza outbreak in a military camp in October 1957. Arch. ges. Virusforsch. 8, 446–452 (1958).Google Scholar
  866. H39.
    Hardy, P. H., and F. L. Horsfall: Eeactions between influenza virus and a component of normal allantoic fluid. J. exp. Med. 88, 463–484 (1948).PubMedCentralPubMedGoogle Scholar
  867. H40.
    Hare, R.: The effect of passive immunisation on experimental virus influenza in mice. J. Path. Bact. 49, 411–428 (1939).Google Scholar
  868. H41.
    Hare, R., and M. Curl: Adsorption of influenza virus. Canad. J. Res. 25, 43–52 (1947).PubMedGoogle Scholar
  869. H42.
    Hare, R., M. Curl, and L. McClelland: The efficiency of the red cell adsorption and elution method for the preparation of influenza vaccine. Canad. J. publ. Hlth 37, 284–291 (1941).Google Scholar
  870. H43.
    Hare, R., and D. M. Mackenzie: The standardisation of influenza vaccine by red cell agglutination and antigenic tests in mice. Canad. J. publ. Hlth 38, 141–148 (1947).Google Scholar
  871. H44.
    Hare, L., L. McClelland, and J. Morgan: A method for the concentration of influenza virus. Canad. J. publ. Hlth 33, 325–331 (1942).Google Scholar
  872. H45.
    Hare, L., and W. C. Ricken: Long-term variation in the titre of neutralising antibody for influenza virus in the sera of adults and children. J. Immunol. 40, 253–266 (1941).Google Scholar
  873. H46.
    Harford, C. G., and A. Hamlin: Effect of influenza virus on cilia and epithelial cells in the bronchi of mice. J. exp. Med. 95, 173–190 (1952).PubMedCentralPubMedGoogle Scholar
  874. H47.
    Harford, C. G., A. Hamlin, and E. Parker: Electron microscopy of early cytoplasmic changes duo to influenza virus. J. exp. Med. 101, 577–589 (1955).PubMedCentralPubMedGoogle Scholar
  875. H48.
    Harford, C. G., and M. Hara: Pulmonary oedema in influenzal pneumonia of the mouse and the relation of fluid in the lung to the inception of pneumococcal pneumonia. J. exp. Med. 91, 245–257 (1950).PubMedCentralPubMedGoogle Scholar
  876. H49.
    Harford, C. G., V. Leidler, and M. Hara: Effect of the lesion due to influenza virus on the resistance of mice to inhaled pneumococci. J. exp. Med. 89, 53–68 (1949).PubMedCentralPubMedGoogle Scholar
  877. H50.
    Harford, C. G., M.E.Smith, C. McLeod, and W. B. Wood: Infection of rats with the virus of influenza. J. Immunol. 53, 163–169 (1946).PubMedGoogle Scholar
  878. H51.
    Harris, S., and W. Henle: Lymphocytopenia in rabbits following intravenous injection of influenza virus. J. Immunol. 59, 9–20 (1948).PubMedGoogle Scholar
  879. H52.
    Hatch, L. A.: An analysis of 101 strains of influenza A virus isolated in England and Wales during the winter of 1955–56 by the laboratories of the Public Health Laboratory Service. Mth. Bull. Minist. Hlth Lab. Serv. 16, 138–141 (1957).Google Scholar
  880. H53.
    Haukenes, Gl., A. Harboe, and K. Mortensson-Egnund: A uronic and sialic acid free chick allantoic mucopolysaccharide sulphate which combines with influenza virus HI-antibody to host material. 1. Purification of the substance.Google Scholar
  881. H54.
    2. Chemical composition. Acta path. microbiol. scand. 64, 534-542 (1965) and 66. 510-518 (1966).Google Scholar
  882. H55.
    Hausen, P., H. Hausen, R. Rott, C. Scholtissek, and W.Schäfer: Early events in the reproduction cycle of animal viruses. Viruses, Nucleic acids, and Cancer. 282-295 (1963), Univ. Texas.Google Scholar
  883. H56.
    Hausler, W. J., and E.C. Dick: The purification and concentration of influenza A virus (PR8) by a method of continuous extraction with glycine of a zinc-virus precipitate. J. infect. Dis. 107, 189–194 (1960).PubMedGoogle Scholar
  884. H57.
    Haussman, H. G., W. Simrock, and L. Betz: Clinical and serological diagnosis of epidemic influenza (German). Z. klin. Med. 147, 51–72 (1950).Google Scholar
  885. H58.
    Heath, R. B., and D. A. J. Tyrrell: The behaviour of some influenza viruses in tissue cultures of kidney cells of various species. Arch. ges. Virusforsch. 8, 577–591 (1959).PubMedGoogle Scholar
  886. H59.
    Heinmetz, F.: Studies with the electron microscope on the interaction of influenza virus and red cells. J. Bact. 55, 823–831 (1948).Google Scholar
  887. H60.
    Heller, L., A. Espmark, and P. Viriden: Immunological relationship between infectious cough in horses and human influenza A. Arch. ges. Virusforsch. 7, 120–124 (1956).PubMedGoogle Scholar
  888. H61.
    Henderson, J. R., and J. E. Kempf: Intracellular proteins associated with the synthesis of the influenza A virus. Virology 9, 72–83 (1959).PubMedGoogle Scholar
  889. H62.
    Henle, G., and W. Henle: Neurological signs in mice following intracerebral inoculation of influenza viruses. Science 100, 410–411 (1944).PubMedGoogle Scholar
  890. H63.
    Henle, G., and W. Henle: Studies on the toxicity of influenza viruses. 1. The effect of intracerebral injection of influenza viruses.Google Scholar
  891. H64.
    2. The effect of intra-abdominal and intravenous injection of influenza viruses. J. exp. Med. 84, 623-637, and 639-660 (1946).Google Scholar
  892. H65.
    Henle, G., A. Girardi, and W. Henle: A non-transmissible cytopathogenic effect of influenza virus in tissue culture accompanied by formation of noninfectious haemagglutinins. J. exp. Med. 101, 25–41 (1955).PubMedCentralPubMedGoogle Scholar
  893. H66.
    Henle, W.: Studies on host-virus interaction in the chick embryo influenza virus system. 1. adsorption and recovery of seed virus.Google Scholar
  894. H67.
    2. The propagation of virus in conjunction with the host cells.Google Scholar
  895. H68.
    3. Development of infectivity, haemagglutination, and complement fixation activities during the first infectious cycle. J. exp. Med. 90, 1-11, 13-22, and 23-37 (1949).Google Scholar
  896. H69.
    Henle, W.: Interference phenomena between animal viruses. A review. J. Immunol. 64, 203–236 (1950).Google Scholar
  897. H70.
    Henle, W.: Status of vaccination against influenza. Mod. Med. 75-81 (1955).Google Scholar
  898. H71.
    Henle, W.: The use of phosphorus 32 in the study of incomplete forms of influenza virus. Trans. N.Y. Acad. Sci. 18, 255–260 (1956).PubMedGoogle Scholar
  899. H72.
    Henle, W.: Persistent infection of L cell cultures by myxoviruses. Ciba Found. Symp. “Cellular biology of myxovirus infections” 299-316 (1964).Google Scholar
  900. H73.
    Henle, W., and L. A. Chambers: The serological activity of extra embryonic fluids of chick infected with virus of influenza A. Proc. Soc. exp. Biol. (N.Y.) 46, 713–717 (1941).Google Scholar
  901. H74.
    Henle, W., and G. Henle: Interference of inactive virus with the propagation of the virus of influenza. Science 98, 87–89 (1943).PubMedGoogle Scholar
  902. H75.
    Henle, W., and G. Henle: Interference between inactive and active viruses of influenza. 1. The incidental occurrence and artificial induction of the phenomenon.Google Scholar
  903. H76.
    2. Factors influencing the phenomenon. Amer. J. med. Sci. 207, 705-717 and 717-733 (1944).Google Scholar
  904. H77.
    3. Cross-interference between various related and unrelated viruses.Google Scholar
  905. H78.
    4. The nature of the interfering agent. Amer. J. med. Sci. 210, 362-369 and 369-374 (1945).Google Scholar
  906. H79.
    Henle, W., and G. Henle: The toxicity of influenza viruses. Science 102, 398–400 (1945).PubMedGoogle Scholar
  907. H80.
    Henle, W., and G. Henle: Effects of adjuvants on vaccination of human beings against influenza. Proc. Soc. exp. Biol. (N.Y.) 59, 179–181 (1945).Google Scholar
  908. H81.
    Henle, W., and G. Henle: The effect of ultraviolet irradiation on various properties of influenza viruses. J. exp. Med. 85, 347–364 (1947).PubMedCentralPubMedGoogle Scholar
  909. H82.
    Henle, W., and G. Henle: Studies on the toxicity of influenza viruses. 3. Immunisation of mice against the toxic effects of influenza virus A. A new potency test for the assay of vaccines of influenza virus. J. Immunol. 59, 45–58 (1948).PubMedGoogle Scholar
  910. H83.
    Henle, W., G. Henle, F. Deinhardt, and V. V. Bergs: Studies on persistent infections of tissue cultures. 4. Evidence for the production of an interferon in MCN cells by myxoviruses. J. exp. Med. 110, 525–541 (1959).PubMedCentralPubMedGoogle Scholar
  911. H84.
    Henle, W., and G. Henle, V. Groupe, and L. A. Chambers: Studies on complement fixation with the viruses of influenza. J. Immunol. 48, 163–180 (1944).Google Scholar
  912. H85.
    Henle, W., G. Henle, B. Hampill, E. D. Maris, and J. Stokes: Experiments on vaccination of human beings against epidemic influenza. J. Immunol. 53, 75–93 (1946).PubMedGoogle Scholar
  913. H86.
    Henle, W., G. Henle, and M. W. Kirber: Interference between inactive and active viruses of influenza. 5. Effect of irradiated virus on the host cells. Amer. J. med. Sci. 214, 529–541 (1947).PubMedGoogle Scholar
  914. H87.
    Henle, W., G. Henle, and E. B. Rosenberg: The demonstration of one-step growth curves of influenza virus through the blocking effect of irradiated virus on further infection. J. exp. Med. 86, 423–437 (1947).PubMedCentralPubMedGoogle Scholar
  915. H88.
    Henle, W., G. Henle, J. Stokes, and E. P. Maris: Experimental exposure of human subjects to the viruses of influenza. J. Immunol. 52, 145–165 (1946).PubMedGoogle Scholar
  916. H89.
    Henle, W., and P. S. Lief: Antigenic analysis of influenza viruses by complement fixation. 4. Strain-specific V antigens in the serodiagnosis of influenza. J. Immunol. 84, 491–500 (1960).PubMedGoogle Scholar
  917. H90.
    Henle, W., F. S. Lief, and A. Pabiyi: Strain specific complement fixation test in antigenic analysis and serodiagnosis of influenza. Lancet 818-820 (1958).Google Scholar
  918. H91.
    Henle, W., and O. C. Liu: Studies on host-virus interactions in the chick embryo influenza virus system. J. exp. Med. 94, 305–322 (1951).PubMedCentralPubMedGoogle Scholar
  919. H92.
    Henle, W., O. C. Liu, and N. B. Pinter: Studies on host-virus interactions in the chick embryo influenza virus system. 9. The period of liberation of virus from infected cells. J. exp. Med. 100, 53–70 (1954).PubMedCentralPubMedGoogle Scholar
  920. H93.
    Henle, W., O. C. Liu, K. Paucker, and F.S. Lief: Studies on host-virus interactions in the chick embryo influenza virus system. 4. The relation between tissue bound and liberated virus materials under various conditions of infection. J. exp. Med. 103, 799–822 (1956).PubMedCentralPubMedGoogle Scholar
  921. H94.
    Henle, W., and K. Paucker: Interference between inactivated and active influenza viruses in the chick embryo. 1. A re-evaluation of factors of dosage and timing using infectivity titrations for assay. Virology 6. 181–197 (1958).PubMedGoogle Scholar
  922. H95.
    Henle, W., and E. B. Rosenberg: One-step growth curves of various strains of influenza A and B viruses and their inhibition by inactivated virus of the homologous type. J. exp. Med. 89, 279–285 (1949).PubMedCentralPubMedGoogle Scholar
  923. H96.
    Henle, W., and M. Wiener: Complement fixation antigens of influenza viruses types A and B. Proc. Soc. exp. Biol. (N.Y.) 57, 176–179 (1944).Google Scholar
  924. H97.
    Hennessen, W. A.: Antigenic analysis of influenza B strains isolated in 1952. Bull. Wld Hlth Org. 6, 481–485 (1952).Google Scholar
  925. H98.
    Hennessy, A. V.: Prevention of influenza by vaccination in infants and children. Quart. Rev. Pediat. 17, 91–94 (1962).PubMedGoogle Scholar
  926. H99.
    Hennessy, A. V., and F.M. Davenport: Epidemiologic implications of the distribution by age of antibody response to experimental influenza virus vaccines. J. Immunol. 80, 114–121 (1958).PubMedGoogle Scholar
  927. H100.
    Hennessy, A. V., and F.M. Davenport: Relative merits of aqueous and adjuvant influenza vaccines when used in a two-dose schedule. Publ. Hlth Rep. (Wash.) 76, 411–419 (1961).Google Scholar
  928. H101.
    Hennessy, A. V., and F.M. Davenport: Eelative antigenic potency in man of polyvalent influenza virus vaccines containing isolated haemagglutinins or intact viruses. J. Immunol. 97, 235–238 (1966).PubMedGoogle Scholar
  929. H102.
    Hennessy, A. V., F.M. Davenport, and T. Francis: Studies of antibodies to strains of influenza virus in persons of different ages in sera collected in a postepidemic period. J. Immunol. 75, 401–409 (1955).PubMedGoogle Scholar
  930. H103.
    Hennessy, A. V., F. M. Davenport, R. J. M. Horton, J. A. Napier, and T. Francis: Asian influenza. Occurrence and recurrence, a community and family study. Milit. Medicine 129, 38–50 (1964).Google Scholar
  931. H104.
    Hennessy, A. V., E. Minuse, and F.M. Davenport: A twenty-one-year experience with antigenic variation among influenza B viruses. J. Immunol 94, 301–306 (1965).PubMedGoogle Scholar
  932. H105.
    Hennessy, A. V., E. Minuse, F.M. Davenport, and T. Francis: An experience with vaccination against influenza B in 1952 by use of monovalent vaccine. Amer. J. Hyg. 58, 165–173 (1953).PubMedGoogle Scholar
  933. H106.
    Henry, C., and J. S. Younger: Influence of normal animal sera on influenza viruses in cultures of trypsin-dispersed monkey kidney cells. J. Immunol. 78, 214–221 (1957).Google Scholar
  934. H107.
    Hers, J. F. P.: The histopathology of the respiratory tract in human influenza. H. Stenpert Kroese, Leiden (1955).Google Scholar
  935. H108.
    Hers, J. F. P., and J. Mulder: Rapid tentative post-mortem diagnosis of influenza with the aid of cytological smears of the tracheal epithelium. J. Path. Bact. 43, 329–332 (1951).Google Scholar
  936. H109.
    Herzberg, K., G. May, and H. Beck: Immunity in influenza. 1. Behaviour of the PR8 and FM1 strains. Z. Immun.-Forsch. 112, 409–419 (1955).Google Scholar
  937. H110.
    Herzberg, K., G. May, and H. Beck: The isolation of seven strains of influenza virus from the epidemic of 1955 (German). Z. Hyg. Infekt.-Kr. 142, 1–14 (1955).Google Scholar
  938. H111.
    Heymann, H., Z. R. Gulick, C. J. De Boer, G. Stevens, and R.L. Mayer: The inhibition of ribonuclease by acidic polymers and their use as possible antiviral agents. Arch. Biochem. 73, 366–383 (1958).PubMedGoogle Scholar
  939. H112.
    Hildebrandt, H. M., H. F. Maassab, and P. W.Willis: Influenza virus pericarditis. Amer. J. Dis. Child. 104, 579–582 (1962).PubMedGoogle Scholar
  940. H113.
    Hilleman, M. R.: System for measuring and designating antigenic components of influenza viruses with analyses of recently isolated strains. Proc. Soc. exp. Biol. (N.Y.) 78, 208–215 (1951).Google Scholar
  941. H114.
    Hilleman, M. R.: A pattern of antigenic variation. Fed. Proc. 11, 798–803 (1952).PubMedGoogle Scholar
  942. H115.
    Hilleman, M. R., E. L. Buescher, and J. E. Smadel: Preparation of dried antigen and antiserum for the agglutination inhibition test for virus influenza. Publ. Hlth Rep. (Wash.) 66, 1195–1203 (1951).Google Scholar
  943. H116.
    Hilleman, M. R., F. J. Flatley, S. A. Anderson, H. L. Luecking, and D. J. Levinson: Distribution and significance of Asian and other influenza antibodies in the human population. New Engl. J. Med. 258, 969–974 (1958).PubMedGoogle Scholar
  944. H117.
    Hilleman, M. R., and F. L. Horsfall: Comparison of the antigenic patterns of influenza A virus strains determined by in ovo neutralisation and haemagglutination-inhibition. J. Immunol. 69, 343–356 (1952).PubMedGoogle Scholar
  945. H118.
    Hilleman, M. R., R. P. Mason, and E. L. Buescher: Antigenic pattern of strains of influenza A and B. Proc. Soc. exp. Biol. (N.Y.) 75, 829–835 (1950).Google Scholar
  946. H119.
    Hilleman, M. R., R. P. Mason, and N. G. Rogers: Laboratory studies on the 1950 outbreak of influenza. Publ. Hlth Rep. (Wash.) 65, 771–777 (1950).Google Scholar
  947. H120.
    Hilleman, M. R., and J. H. Werner: Influence of non-specific inhibitor on the diagnostic haemagglutination-inhibition test for influenza. J. Immunol. 71, 110–117 (1953).PubMedGoogle Scholar
  948. H121.
    Himmelweit, F.: Influenza B virus isolated from a fatal case of pneumonia. Lancet 793-794 (1943).Google Scholar
  949. H122.
    Hinz, R. W., and J. T. Syverton: Mammalian cell cultures for study of influenza viruses. 1. Preparation of monolayer cultures with collagenase.Google Scholar
  950. H123.
    2. Virus propagation. Proc. Soc. exp. Biol. (N.Y.) 101, 19-22, and 22-26 (1959).Google Scholar
  951. H124.
    Hirsch, A.: Handbook of geographical and historical pathology. The New Sydenham Society. London Vol. 1 (1883).Google Scholar
  952. H125.
    Hirst, G. K.: Agglutination of red cells by allantoic fluid of chick embryos infected with influenza virus. Science 94, 22–23 (1941).PubMedGoogle Scholar
  953. H126.
    Hirst, G. K.: The quantitative determination of influenza virus and antibodies by means of red cell agglutination. J. exp. Med. 75, 47–64 (1942).Google Scholar
  954. H127.
    Hirst, G. K.: In ovo titrations of influenza virus and of neutralising antibodies in chick embryos. J. Immunol. 45, 285–292 (1942).